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Summary
Little is known about the importance of mycoplasmas in equine 
respiratory disease, and this project was undertaken to investigate the 
occurrence of mycoplasma antibody in horses.
Two mycoplasmas, M.equirhinis and an unnamed species, N3» were 
selected from 13 strains recently isolated from the nasopharynx of 
horses. Immunization of rabbits and horses resulted in the develop­
ment of specific antibody. Complement-fixation (CF) was found to be 
more sensitive than metabolic-inhibition and growth-inhibition for the 
detection of antibody in equine hyperimmune sera, and this method was 
used for ithe survey of antibody in other horses. .
Six ponies were chosen which were apparently free of mycoplasmas, 
without CF antibody to M.equirhinis and with low levels to N3. Two 
were ..inoculated intranasally with M.equirhinis, two with N3 and two 
remained as controls. N3 was not recovered from any pony, but within 
five days M.equirhinis was recovered from every animal, indicating that 
it had spread naturally from the inoculated ponies to the others.
After six weeks it became difficult to isolate the organisms, and levels 
of CF antibody rose first in the nasal secretions and later in the sera. 
After several weeks antibody declined to indetectable levels. Ho 
clinical signs of infection were seen.
In a survey of 817 sera taken over one 'Jrear from 85 racehorses in 
seven stables, every horse was found to have CF antibody to M.equirhinis 
and N3 at some time during the sampling period. In five stables most 
horses had no M.equirhinis antibody when they entered the stable, but 
within two months they invariably developed significant titres, implying 
that they had been infected. When compared with a survey of 256 sera 
from 81 horses completed two years previously, it appeared that Jantibody 
to-both mycoplasmas was more prevalent in the recent survey.
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Introduction
Equine Mycoplasmas
Mycoplasmas have been isolated from a diverse range of'animals, (Hayflick 
1969) and have been the subject of many studies, especially where the 
organisms are suspected of pathogenic activity to hosts of economic import­
ance, e.g. men, cattle, sheep, pigs and poultry (Sharp 1970 > Whittlestone 
1972a). Although horses are now kept almost entirely for pleasure, it is 
rather surprising that there have been few attempts to isolate mycoplasmas 
from horses and other Equidae.
The first mycoplasma isolation from a horse was reported by Beller (1944) 
in Germany and in i960 Ito in Japan reported the isolation of Acholeplasmas 
from the equine respiratory and genital tracts, but very few workers 
concerned with equine respiratory disease appear to have considered myco­
plasmas as possible etiological agents. Hoyt (1963) mentions briefly that
organisms resembling mycoplasmas were considered as a cause of pneumonia by
/ V"earlier workers, but that this was/soon discounted.
A.
McChesney et al (l97p) and Saxegaard et al (l97l) looked for mycoplasmas 
in the tissues of foals which had died from respiratory disease. None were 
detected; an adenovirus infection and a Bordetella bronchiseptica infection 
were implicated in the above two cases.
A positive report of mycoplasma isolations from American horses appeared 
in 1972 (Bellinger and Jasper). Three strains were described, two from the 
nasal passages of working horses with a pneumonia-like condition and one 
from a debilitating joint condition in a yomig thoroughbred colt. No 
information was given about the nutritional requirements or characterization 
of the organisms; but proteins extracted from these cultures and subjected 
to polyacrylamide-gel electrophoresis analysis gave three different patterns, 
unlike any of the nine bovine strains to which they were compared.
In the same year Kirchhoff et al (1972) studied a large group of German
horses and isolated 9 mycoplasmas from the pharynx and gutteral pouches of 
horses most of which were suffering from acute febrile respiratory disease. 
The mycoplasmas were tested for antibiotic sensitivity, but not otherwise 
characterized. In 197-4 Kirchhoff reported the isolation and characteri­
zation of 50 strains, 19 from the respiratory tract, 18 from the cervix :and 
13 from aborted foetuses. Seven strains, (including 2 from the respira­
tory tract) were identified as A.laidlawii but the rest, which fell into 5 
groups, were considered to be new species and were termed M.equipharyngis, 
(the remaining 17 respiratory tract isolates were of this type), M.equi- 
genitale, A.hippikon and A.equifoetale. The fifth type, able to utilize 
urea, was not named.
Frey et al (1973) commented that they had isolated several mycoplasmas 
from horses, but no details were reported. Allan et al(l973) surveyed 
278 animals from ioany types of stable in various locations in England. A 
total of 9 Mycoplasma and Acholeplasma strains were cultured from naso­
pharyngeal swabs from 2 of healthy horses and Gfo of horses showing clinical 
symptoms of respiratory disease. The isolates were thought to include at 
least 6 different species, among which were A.laidlawii and A.oculi, 
(formerly A.oculusi, Allam and Lemcke 1975)* The remaining isolates were 
mycoplasmas, 3 arginine-metabolizing and 4 glucose-metabolizing strains. 
Growth inhibition (G.I.) tests indicated that the 3 arginine-metabolizing 
isolates were identical, but of a species which had not previously been 
described. The other strains were not yet characterized, but fell into 
at least 3 different types.
More recently these workers, (Allam and Lemcke 1975) using trachea 
swabs from 21 freshly-slaughtered horses as well as continued samples from 
the previous groups, have increased the number of isolates to 16, two of 
which were from the trachea swabs. Eleven of the isolates were from 
horses with acute respiratory disease.
Windsor (1973) using duplicate swabs from the same freshly-slaughtered 
horses as Allam and Lemcke used in part of their study, obtained 7 isolates. 
All Mycoplasma and Acholeplasma isolates from these horses were characterized 
by Allam and Lemcke (1975) and the 23 isolates formed 7 distinct groups; 
A.laidlawii (2 isolates),- A.oculi, an unidentified Acholeplasma species*(2 
isolates), M.pulmonis type (3 isolates), M.felis type (9 isolates), N3 type 
(2 isolates) and the new arginine-metabolizing strains, now named M.equi­
rhinis (4 isolates). Kirchhoff!s nM.equipharyngis" was also character­
ized by Allam and Lemcke, and this organism was found to belong to the 
M.felis type.
Of the 7 groups, only M.pulmonis and the N3 type were found exclusively 
in animals with acute respiratory disease.
Ogata et al (1974) in Japan has reported the isolation of 102 
Acholeplasma strains and 8 Mycoplasma strains from 26 healthy horses sampled 
just after slaughter. Samples were taken from the respiratory and uro­
genital tracts and 30i° of the swabs were positive. The Mycoplasma strains 
and 7 of the Acholeplasmas were not typed, but the remaining 95 Acholeplasmas 
fell into 5 serological groups, -A.laidlawii (76/95)> A.granularum (l/95)> 
A.axanthum (l/95) nnd two other distinct types, (13/95 and 4/95 respectively). 
The high percentage of Acholeplasmas isolated may have been due to the method 
used; swabs were streaked directly onto agar plates which were incubated 
aerobically. If parallel incubation in an.atmosphere with increased carbon 
dioxide and decreased oxygen had been tried, some of the more fastidious 
mycoplasma species might have been revealed.
Moorthy and Spradbrow (1976) reported the isolation of mycoplasmas 
from the respiratory tract of horses in Australia. The isolation rates 
were low; only 2 organisms were recovered from 43 nasal swabs and 1 organism 
from 28 trachea swabs (from slaughtered horses). The strains, some of 
which were probably mixed, were not characterized beyond comparing the
colony morphology, haemolytic activity and a few biochemical tests with 
descriptions of Kirchhoff’s (1974) strains, (also uncharacterized).
Poland and Lemcke (1976) described a new type of mycoplasma which 
may turn out to be a common inhabitant of the equine nasopharynx. Eight 
strains of a slow-glucose-metabolizing (SGM) mycoplasma were recovered 
from healthy racehorses. Metabolic-inhibiting antibody to this mycoplasma 
was subsequently found in several horses in the stables from which the SGM 
had been isolated. Inoculation of the mycoplasma into 2 minimal-disease 
foals elicited an antibody response and the organism was recoverable for 
7 weeks after inoculation, but there were no clinical symptoms.
A bovine mycoplasma, M .bovigenitalium was recovered by Langford (1974) 
from the lung of a foetus obtained as a result of a mysterious epizootic 
of abortions affecting 8 mares in one bam in America. Kirchhoff et al 
(1976) also investigated the occurrence of mycoplasmas in aborted foals. 
From the lungs of 196 foetuses, 10 Acholeplasmas and 3 Mycoplasmas were 
recovered. A similar isolation rate was obtained in mares as 21 strains 
were obtained from 404 cervical swabs*
Thus the amount of information on equine mycoplasmas is gradually 
increasing, and it seems probable that several Mycoplasma and Acholeplasma 
species are present in the respiratory and urogenital tracts as part of the 
normal microbial flora of horses. Ogata et al (1974) indicated that their 
Acholeplasma species were non-pathogenic, but Kirchhoff et al (1972) and 
Allam et al (1973) obtained higher isolation rates from sick horses. In 
all these reports, however, the extent of the involvement of mycoplasmas 
in disease was not clear and requires further investigation.
Equine Respiratory Diseases
History.
A fascinating guide to the history of equine respiratory disease 
is given by Flemming (l87l) in an extensive review of animal plagues 
covering many centuries. Numerous cases are documented, some well 
enough to allow a retrospective diagnosis.
The earliest account cited is that of Apsyrtos in A.D. 400* "The 
horse is sick of fever, hangs his head heavily as if immovable, the 
eyes are swollen, he can scarcely open them. Lips and body are 
flaccid, breath and body have burning heat. He fixes his limbs, is ' 
insensible to blows and when compelled to walk often falls. The 
horse abhors food and only cares to drink. If the disease increases 
in intensity, he dies in three days”.
An outbreak of disease described by Arab horse doctors in Yemen 
in 1328 was regarded by Flemming as influenza.
From the seventeenth century onwards there were many reports of 
influenza outbreaks in Europe. In 1648 an outbreak in French army 
horses stationed in Germany was characterized by "a fever, tears 
running from their eyes, abundant green mucus from their nostrils, 
cold ears, loss of appetite and death".
The 1688 epidemic caused thousands, of deaths. Its onset was
sudden, followed by nasal discharge and collapse. Non-fatal catarrhal
outbreaks were also common, the years 1647> 1693 and 1699 being particu­
larly noted.
In 1727 a coughing disease occurred in the Midlands in November 
and by December it had reached Dublin. These horses, some of which 
died, were "weak and short of breath, had sore throats, nose bleeds 
and large discharge of thick phlegm from the nose". By Christmas
the horses were recovering, but "coughing and sore throats siezed 
mankind in Dublin". Again in 1732 it was noted that the horses were 
"siezed with catarrh before mankind".
There is a splendid description of an outbreak in 1732* "A very 
remarkable distemper among horses in London.... .Many (the horses) were 
afraid of a mortality coming among them, and indeed the only good sign 
they had was the vehemence of their cough, that both kept their blood
in motion and speedily set them a-running at the nose and
continued in so profuse a manner for five or six days that some of 
them discharged as much as two or three pails would hold of purulent 
matter, which however was generally of a laudable colour and good 
consistence u
Surprisingly, all these horses seemed to recover with no ill 
effects. It was also noted that "the horses which chiefly escaped 
the distemper were those that had been kept in constant strong exercise 
or full-aged old horses, many of which were in no ways infected though 
very much exposed to it."
Strangles, also kncwn as morbus anginosus, was first written of 
in 1731» it was common in that year, and killed many horses.
Irish horses were very ill in the mid-eighteenth century, and it 
was reported that "since the epizooty of 1750 > ihe disease has been 
widespread, affecting all types and ages of horses throughout that 
and the following year". A fatal "plague amongst horses" occurred 
in Austria in 1755. Animals had a suffocating catarrh, and 
inflammation of the lungs which generally killed them. Outbreaks of 
respiratory disease were regularly reported with notable epidemics 
cropping up in Scotland and London 1758 > England I76O and 17&2,
Sweden and Denmark 1762. An outbreak started in China in 1781, and 
travelled through Asia reaching Moscow in 1781, Prussia, Germany and
Denmark in 1782 and then to Spain and Italy. In 1783 it spread to 
England and America where it was fatal to horses and also apparently 
to homed cattle. Influenza was prevalent in England at that period, 
and Darwin, cited by Flemming, commented that "catarrhos .contagiosos” 
was a frequent disease amongst horses and dogs. He hypothesized that 
the spread of the disease was due to miasmata diffused in the atmos­
phere because so many of the animals received it at the same time, and
i
also the epidemics occurred more frequently and with greater fatality 
amongst horses and dogs than amongst men, because the animals had 
larger nostrils and thus more mucous membrane available for attack.
Other bad epidemics were in 1803? when horses, cattle, cats and 
dogs were reported to be struck by a similar distemper, and in 1805• 
After this, the disease was extensively described; and horse influenza 
became a specific diagnosis. The last epidemic of any size was in 
America in the winter of 1872-73 > when there was no traffic in the 
large cities as no healthy horses could be found. Doll (1963) 
attributed this and many subsequent epizootics to equine arteritis 
virus, but others have considered this outbreak to be caused by a 
true influenza virus (Gerber 1970).
Bryans (1964) described a type of ’flu that was common in the 
early twentieth century. In Germany it was known as rotlautseuche, 
or influenzae erysipelatosa; in England it was called typhoid fever 
or the epizootic cellulitis-pinkeye syndrome. In 1908 the disease 
was proved transmissible by inoculation of infected blood, and during 
World War 1 the Germans took advantage of this observation by 
deliberately infecting their chargers with diseased blood to render 
them immune by the time they were used in action.
Equine .diseases were much remarked on in this period, undoubtedly 
because of the economic importance of the horse. Remedies were
rather drastic, involving bleeding and administering curious 
medicines; they were generally unsuccessful.
The respiratory tract has a rather limited response to foreign 
bodies so that a wide range of biological agents, chemical irritants 
and allergens may produce symptoms and lesions that are similar in 
character. Up to about I960, several respiratory diseases were 
labelled "influenza". A group of diseases had similar clinical 
symptoms and to add to the confusion 2 viruses causing abortion in 
mares were found to be identical to 2 respiratory viruses However, 
since the isolation from horses of true influenza viruses, (Sovinova 
et al 1958? Waddell et al 1963), the etiology of equine viral 
respiratory diseases has become clearer.
Table 1 lists several types of respiratory disease, the most 
important of which will be discussed further. The agents of 
uncertain pathogenicity undoubtedly contribute to respiratory 
illness, but more information is required to assess their importance. 
Mixed infections are also likely to be responsible for many cases of 
respiratory disease in which no obvious pathogens can be implicated 
but there has been almost no research in this field, because of the 
complexity of the problem presented by an illness caused by two or 
more agents.
Equine Influenza.
The isolation of a true influenza virus, A. Equi 1 / Prague/56, 
from horses (Sovinova et al 1958? Tumova and Sovinova 1959) made it 
logical for the term "equine influenza" to be restricted to diseases 
caused only by this type of virus.
A.Equi l/Prague 56 was responsible for an epidemic which started 
in Sweden in 1955 and spread to Germany and East Europe; it 
eventually reached England in 1963 (Beveridge et al 19^5)• However
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serological studies indicated that the virus had been present in 
England for many years as sera collected in 1948 had- antibody to 
A. Equi 1. In retrospect, outbreaks of respiratory disease in 1935 > 
1947> 1955 and 1959 were probably influenza. A second influenza 
virus, A. Equi' 2/Miami/l/63, was isolated in America by Waddell et 
al (I963) and there is no evidence for the existence of this 
serotype before this date (Gerber 1970). The A. Equi 2 virus was 
responsible for many recent outbreaks of equine 'flu in America, 
(Knowles and King 1963>' McQueen 1966a); in France, (Brion et al 1966); 
in England,(Rose, 196-5, 1966;) and throughout Europe, (Gerber 1970).
Equine influenza is an acute febrile disease involving serous 
rhinitis, conjunctivitis, apathy, fatigue, muscular soreness and 
stiffness, edema of the legs and loss of appetite. Body 
temperature may rise to 41°C, (normal is approximately 38°0)> and 
the uncomplicated fever may last from 2 - 10 days. Symptoms 
start with a dry cougb which becomes moist and is accompanied by 
a mucinous or mucopurulent nasal discharge. The trachea is 
usually inflamed and the disease is mainly localized in the lower 
respiratory tract. A.Equi 2 tends to cause the more severe 
disease (Gerber 1970), but fatalities are rare from uncomplicated 
cases which, with complete rest, resolve in 1 - 3 weeks; however 
if the horse is worked when ill, secondary infection may give rise 
to bronchitis, pneumonia and pleurisy, (Steele, I960’, McQueen et 
al 1966b).
A serological survey by Kaplan and Payne (1959) showed the 
presence of antibodies to human-type A influenza in horse sera from 
many countries and similar types of virus have been isolated from both 
humans and horses (Domracheva 1961, Marois et al 1963)* Humans were 
first experimentally infected with equine 'flu by Kasel et al (19^5)
and later ponies were infected wi’th human 'flu (Kasel and Couch 1969). 
Clinical illness was produced and antibody developed in humans and 
horses, although clinical symptoms were more frequent in the humans.
In addition, over half of the humans inoculated with A/Equi2/Miami 63 
also showed antibody rises to the human strain A2/Hongkong 68, and 
challenge with the human strain showed that the humans had acquired 
some degree of protection from immunization with the equine virus. To 
a lesser extent, the cross-immunization effect was also observed in 
the ponies. This protection gained from a different strain of the 
virus is unusual since in naturally occurring equine outbreaks no 
cross-immunity exists between the influenza subtypes (Powell 1975)•
Todd et al (1970) in similar experiments, inoculated ponies with 
A2/Hongkong 68 and obtained a significant antibody rise to the Hongkong 
virus, to A Equi 2 virus and in one case to A.Equi 1 virus also. In 
these experiments, only the operator administering the inoculations . 
exhibited clinical symptoms of influenza!
The two serological types of equine influenza appear to co-exist 
in nature and epidemiological studies have been carried out by Bryans 
(1964)» Bryans et al (l967)> McQueen et al (1968) and Gerber (1970)* 
Outbreaks have occurred throughout Europe, America and Asia, and 
serological surveys indicate that the virus is present in most other 
countries, Australia being a notable exception (Lewis 1969).
The disease has a short incubation period of 1 - 5 days and is 
transmitted between horses in close contact by aerosols formed by 
coughing. In a susceptible population, the disease appears explo­
sively affecting animals of all ages; in a partially immune popu­
lation sporadic outbreaks occur. Immunity may last for several 
years and therefore in endemic areas the disease is primarily seen
in young horses. Rouse and Ditchfield (1970) experimentally 
infected ponies with A Equi 2 and found that animals with a serum 
haemagglutination inhibition titre of I/40 or more were resistant 
to further challenge. The ponies also had detectable nasal antibody. 
Bivalent (A Equi 1 and A Equi 2) vaccination with inactivated viruses 
gives adequate protection for about 6 months (Kemen 1975) "but very 
little information about the efficacy of influenza vaccine is 
available as no large scale controlled trials have been done; it 
appears, however, that horses vaccinated in England in 1973 were 
protected during the widespread outbreak in that year (Powell 1975)* 
There is some evidence that antigenic drift may be occurring (Pereira 
et al 1972, Powell et al 1974b, Rose et al 1974) i*1 both the Al and 
A2 subtypes, but so far the changes have been minor and within each 
subtype the viruses are still cross-immunogenic.
Equine Viral Rhinopneumonitis.
This disease was first investigated in America as equine virus 
abortion in Kentucky (Dimock 1940) and as equine 'flu in Virginia 
(Jones and Maurer 1942). The first association of the abortions 
with the respiratory disease was made in Hungary by Manninger and 
Csontos (l94l)« Doll and Kinter (1954) found the abortion virus to 
be identical with the 'flu virus and later they suggested that this 
virus should be referred to as the equine rhinopneumonitis virus to 
avoid confusion with the two old names, and clearly differentiate it 
from the equine arteritis virus which has similar clinical symptoms 
(Doll et al 1957a). The term ’’influenza" was dropped, as these 
viruses did not resemble the human and swine influenza viruses. The
rhinopneumonitis virus was later classified as equine .herpes virus 
type 1 (EHVl) (Tajima et al 1961, Plummer and Waterson 1963).
Doll (1961) and Doll and Bryans (1963a) have described the disease
in detail. Acute rhinopneumonitis infections are characterized by
fever, leucopenia, catarrhal inflammation of the respiratory tract
and a serous discharge from the nose. The temperature of the
o
animal may reach 41 C an(l the fever, sometimes of a diphasic nature, 
lasts for 1 - 7  days in uncomplicated cases. The disease can be 
mild and asymptomatic, but if the animal is worked or stressed while 
harbouring a rhinopneumonitis infection, secondary infection 
invariably follows which may lead to persistent coughing, pneumonia 
pleuritis, enteritis and diarrhoea. Re-infection can occur at 
intervals of as little as three months and while these are normally 
harmless and asymptomatic attacks in adult working or breeding 
horses, the long term effect on a young (l - 4 years) racehorse in 
training has not been investigated.
Abortion is a serious consequence of this disease, which may occur 
at any time from the fifth month of gestation to full term (eleven 
months), and is usually uncomplicated. Abortion seems to take place 
independently of the disease of the mare, i.e. it can be 3 weeks to 
4 months after the mare has shown respiratory symptoms. Barely, a 
mare carrying a virus-infected foetus may become paralysed. Sometimes 
she will recover if abortion occurs or is induced in the early stages 
of the paralysis, which is characterized by incoordination of the hind 
limbs. Saxegaard (1966), Bitsch and Dam (1971) Jackson and 
Kendrick (l97l) investigated the paralytic syndrome more fully.
The uncomplicated disease is not fatal in adult horses, but 
experimentally infected and killed animals may show edematous lesions 
of respiratory lymph nodes. Lesions in aborted foetuses include 
edema of the lungs, excessive fluid in the pleural cavity and necrosis 
of the liver.
Rhinopneumonitis occurs enzootically on breeding farms in America 
many of which have yearly outbreaks in the Autumn. The disease has 
a short incubation period (Kemen 1975) spreads rapidly by direct
contact, fomites and aerosolized secretions» all horses on a farm being 
infected within a few days. Some horses are carriers, which enables 
the infection to become widely distributed at sales, race meetings and 
studs etc. Horses may show immunity after natural or experimental 
infection, but this is short-lived and the foetus can be invaded with 
virus and aborted while the mare shows high levels of neutralizing 
antibody. Bepeated infections in a young horse eventually lead to a 
serviceable immunity from the respiratory illness and a course of 
planned infections was the recommended way of controlling the disease 
(Doll and Bryans 1963b, Bryans 1964) despite the risk of occasional 
abortions. A safe cell culture-adapted modified live vaccine is now 
favoured (Kemen 1975) but protection only lasts for a few months.
Burrows (l969) has shown that the virus is common in Britain and 
Ireland, and surveys by Matumoto et al (1965) and Bagust (l97l) show 
world-wide distribution of the infection although some areas seem to 
be free of the abortigenie form of rhinopneumonitis (Coggins and Kemen 
1975) Further studies on equine rhinopneumonitis have been reported 
by Searl (1967), Lewis (1969), Studdert et al (1970) and Turner et al
(1970).
Equine Viral Arteritis.
Doll et al (1957a) first isolated the virus causing equine 
arteritis from an aborted foetus in 1953* The foetus was one of several 
on a single farm where many horses also had symptoms of influenza. The
arteritis virus was differentiated from the commoner equine rhino­
pneumonitis virus and this group of workers further characterized the 
arteritis virus and its effects on horses, (Bryans et al 1957, Jones
et al 1957, Loll et al 1957b, Loll 1961, Loll 1963, Bryans 1964)- 
Some cases previously described as epizootic cellulitis, pinkeye, 
shipping fever and distemper were probably caused by the arteritis 
virus which has recently been found to have the characteristics of a 
togavirus (Coggins and Kemen 1975)*
Pathological studies revealed that the specific lesion caused by 
the virus is a degeneration and necrosis of the media of small 
muscular arteries, occurring in all parts of the body, which lead to 
other symptoms. The disease starts as a fever lasting 3 - 7 days 
and can be accompanied by leucopenia, nasal discharge, photophobia, 
conjunctivitis, edema of the eyelids and legs, loss of appetite, 
dyspnea., colic, diarrhoea, dehydration, depression and weakness. 
Lesions are primarily edematous and occur.in the lungs, mediastinal 
tissue, mesentery, intestines and uterus. The pleural and peri­
toneal cavities may contain several gallons of a serom-like fluid 
and hemorrages occur on all serous and most mucosal surfaces. 
Experiments carried out by McCollum et al (1971) showed that after 
infection by inhalation, the virus first attacked the luhg cells, 
then the bronchial lymph nodes and from there it passed into the 
circulatory system and was widely distributed in the body within 
3 dp,ys. Under experimental conditions 30^ - 50^ of cases are fatal, 
the worst affected animals being those -which are young, old or in 
poor condition. However, mortality is negligible in natural out­
breaks, respiratory symptoms are uncommon and the mare may just 
show a slight fever (Rooney 1969). The severe loss is from abortion 
which occurs in 80/ of the mares shortly after the signs of infection. 
Aborted foetuses are commonly decomposed and have no specific lesions 
but the vims is readily recoverable from their tissues (Boll 1963).
Inapparent infection is frequent and the virus can be isolated
from 75$ - 85$ of adult horses in certain areas (McCollum and Bryans 1975) 
The virus is spread by inhalation of infective particles, direct contact 
or through the semen of infected stallions. The incubation period is 
from 2 - 1 0  days and an uncomplicated case lasts 10 - 14 days. The 
production of an effective vaccine was under way by 1965 (Bryans 1964,
Doll et al 1968,Anon 1969)and immunity appears to he lifelong (Studdertl97 
The vaccine is not produced commercially because of lack of denand (Konen 1975 
Strangles.
Strangles is an acute contagious respiratory disease, caused primarily 
by Streptococcus equi (Bone 1963). Illness starts with an elevated 
temperature of up to 41°C, increased respiratory rate, anorexia and 
depression, accompanied by a mucapurulent inflammation of the nasal and 
pharyngeal mucous membranes, producing a catarrhal discharge. This is 
followed by swelling of the submaxillary and pharyngeal lymph nodes, 
which may abcess and rupture. Occasionally the infection spreads along 
the lymphatics to the posterior cervical and mediastinal lymph nodes and 
the disease may become fatal. Continued high temperature after the 
throat abscesses have stopped draining indicates internal abcess formation.
The etiology of strangles has always been a controversial topic.
Bryans et al (1964) reviewed some of the earlier work and reported the 
results of experiments designed to clarify the situation. There is 
general agreement that Streptococcus equi is the major pathogen involved 
and it can always he isolated from cases of strangles, hut some workers 
encountered difficulty in reproducing the clinical symptoms with pure 
cultures of this bacterium although the disease was readily transferable 
using pus from an infected animal. Other agents implicated were 
viruses, (Manninger 1949) and Streptococcus pyogenes, (Searl 1967).
Despite the many contrary reports, strangles can he experimentally 
reproduced with pure cultures of Streptococcus equi. Bryans et al (l9;64)
tested several strains with and without other biological agents and 
proved that the disease could be produced by simple intranasal 
inoculation with broth cultures in the log phase of growth.
Young animals are the most' susceptible, the incidence of strangles 
being increased when horses are subjected to stress, fatigue, chills 
etc. This disease can usually be cured with the aid of antibiotics, 
rest and good care; infected animals should be strictly isolated since 
the disease is very contagious. A specific bacterin is available for 
prophylaxis (Anon 19&9) but "there are divergent vie vs on the safety 
of vaccinating young or sensitized animals. Great care must be taken 
with the dose administered and immunity gained may not last for more 
than 6 months, necessitating fairly frequent boosting for. protection 
from the disease.
Strangles is now infrequent in England (Tutt 1968) and immunization 
is not in general practice in this country.
Mycoplasma Respiratory Diseases
Mycoplasmas as Respiratory Pathogens.
Despite the fact that mycoplasmas have been associated with disease 
for many years and that specific mycoplasmal diseases have been 
described since the early eighteenth century, there has been consider­
able uncertainty about the pathogenicity of many mycoplasmas. This 
was partly due to the difficulties in handling the organisms so that 
they retained virulence, which led to failures in satisfying Koch*s 
postulates, but recent advances in serology and cultural techniques 
have helped to clarify the situation. Unlike the heated controversy 
still surrounding the role of mycoplasmas in genital disease, there 
is no longer any doubt . that they are capable of producing respiratory
diseases in many species of animal.
The mechanism of the production of disease is something of a 
mystery. In many instances, e.g. contagious bovine pleuropneumonia 
(Lloyd and Trethewie 1970)» chronic respiratory disease of poultry 
(Adler i960), porcine respiratory disease (Goodwin et al 1968) and 
murine respiratory disease (KZLeineberger-Nobel and Cheng 1955)> it 
has proved very difficult to reproduce the natural disease experi­
mentally by inoculation of pure mycoplasma cultures. Stress factors 
including pre-existing infections, mixed infections, poor physical 
condition, overcrowding and bad weather are usually acknowledged to 
be important in establishing mycoplasma diseases. Actual illness 
may be the result of a disruption of a delicate commensal balance 
into a damaging host-parasite relationship-.
Organisms usually enter the body by inhalation of droplets 
carrying infective particles, and even mycoplasmas causing disease 
elsewhere in the body may penetrate from the respiratory tract.
M .neurolyticum, a pathogen of the central nervous system, can be 
found on the nasal mucosa of normal mice, and M .ar.thritidis, which 
causes joint infections, is commonly found in the nasopharynx of 
healthy rats. ("Whitt lest one 1972a). Inhaled organisms lodge in the 
ciliated epithelium of the trachea and bronchi and may survive there 
for long periods. The mechanism of their existence is not under­
stood; phagocytes do not appear to mop up all the cells, and local 
antibody may not be produced. A close association with the cell 
membrane may be essential for their survival. M.pneumoniae, the 
only mycoplasma which definitely causes a human respiratory disease, 
has been shown to bind firmly to neuraminic acid receptors of res­
piratory tract epithelial cells, whereas other mycoplasmas that 
infect man do not (Sobeslavsky et al 1968), and electron microscopy
has provided evidence that the avian respiratory pathogen M.galli- 
septicum attacks the respiratory epithelium with a bleb, and forms 
a very intimate association with it while the nonpathogenic M. gall in­
arum is randomly dispersed over the same surface (Abu Zahr and Butler
1974).
The way in which mycoplasmas spread from the epithelial surface 
to become localized in lesions or other tissues is not fully . .
appreciated. Lloyd and Trethewie (1970) suggested that M.mycoides 
var. mycoides cells are deposited in the alveoli or other non-ciliated 
parts of the respiratory tract where they are ^ phagocytosed by alveolar 
macrophages or other phagocytic cells and are then transported into 
the lymphatic system. Cells collecting in regional lymph nodes are 
in a position to stimulate the development of a germinal centre from 
which the infection may spread along the lymphatic system throughout 
the body. Also the lymph flow may be retarded causing the surrounding 
tissue to become edematous, which gives rise to further inflammatory 
response and disruption of the normal bodily organization.
None of the mycoplasmas causing respiratory disease have been 
shown to produce a strong toxin although there is evidence of a slight 
toxic effect from some species. Intravenous injection of a huge dose 
of live M.gallisepticum produces neurotoxic symptoms in turkeys 
(Thomas et al 1966, Jordan 1975a), and actively growing cultures of 
M.mycoides var. mycoides contained in a semipermeable membrane and 
implanted in cattle cause an inflammatory response in the surrounding 
muscle tissue (Lloyd and Trethewie 1970)• Several species, e.g..
M.pneumoniae, M.pulmonis, M.mycoides var. capri and M .neurolyticum 
produce hydrogen peroxide which is damaging to the cell membranes of 
the host, but as equal quantities can be formed by both virulent and 
avirulent strains (Lipman and Clyde 1969) and several non-pathogenic
mycoplasmas (Cole et al 1968) also produce hydrogen peroxide, it can 
only be one of many factors contributing to pathogenicity.
Disease in Humans.
Mycoplasmas have been known to cause disease in animals for many 
years but it was only recently realized that man was also prone to 
mycoplasmal diseases. The agent responsible for primary atypical 
pneumonia was first isolated in 1944 by Eaton et al. It was considered 
to be a virus-until Goodbum and Marmion (1962) demonstrated that the 
organism, known as the Eaton agent, could be inhibited by gold salts 
and antimicrobial drugs. They also visualized cocco-bacilliform 
bodies in the tissues of experimentally infected animals, and from 
this evidence suggested that the agent was a mycoplasma. Chanock et 
al (1962a and 1962b) succeeded in growing the agent on cell-free media 
and later named it M. pneumoniae (Chanock et al 1963) • However it 
takes a long time for the correct nomenclature to percolate through 
to the medical profession and most general practitioners still refer 
to the disease caused by M.pneumoniae as "viral " pneumonia.
The spectrum of illness ranges from an inapparent infection to 
severe pneumonia and there is no definite clinical pattern which 
permits diagnosis. It is similar to other pneumonias except that 
it has a long incubation period, and the illness, if' untreated, is 
of longer duration. Symptoms include headache, earache, fever, chills, 
coughing, general malaise and unilateral patchy pneumonitis in the 
lower lung. Further lung involvement only occurs in 25^ of cases. 
Nevertheless, the illness can be severe, sometimes persistent and 
relapse is not uncommon (Taylor-Robinson 1975)* The only signs of 
a mild infection may be a slight upper respiratory tract disease or 
bronchitis. Experimental infection can lead to myringitis (middle 
ear infection), and there have been reports of M.pneumoniae infections
being linked with central nervous system disturbances (Taylor et al
1967). The disease is rarely fatal and even untreated, infections 
usually resolve within a month; antibiotic therapy with tetracycline 
speeds recovery and prevents secondary infection (Chanock et al 1970). 
The■organisms can be recovered from the respiratory tract of infected 
patients and may continue to be exhaled for 3 months. Antibiotics 
relieve clinical symptoms and suppress the level of mycoplasmas but 
without completely eradicating them. Surviving organisms are not 
antibiotic resistant, (Smith et al 1967a) and probably exist closely 
associated with the respiratory epithelium which may provide some 
protection from chemotherapeutic agents.
M.pneumoniae has been found in people in every country where it 
has been looked for, and is almost certainly distributed throughout 
the world. It exhibits an endemic pattern of infection in large 
communities, mainly affecting children and young adults, and it is 
apparent throughout the year. Despite the prolonged carrier state 
often observed, infection is slow to spread and is usually restricted 
to family groups, schools or institutions where close and prolonged 
contact between individuals is maintained.(Grayston et al 1969). In 
the general population it accounts for about 14$ of all pneumonias 
but in institutionalized groups it is responsible for 40$ of pneumonia 
cases (Chanock et al 1970).
Once the organism had been cultured on cell-free media, many 
attempts were made to produce a vaccine (Metzgar et al 1966, Jensen 
et al 1965> Smith et al 1967b). Only killed vaccines could be used 
with safety as attenuated live strains caused illness in an 
unacceptable proportion of volunteers (Couch et al 1964) • Lipman 
and Clyde (1969) showed that an avirulent strain could become fully 
pathogenic after only 8 intranasal passages in hamsters and also
Femald and Clyde (1970) demonstrated that vaccination with avirulent 
strains did not protect hamsters from subsequent challenge with an 
unrelated virulent strain. Inactivated vaccines have been used 
experimentally but Smith et al (1967b) found that occasionally 
vaccination sensitized the volunteer so that these people developed 
a more serious Illness than unvaccinated controls when both groups 
were subjected to challenge with M.pneumoniae. Mogabgab (1973) 
reported the results of a large field trial in which an inactivated 
vaccine effectively reduced the cases of pneumonia due to all causes 
by 50^ with no adverse sensitizing effects. However the general 
opinion is that inactivated vaccines are not yet efficient enough to 
warrant widespread use (Whittlestone 1975)*
- Recent work on the development of a live attenuated vaccine has 
involved artificially-induced mutants of M.pneumoniae. Steinberg et 
al (1969), Brunner et al (1973a) and Helms et al (1974) selected 
mutants that grew at 32°C, hoping that these organisms would grow in 
the nasopharynx but not at the higher temperature of the lungs. The 
success of this idea depends on the stability of the temperature- 
sensitive mutants and the degree to which a nasopharyngeal infection 
would stimulate the production of protective antibody.
M. pneumoniae is the only human mycoplasma which has been proved 
to be pathogenic, but other species have been associated with disease 
(jao et al 1965? Crawford and Griffin 1966, Morton 1970). M.hominis 1 
caused exudative pharyngitis when inoculated into volunteers under 
experimental conditions (Mufson et al 1965), but subsequent attempts 
to show that this organism is the cause of naturally-occurring sore 
throats were unsuccessful (Mufson 1970). Other species occasionally 
under suspicion for participation in human respiratory disease are 
M.orale 1, M.orale 2, M . salivarium and M - fermentans,but the extent to
which they are pathogens, secondary invaders or commensals is not 
clear.
Disease in Cattle.
Contagious bovine pleuropneumonia was first recognised in Germany 
and Switzerland in 1713» and- by the middle of the nineteenth century 
it had spread, or been recognised, in most of Europe, North and South 
America, Africa and Australia. More recently it has been reported in 
India, China and parts of the U.S.S.R. (Cottew and Leach 1969). The 
organism has now been eradicated from many areas by vigorous slaughter 
policies but It is still a great problem in many African countries 
south of the Sahara and possibly also in parts of Asia, but little 
information is available from this area (Chalmers 1975)*
The etiological agent, isolated in 1898 by Nocard and Roux, was 
regarded as a unique virus for the next 25 years. By 1940 several 
other similar organisms had been isolated and they formed the group 
of pleuropneumonia-like organisms (PPLO). The agent of contagious 
bovine pleuropneumonia was given many interesting and descriptive 
names between 1910 and 1956 > when Edward and Freundt prepared a system 
of classification and nomenclature for the pleuropneumonia-like 
organisms. Since then the organism has been known as M.mycoides var. 
mycoides (M.mycoides).
- An acute infection in cattle is characterized by broncho-pneumonia 
with gross sero-fibrinous pleuresy and symptoms include fever, shallow 
breathing, coughing and nasal discharge. The interlobular connective 
tissue in the lungs becomes distended, the lymphatic ducts block up 
and as much as 10 litres of pleural exudate may accumulate in the 
lungs. In excessively severe cases the lungs collapse and the beast 
dies (Lloyd and Trethewie 1970). Strains vary in virulence and 
mortality has reached 90$ in Nigeria and India (Cottew and Leach 1969);
but it is more usual for animals to recover, although areas of lung 
tissue may be permanently damaged-. Persistent mycoplasmas are able 
to survive in sequestrated lesions for many months as impaired 
circulation in affected areas hinders the activity of antibiotics and 
antibodies. There is evidence that a mild toxin is produced by the 
organism (Lloyd 1966), the effect of which is not fully understood, 
but it may contribute to the formation of lung sequestrae in natural 
infections. Another factor aiding the survival of mycoplasmas in 
tissues is the production of a type of capsule. Organisms are found 
embedded in a matrix composed of an unusual galactan produced by the 
mycoplasmas which may inhibit phagocytosis and bind circulating 
antibodies. No other mycoplasmas are known to produce similar galactan 
capsules. About IQffo of the infected animals become carriers, which 
allows the disease to spread rapidly between cattle in close contact, 
transmitted by inhalation of infective droplets. Infection is not 
spread by contaminated bedding, fodder or buildings (Hudson 1971)•
The incubation period is very variable, ranging from 3 bo 17 weeks 
(Hudson and Turner 1963) a n ^  i-n a  n o n - i m m u n e  herd, ..the morbidity is 
high, foetuses and calves probably being more severely affected than 
adults (Masiga 1976). There is usually a proportion of cattle, (10^
- 2Qffi) which appears to be resistant to natural or experimental 
infection (Turner 1954) ancL different breeds of cattle vary in their 
susceptibility to the mycoplasma.
Because of the economic loss involved, much work has gone into 
the study of immunity and production of vaccines. Killed vaccines 
have not, so far, proved effective in producing an active immunity 
and adjuvented vaccines can sensitize the animal so that it is more 
susceptible to challenge than untreated controls (Shifrine and Beech
1968). Cattle that recover from the natural disease are normally
immune to re-infection and prophylactic inoculation against the disease 
has been practised for many years. It is based on the fact that even 
fully virulent strains inoculated subcutaneously do not generally 
produce pneumonia but cause a subcutaneous lesion. The severity of 
this reaction depends on the site of the inoculation and virulence of 
the M.mycoides strain, but cattle surviving inoculation are immune for 
a considerable period of. time (Gourlay*1975)• Tail tip vaccination 
was commonly employed as it was of relatively minor importance if only 
the tip of the tail was badly affected or sloughed off as a result of 
the lesion, but less damaging attenuated M.mycoides strains can be 
inoculated into other sites. Many different live vaccines of varied 
immunogenicity and virulence are in general use and great care is 
necessary to ensure the safety of the vaccine, since a strain which 
gives good protection to one type of cow may cause severe reactions 
in others. A satisfactory vaccine may provide protection for 3 - 4 
years (Hyslop 195&)> but it is very difficult to test the potential 
usefulness of a vaccine. At present there is no reliable method of 
measuring resistance except by challenge with virulent mycoplasmas; 
an expensive procedure if the vaccine is found to be ineffective. 
Antibody response to vaccination can be readily measured by complement 
fixation tests (Campbell and Turner 1953)> agglutination tests,
(Turner and Etheridge 1963) and indirect haemagglutination tests 
(Cottew i960), but antibody detected by these tests did not correlate 
with immunity to the disease. Similarly Davies (1969s) concluded 
that locally produced antibody was not a marker of immunity when he 
failed to detect specific IgA antibody in the nasal mucous of infected 
cows.
The use of a smaller animal than a cow for experimental work 
should make the problems of measuring immunity and detecting the
antigen which induces resistance easier, and recent work by Smith (1967) 
has shown that the mouse is a suitable animal for laboratory studies. 
Intraperitoneal inoculation of M.mycoides caused a bacteriaemia in 
mice, the presence and duration of which was directly related to the 
virulence of the M.mycoides strain inoculated (Smith 1968, Dyson and 
Smith 1976). In addition mice could be protected from the bacteriaemia 
by the previous subcutaneous injection of immune serum from mice, 
rabbits or cattle (Smith 1971) • Bovine "mouse protective antibody"
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detected in naturally infected cattle and cattle which were immunized 
with living or killed vaccines was distinct from complement-fixing and 
precipitating antibodies, and it seems possible that this antibody plays 
some pari in resistence to the disease in cattle (Dyson and Smith 1975)*
Several other mycoplasmas may be involved in bovine respiratory 
disease and in particular with calf pneumonia. M.dispar, a TJreaplasma 
species and M.agalactiae subsp.bovis have been recovered from over 5®/° 
of pneumonic lungs of calves and these organisms all produced pneumonia 
when inoculated alone or together into conventional and gnotobiotic 
calves (Gourlay and Thomas 1969? Gourlay and Thomas 1970, Gourlay 1976). 
Bovine mycoplasmas isolated from cattle with respiratory symptoms for 
which there is at present insufficient evidence of pathogenicity are 
M.bovirhinis, M .bovigenitalum and M.arginini (Fabricant 1973? Taylor-
Robinson 1975)*
Disease in Pigs.
Chronic porcine pneumonia is a very common disease where pig rearing 
is practised on a large scale. Of the several mycoplasmas to have been 
isolated from infected pigs, M .hyopneumoniae (also known as M.suipneu- 
moniae) appears to be the primary pathogen. Mare and Switzer (1965) 
and Goodwin et al (1965) disproved the previous viral etiology theories 
by demonstrating that porcine pneumonia could be reproduced with pure
cultures of the mycoplasma.
In the early stages of the disease animals may cough and have a 
copious frothy catarrhal exudate in the trachea and major bronchi.
The condition may resolve, become chronic or develop into moderate or 
extensive pneumonia. Pneumonic lesions, harbouring mycoplasmas, 
develop progressively for several weeks in areas of the lung where 
exudate accumulates. The lesions are slow to resolve and may be 
still apparent nine months after initial infection ("Whitt lest one 1972b). 
The disease is rarely fatal, but the chronic condition causes 
considerable economic loss, as infected pigs are slower to gain weight 
and they consume more food than healthy animals.
M.hyorhinis has been consistently isolated from pigs with chronic 
respiratory disease (Switzer 1955 and Friis 1971)• Initially workers 
found difficulty in reproducing respiratory disease with pure cultures 
(Goodwin et al 1968) and M.hyorhinis was regarded as a secondary 
invader; but Gois et al (l97l)» Poland et al (l97l) and Gois and 
Kuksa (1974) managed to induce disease in gnotobiotic "pigs with pure 
cultures. The organism will not promote illness unless conditions 
such as the route of inoculation, the age, titre and passage history 
of the culture are favourable, and its role in producing natural 
disease is not clear.
M .hyosynoviae has been isolated from both catarrhal and healthy 
pigs and is of questionable pathogenic significance (Friis 1970)•
Enzootic pneumonia is a problem throughout the world and is the 
most important disease of growing pigs. It is readily transmissible 
between pigs in close contact and it has been estimated from . post 
mortem examinations of gross pneumonic lesions that 25$ - 80^ of bacon 
pigs suffer from the disease (Rees 1964? Edwards et al 1971)•
Vaccination gives poor immunity compared to that produced by natural
infection, and is not used as a method of controlling the disease at 
present (Whittlestone 1975)* Like the bovine pleuropneumonia situ­
ation, antibody rises after infection of pigs are readily measured by 
complement-fixation tests, indirect haemagglutination tests and meta­
bolic inhibition tests, but there is no apparent relationship between
i
serum antibody levels and immunity (Goodwin et al 1969a, 1969b) and 
further work is needed to investigate the mechanisms of resistance.
Other species occasionally associated with respiratory disease in 
pigs are M.flocculare, A.granularum, A.laidlawii (Ross 1973) and 
A . axanthum (Stipkovits and Varga 1974) But the pathogenicity of these 
strains has not been established.
Disease in Goats and Sheep.
One of the most serious epizootic diseases in goats is contagious 
caprine pleuropneumonia. The disease occurs in Africa, Southern 
Europe* the Middle East, Southern Asia, Mexico and occasionally in 
America (Taylor-Robinson 1975)* The etiological agent, M.mycoides 
var.capri (M.capri) will also cause a respiratory illness in sheep 
when inoculated experimentally. The onset of the disease under 
natural or experimental conditions is rapid, characterized by fever, 
coughing, a mucous nasal discharge and severe depression. Damage to 
the lungs can be expensive, affecting one or two lobes with massive 
edema and consolidation with a frothy fibrinous pleural exudate. The 
pharynx and larynx may be congested with nasal discharge and the 
bronchial and mediastinal lymph nodes may become enlarged and edematous. 
(Hudson et al 1967.)
The disease can be mild, lasting for a few days only, but it is 
usually acute and often fatal. Animals infected during pregnancy 
invariably abort the foetus. If the animal does recover, the condition 
assumes a chronic form. Recovery is slow, animals may develop
arthritis, cough, have a continual nasal discharge and become 
generally emaciated. However, the lung lesions do regress, and are 
non-infective; sequestration does not occur (Cottew and Leach 1969)*
The disease, transmitted by aerosol formation, spreads rapidly and 
extensively through the available population. The incubation period 
is 3 “ 5 weeks, and when the infection becomes apparent death can 
occur in 3 days. The situation is worsened by bad weather when 
morbidity and mortality rates can reach IQQffo,
Little is known about immunity to the disease and although vaccines 
developed from attenuated and killed strains are said to be effective 
there have been no publications about controlled vaccine trials or 
the use of chemotherapy as a prophylactic measure.
Several unclassified mycoplasmas have been- isolated from sheep and 
goats with various respiratory ailments. Cottew (1970) reviewed many 
reports and it seems likely that there are several mycoplasmas capable 
of infecting sheep and goats, many existing as part of the normal 
microbial flora and a few which are probably pathogenic to some degree. 
M .ovipneumoniaeand M.arginini are frequent inhabitants of the respira­
tory tract of healthy and pneumonic sheep and M. ovipneumoniae in 
particular is often suspected of being pathogenic (Alley et al 1975?
St.George and Carmichael 1975? Foggie et al 1976, Jones and Gilmour 
1976). •
Disease in Poultry.
M.gallisepticum is one of the primary etiological agents of chronic 
respiratory disease of chickens and turkeys. Other birds including 
pheasants, guinea fowl, partridges and pigeons are also susceptible 
to experimental infection. Delaplane and Stuart (1943) suggested the 
name"chronic respiratory diseasd' because the illness was characterized 
by a slow spread and a long duration. In turkeys the condition is
also known as infectious sinusitis. Dodd (cited by Fabricant 1969) 
described what was probably M. gallisepticum infection of turkeys in 1905 
and by 1935 Nelson had visualized coccobacilliform bodies in exudate 
from chickens with a chronic coryza. Markam and Wong (1952) finally 
showed that the organism was a pleuropneumonia-like organism when they 
succeeded in growing it in cell-free media.
Symptoms of the disease appear after an incubation period of up 
to 3 weeks, and include coughing, respiratory rales, rhinitis, sinusitis, 
tracheitis, pneumonia, airsacculitis and depression (Jordan 1975a) .
The extent of bronchial and air sac involvement in chickens varies 
in separate outbreaks but turkeys are particularly prone to swelling 
and distension of the infra-orbital sinuses and to air sac infections.
A mucogelatinous exudate collects in the trachea and covers the inflamed 
air sacs, becoming caseous after two to three weeks. Other effects 
may be vascular damage, arteritis, abscesses, brain damage, arthritis, 
diarrhoea and anaemia (Olesiuk and Van Roekel I960, Adler 1970).
In young chickens the uncomplicated disease is mild and often 
inapparent, but older birds are more severely affected and may have 
clinical symptoms for 2 months. Turkeys are very sensitive to 
infection, sub-clinical infections are rare, and the condition is 
usually severe, progressive and prolonged (Fabricant 1969). A 
neurotoxic effect can be produced by M.gallisepticum. Intravenous 
inoculation of 10^ live organisms causes ataxia, torticollis and 
paralysis, followed by death in two hours. A similar dose of 
inactivated mycoplasmas has no effect (Thomas 1970)•
The most important factor in the spread of chronic respiratory 
disease is egg transmission. This may occur at a low level, but 
since poultry are kept in close contact in large enclosed flocks, a 
small stock of infected chicks will pass on the mycoplasmas to the
whole hatch by airborne spread. Similarly the introduction of 
infected or carrier birds into a flock will result in an outbreak of 
chronic respiratory disease. Contact spread is accelerated by the 
presence of other respiratory infections within the flock. Concurrent 
infection with adenovirus (Aghakhan et al 1976), infectious bronchitis 
virus (Chu and TJppal 1975)? Newcastle disease virus, E.coli or Asper­
gillus fumigatus frequently increases the severity of the condition 
and at present it is difficult to assess the relative importance of 
these agents and M.gallisepticum (Berry 1969? Taylor-Robinson 1975)*
Commercial breeders suffer considerable economic losses from 
lowered weight gains (Gale et al 1967), lowered egg production and 
deaths. The problem is world wide in distribution and occurs wherever 
poultry is raised in large flocks.
Control depends on prevention of egg transmission. Antibiotics 
have been extensively used to treat affected birds, newly-hatched 
chicks and eggs. The result is an improved clinical condition, but as 
the mycoplasmas are not completely eradicated, birds are likely to 
become carriers as well as being open to further infection. Because 
of the dangers of inducing antibiotic-resistant micro-organisms, heavy 
medication is becoming an unpopular method of treating birds bred for 
human consumption. A strong immunity follows recovery from natural 
infections and vaccination is a safer method of control. Intranasal 
administration of live vaccines can confer a high degree of resistance 
(Jordan 1975B, Papageorgiou and Bar 1976); inactivated vaccines are 
less effective (Adler 1970) but neither procedure has yet proved good 
enough for routine use. Control of the disease in turkeys has been 
achieved by a policy of repeated serological testing, slaughter of 
infected birds and strict animal hygiene procedures (Adler 1970).
M.meleagrides causes airsacculitis in young turkeys and as
M.gallisepticum infections have largely been controlled, it is now 
the most common mycoplasmal infection of turkeys. Adler et al (1958) 
first detected the organism in newly-hatched turkey poults with air 
sac lesions The infection is egg-transmitted and the mycoplasma was 
later found in almost all large commercial flocks in association with 
a mild chronic respiratory condition. Its pathogenicity is difficult 
to assess, and there is a synergistic effect with Newcastle disease 
virus and infectious bronchitis virus (Jordan 1975a); it may also be 
a cause of some embryonic deaths.
Airsac lesions (which do not extend to the lungs) are a major 
cause of condemnation of turkeys in America, but they tend to decrease 
in severity and eventually disappear with age. The mycoplasma is also 
a genital tract inhabitant and control of the infection depends on 
breaking the cycle of egg and venereal transmission by breeding from 
healthy stock only.
Until fairly recently, the only diseases considered to be caused 
by M.s.ynoviae in poultry were arthritis and infectious synovitis, 
conditions characterized by swollen joints and visceral lesions 
(Adler 1970)* However, over the last few years its involvement in 
airsacculitis has become increasingly obvious, particularly as measures 
taken to control M.gallisepticum have been effective (Taylor-Robinson 
1975)* Airsacculitis caused by M. synoviae alone or particularly in 
mixed infections with Newcastle disease virus and infectious bronchitis 
virus is associated with stunted growth in broiler poultry (Kleven et 
al 1972, King et al 1973)* The infection is spread by egg transmission 
and control procedures are dependent on the serological identification 
of infected birds and clean breeding stock. Antibiotic therapy only 
provides a temporary alleviation of symptoms in infecte.d flocks and 
does not eradicate the mycoplasmas.
M.anatum is reported to cause respiratory illness in ducks (Jordan 
1974)? A.axanthum to cause severe airsacculitis in young geese, 
(Stipkovits et al 1974&) an(l a Ureaplasma species to cause pneumonia 
and airsacculitis in chickens (Stipkovits and Rashwan 1976) hut the 
importance of these organisms cannot be assessed without further 
enquiry.
Disease in Rats and Mice.
Respiratory ailments in rats and mice have been a problem for as 
long as these rodents have been used for research purposes. The 
clinical condition, now usually referred to as chronic respiratory 
disease (CRD) has had a varied nomenclature over the years (Cassel et 
al 1973) and the etiology is still a controversial topic. The disease 
may not appear in young animals but the occurrence of CRD increases as 
the animals age or are stressed. Typical symptoms in mice are 
chattering, ruffled coats and gradual loss of weight and in rats 
snuffling, encrustations around the nose and again, loss of weight 
and condition< The disease is normally chronic and eventually leads 
to pneumonia and in rats particularly, to bronchiectasis (Taylor- 
Robinson 1973)* The occurrence in rats may be up to \OQffo in adult 
animals (Lindsay et al 1971) but fatalities are uncommon in young 
animals.
Mycoplasmas were first isolated from lung lesions of rats by 
KLeineberger and Steabben in 1937 > and in the same year Nelson (1937a 
and 1937b) isolated a similar organism from the nasal exudate of mice. 
Since then, the organism M.pulmonis has been recovered regularly from 
rodents with CRD, but its ability to cause the disease has often been 
questioned.
Whittlestone et al (1972) and Jersey et al- (1973) produced CRD 
in rats with pure cultures of M.pulmonis, but although this is
undoubtedly one of the primary causative organisms, it is likely that 
the disease is often complicated by other agents. Gay et al (1972) 
could produce CRD in mice with inoculation of diseased lung tissue, 
but not from pure cultures of M.pulmonis isolated from the tissues. 
Lutsky and Organick (1966) produced pneumonia in conventionally reared 
mice by the inoculation of M. salivarium, M.pneumoniae and Mr pulmonis 
but only M> pulmonis caused the disease in gnotobiotic mice- These 
workers also showed that intranasal inoculation of conventional mice 
with sterile broth often induced lung lesions from which M. pulmonis 
could be recovered* These experiments indicate that conventional 
healthy animals often harbour M,pulmonis in the respiratory tract and 
that other infectious or irritant agents induce or increase the 
severity of the mycoplasma infection.
The condition is of considerable economic importance because of 
the numbers of rodents used in research and the results of long term 
projects with rats and mice are often influenced by CRD (Lindsey et 
al 1971). Workers with young animals and short term projects may 
find the infection inapparent and thus of little consequence, but 
even brief experiments can be adversely affected by the unintentional 
stimulation of latent mycoplasma infections.
Control of the condition depends on the use of specific pathogen- 
free animals and a rigidly maintained standard of hygiene, although 
Taylor and Taylor Robinson (1976) have shown that parenteral immuni­
zation of mice with.viable M.pulmonis protected the animals from intra- 
nasal challenge and passively transferred immune serum enhanced the 
clearance of mycoplasmas from the respiratory tract and prevented 
pneumonia,
Serology
General Immunological Response.
Developments in immunology have simplified the problem of diagnosis 
of mycoplasma infections which are often subclinical or have symptoms 
which could be due to many causes. The detection of specific serum 
antibody may be the only evidence of past or present encounter with a 
mycoplasma antigen. Many factors contribute to the extent of the 
antibody reaction and these include the route of infection or immuni­
zation, the history and preparation of the antigen, the condition of 
the animal about to be. infected and the" natural variation in the 
response of individuals.
Antibodies are associated with the immunoglobulin (ig) group of 
proteins which are subdivided into three main classes, IgG, IgA and 
IgM. IgG, which accounts for approximately 85rfo of the immunoglobulins 
in vertebrates, is further subdivided in horses into IgGa, IgGb, IgGc 
and IgGT (Roberts 1975) • The molecular weight (MW) in the horse is 
about 152,000 and the average sedimentation constant is about 7 
Svedberg (s) units. IgA has similar centrifugation properties and 
the major component is 7S, making it difficult to separate from IgG 
but lesser quantities of polymeric forms such as 10.5S, 13S and 17S 
can also be detected. In the horse a-dimeric form predominates, the 
MW is approximately 350? 000 and about 10^ of the serum immunoglobulins 
is IgA. However, IgA is the predominant immunoglobulin in many 
bodily secretions, e.g. saliva, tears, milk, nasal and bronchial 
fluids, intestinal, tract secretions and urine. The major secretory 
IgA fraction is different from that found in serum, having 11 S 
components, a MW usually greater than 350,000 and correspondingly 
different polymeric forms The difference is attributed to the
presence of a secretory component with a MW of about 80,000 (Pahud 
and Mach 1972).
The IgM class comprises 5$ - 10$ of the serum immunoglobulins, 
has a MW of about 990? 000 and an average sedimentation constant of 
19S, but 298 and 38S polymers also occur.
Other equine immunoglobulins recently isolated and not yet fully 
characterized are IgB, 10S&1, IgZ, IgX, Ig-Y and Q, (Allen et al 1976). 
IgP, IgE and IgL have been found in very small quantities in the sera
of some animal species (Abramoff and LaVia 1970) but not in the horse.
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Following antigenic stimulation 19S (igM) antibodies are usually 
detectable first and the 7S (IgA and IgG]types appear later (Femald ' 
et al 1967a). The formation of IgM antibodies is usually transient 
and within 2 or 3 weeks the principal class of immunoglobulin being 
produced is IgG. IgM is particularly abundant after exposure to 
paiticulate antigenic matter, e.g. blood cells and bacteria, which 
are rapidly coated with antibody. 7S antibody may be produced by a 
smaller number of cells which take longer to respond to antigenic stim­
ulation but the resulting immunoglobulins effectively bind soluble 
antigenic material and remain in the circulation for long periods of 
of time. 7S antibody may participate in the development of a lasting 
immunological memory which is demonstrated by the rapid production of 
high titre specific 7S antibody following stimulation with an antigen 
previously encountered by the immunological system. A low dose of 
antigen or a poorly antigenic material may result in only 19S anti­
body production and this does not usually lead to the development 
of any immunological memory, although exceptions can occur. Porter
(1966) demonstrated that bovine serum albumin injected into rabbits 
resulted in prolonged 19S immunologic memory.
The facts that different immunoglobulins are produced at different
stages of an infection and that a given serological test may detect 
antibody from only one class of immunoglobulin emphasizes the import­
ance attached to the choice of an appropriate serological technique 
when searching for specific antibody. Sera which give a negative 
result with one serological method may have significant levels of 
antibody when tested with another technique.
Having generalized about the reaction to an antigenic stimulus, 
a brief look at the reported work on mycoplasma serology shows that 
very many varied immunological responses can occur. This may be 
partly due to frequent low level antigenic stimulation by subclinical 
or chronic infections which are common features of mycoplasma 
respiratory tract diseases.
The detection of specific antibody can be assumed to be evidence 
of past or present contact with the relevant antigen, but even high 
titres of circulating or locally produced mycoplasma antibody are not 
necessarily indicative of immunity to further infection from these 
organisms (Davies and Hudson 1968, Davies 1969a, Whittlestone 1975)* 
Complement Fixation (CF).
The test was first recommended for the diagnosis of mycoplasma 
infections by Turner et al (1935) and Campbell and Turner (1936), who 
described a method suitable for the detection of contagious bovine 
pleuropneumonia. Since then the technique, although somewhat modified, 
has been very widely used for both the detection of antibodies, 
(Beveridge et al 1946, Takatori et al 1968, Kleineberger-Nobel i960) 
and the comparison of mycoplasma strains (Huysmans-Evers and Ruys 1956, 
Card 1959? Taylor-Robinson et al 1964? Lemcke 1964a, Lynn 1965? Leach 
1967? Hollingdale and Lemcke 1970)*
The method has not been easy to standardize. Fresh pooled guinea 
pig serum is the best source of complement and the optimum storage
conditions are probably at -196°C, when it can be kept without 
noticeable deterioration for at least 2 years (Dr. J.H. Derbyshire, 
personal communication). Preserved or freeze-dried complement is 
also widely used (Bradstreet and Taylor 1962). The commonest problem 
with the test has been that mycoplasma antigens are often anti- 
complementary and several ways of treating the antigen to overcome 
this problem have been reported. Campbell and Turner (1953) advised 
heating M.mycoides antigen to boiling for 10 minutes, using 0.5$ phenol 
for preservation and storing the- suspension at 4°C for 6 weeks before 
use. This method was said to produce a stable, high titre antigen. 
Card (1959) nsing fresh and boiled antigens preserved with merthiolate 
at 4°C found that boiling destroyed antigenic components of several 
human mycoplasma strains tested. Chanock et al (l962t>) investigated 
the production of M. pneumoniae CP antigen in broth cultures and 
reported that treatment with 0.5$ phenol at 37°C for 4 days decreased 
the anti-complementary activity and increased the titre of the antigen. 
Further work on M.pneumoniae reported by Kenny and Grayston (1965) 
indicated that anfci-complementary activity could be eliminated by 
boiling for 5 minutes, heating to 56°C for 2 hours of by extracting 
the antigen with a chloroform and methanol mixture. Taylor-Robinson 
et al (1966c) used a combination of methods for M.pneumoniae antigen; 
they incubated the organisms, at a sub optimal temperature of 36°C in air 
for 16 days, then added 0.5$ phenol and re-incubated for a further 5 
days. The preparation was finally heated to 56°C for 30 minutes.
A good M.pneumoniae antigen was prepared by Somerson et -al (1967) by 
culturing the cells on glass surfaces in a slightly deficient medium.
A thick confluent layer of mycoplasmas colonized the surface in 5 - 6 
days. As the cells adhered strongly to the glass they were easily and 
thoroughly washed by repeated rinsing with buffer solution. Clean
cells were finally scraped off the glass to produce a high quality 
antigen. Alternatively, anti-complementary activity can be removed 
by incubating antigens with complement at 37°C and then heating to 
56°C for hour (Taylor-Robinson et al 1964). Nevertheless, some 
strains are very difficult to cope with and Lemcke (1964b) found that 
heating, sonic treatments and ether extraction all failed to reduce 
anti-complementary activity in some Acholeplasma strains. The only 
way to obtain a satisfactory antigen for some of these strains was 
to incubate the cultures for 15 - 24 days before harvesting the cells. 
However not all antigens are so troublesome and some mycoplasmas can 
be used after simple washing in buffer and storage at -25°C with no 
preservatives, and in other cases dilution of the antigen to eliminate 
anti-complementary activity is adequate as the final antigen has a 
sufficiently high titre (Metzgar et al 1966, Goodwin et al 1969a, 
Boulanger and L’Ecuyer 1968).
Sera can also be anti-complementary (Lynn 1967) but this is 
usually eradicated by heating at 56°C for g-hour, or by adsorption 
with fresh guinea pig serum followed by heat inactivation. (All sera 
used in the CE test are routinely heat-inactivated).
Pig serum has been found to contain pro-complementary substances 
which increased the haemolytic activity of guinea pig complement 
(Roberts 1968), but this could normally-be diluted out at l/20 and 
as mycoplasma antibody titres in infected pigs were often significantly 
higher than l/20, the test could be successfully applied to swine sera.
The mechanics of the test, described in detail by Bradstreet and 
Taylor (1962), differ slightly in almost every laboratory where the 
method is routinely used. The test is usually performed with a unit 
volume of 0.1 ml but it can easily be scaled down and performed in 
microti.tre plates with a unit volume of 0.025 nil (Sever 1962). The
concentrations of antigen, complement, blood cells and haemolytic 
serum; the time and temperature allowed for fixation and the preparation 
of the haemolytic system are largely matters of personal preference.
Complement-fixation is a sensitive diagnostic tool but it is not 
always very specific and cross-reactions can’ occur between unrelated 
mycoplasma antigens (Lemcke et al 1965)* One possible reason is that 
a variety of membrane and intracellular antigens participate in CP 
(Riggs and Sharp 1970? Lemcke 1973)* The more specific growth- 
inhibition type of test probably only involves membrane antigens.
When using hyperimmune or artificially-raised sera, other sources of 
shared antigens are the medium components. Antisera raised in an 
animal injected with mycoplasmas and traces of contaminating medium 
proteins may react in the CP test not only with the homologous myco­
plasma antigen but also with any traces of media adhering to the 
antigen. This problem occurs with many other serological tests with 
the exception of the growth and metabolic-inhibiting types of test in 
which the result is dependent on the viability of the mycoplasma cells. 
Repeated washing of the organisms rarely removes all traces of medium 
components and to avoid the problem Taylor-Robinson et al (1963) 
inoculated rabbits with mycoplasmas grown in a rabbit infusion broth 
and rabbit serum medium. Cross-reactions were eliminated but it was 
very difficult to adapt some mycoplasmas to growth in rabbit media.
An alternative method is to* grow the strains for immunization of 
rabbits in a different medium from that used for culturing the myco­
plasmas for CF antigen. Medium antibodies will be produced by the 
rabbit, but they will not have a homologous antigen to react with in 
the CP test. This method is easy practically, as most mycoplasmas 
can be adapted to grow in pig, horse and human serum medium.
Rabbits are the commonest animals used for raising antisera as
they are a convenient size and usually produce high titre antibody, 
but pooled rabbit sera may show non-specific fixation of complement 
and it seems that isoantibodies or some other factor may be produced 
which accounts for the fact that antibodies in one rabbit serum some­
times react with another rabbit serum (Coriell i960).
For many years rabbits were considered to be free from mycoplasmas 
but almost inevitably with better isolation techniques mycoplasmas 
have been isolated from the. respiratory tract (Deeb and Kenny 1966) 
and appear to be part of the normal microbial flora. Some rabbit 
mycoplasmas had a lipid CF antigen very similar to that of M.pneumoniae, 
which could be a source of non-specific cross-reactions.
Barber et al (1970) detected GF antibody 7 days after experimental 
infection of cattle with M.mycoides. Maximum titres were obtained 
between 2 and 4 weeks post infection, but significant levels were still 
found after 22 weeks. Fractionation of the sera showed that 19S (igM) 
antibodies were found in sera taken from 7 - 8 4  days, the maximum 
levels were recorded between 3 and 6 weeks. 7S (igG) first appeared 
at 2 weeks, peaked at 4 weeks and then gradually declined over the 
next 18 weeks. The maximum 7S titre was higher than the maximum 19S 
titre..
In humans CF antibody can also be detected as early as 1 week after 
infection with M.pneumoniae and as before, the response peaked at about 
1 month and then declined slowly. IgG was the predominant immuno­
globulin in the later stage (Femald et al 1967a). This pattern may 
differ, and Biberfield (1968) reported the prolonged production of 19S 
antibody for several months after primary infection with M.pneumoniae. 
Complement-fixing antibody to swine mycoplasmal infections follows the 
normal response; antibody appears in 2 - 3 weeks and reaches maximum 
levels from 5 “ 9 weeks after infection (Goodwin et al 1967? Takatori
et al 1968).
Complement-fixation is a useful technique for surveying sera and 
it detects a moderately wide range of immunoglobulins. However CF 
antibody is not particularly long-lasting and the technique is not as 
sensitive as some other methods in common use (Taylor-Robinson et al 
1966c). The high level of cross-reactions limits the value of the 
test and mycoplasmas apparently related when compared by CF have been 
shown to be distinct by more specific tests (Taylor-Robinson et al 
1964, 1965a). In spite of its drawbacks the test has been, and still 
is, very extensively used for epidemiological studies of mycoplasma 
infections in man and animals (Chalmers 1975? Catelle et al 1976, 
Skodnik-Jansa et al 1976? Farrington et al 1976), and it has been 
much used with horse sera especially in the study of equine influenza 
and equine rhinopneumonitis (boll et al 1953? Sovinova et al 1958? 
Shimizu et al 1961, Doll and Bryans 1963a, Waddell et al 1963? Marois 
et al 1963? Knowles and King 1963, Matumoto et al 1965? Beveridge et 
al 1965? Beveridge and Rose 1967? Bryans et al 1967).
Growth Inhibition (Gl) and Neutralization.
Growth inhibition’, immune inhibition and neutralization are some 
of the terms applied to serological techniques which depend on the 
effect of antibody on the activity of viable mycoplasmas. The methods 
used for solid and liquid medium tests differ; the solid medium tests 
usually provide a result directly, but the liquid medium tests are 
carried out in two stages.
a) Solid Medium Tests. Nic .iol and Edward (1953) noted that the incor­
poration of specific antisera into medium inhibited growth of the 
homologous mycoplasma and Edward and Fitzgerald (1953? 1954) 
described the technique in detail. Sera were inactivated at 56°C 
for 30 minutes and mixed with agar growth medium at dilutions of
up to 1/25. Mycoplasmas were streaked over the surface of the 
plate which was then incubated in the normal way. Provided the 
inoculum was not too large, the test was effective and specific.
Too heavy an inoculum resulted in incomplete inhibition, character­
ized by reduced colony size. Edward (1954) stated that the best 
antisera retained some inhibitory activity when used at a final 
dilution of l/l,OOQ in agar, but this was rather rare and the test 
generally utilized a relatively large amount of antiserum (Kelton 
and Van Roekel 1963? Eabricant i960, G-ois 1968). A modification 
introduced by Hpysman-Evers and Ruys (1956) economized on antisera 
by placing a small (5 - 6mm diameter) filter paper disc soaked in 
serum onto a plate streaked with mycoplasmas. Where inhibition 
occurred, the zone of agar surrounding the disc remained free of 
colonies. The area of the zone was related to the potency of 
the serum, but for repeatable results the depth of agar, inoculum 
concentration and quantity of antiserum all had to be standardized.
Clyde (1964) obtained an even lawn of mycoplasmas on the plate by 
flooding it with a suspension of organisms, removing the excess 
fluid and drying the plate before applying the antisera disc. A 
variation used by Herderschee (1963) was to allow drops of serum 
to soak into the agar before streaking the surface with mycoplasmas, 
but the disc technique was the more' efficient method and with 
standard antisera, it came to be widely used for the characterization 
of unknown mycoplasma strains (Minck and K im i960, Edward i960, 
Taylor-Robinson et al 1964? Leach 1967). A further refinement 
was to preserve antiserum-soaked discs by drying and storing at 
-20°C, or freeze-drying and storing at 4°C. Such discs could be 
kept without loss of activity and without danger of contamination 
for at least 2 years (Stanbridge and Hayflick 1967? Dighero et al
1970)* Jensen (1963) varied the method for use with M.pneumoniae 
by filling small cups in disposable trays with solid growth medium. 
On each cup of agar was placed 0.1 ml of a mixture of organisms 
and antisera. The tray was sealed and incubated, after which 
growth was. recorded directly by the presence of mycoplasma colonies 
When the colonies were too crowded to assess the numbers accurately 
the cups were overlaid with an agar containing guinea pig blood and 
re-incubated for 4-0 hours. Colonial growth was then quantified 
by the zone of haemolysis in the blood agar caused by the M. pneu­
moniae .
Inhibition and neutralization are not entirely dependent on the 
activity of immune serum on growing mycoplasmas. Domermuth and 
Gourlay (1967) incubated M.mycoides and immune sera at 21°C for 
24 to 72 hours and then washed off the serum and re-incubated at 
37°C to assess growth. Some neutralization occurred at 21°C, a 
temperature at which the mycoplasma was not able to grow.
The result of the GI test can be influenced by many factors,
and when applying the test to ureaplasmas, Black (1973) stressed
the need for the determination of the optimum inoculum size, method 
of application of antiserum, period and temperature of incubation 
and the pH of the medium.
Hyperimmune antisera against some species of mycoplasma do not 
appear to have growth-inhibiting properties (Huismans-Evers and 
Ruys 1956)• particular the disc GI test has proved to be
unsatisfactory for use with M0hyorhinis (Dinter and Taylor-Robinson
1969). However, Roberts and Pijoan (l97l) reported that the
addition of fresh horse serum to the agar medium resolved this
problem; the horse serum and antiserum appeared to act synergistic- 
ally to inhibit the growth of M.hyorhinis.
Liquid Medium Tests. Growth inhibition or neutralization tests 
in a liquid medium involves a period of incubation of organisms and 
sera followed by an estimation of the remaining viability. Eaton 
et al (1945) were probably the first workers to use the neutrali­
zation test for mycoplasmas, although at the time the agent of 
primary atypical pneumonia (M . pneumoniae) was considered to be a 
virus. A suspension of infected chick embryo tissue was mixed 
with an equal volume of antisera diluted in horse serum and incubated 
at room temperature for 20 minutes. The mixture was assayed by 
inoculation into hamsters or rats which were later killed and 
examined for lesions. The test was effective in that it detected 
a significant rise in neutralizing antibody in over GOffo of people 
with a clinical diagnosis of primary atypical pneumonia. Priestley 
(1952) observed neutralization of M.mycoides when investigating 
immunity to bovine pleuropneumonia. Sterile, defibrinated bovine 
blood was seeded with mycoplasmas and incubated.' Daily samples 
were taken and inoculated into mycoplasma growth medium. Myco­
plasmas were killed by blood from animals recovering from the 
disease, but not by blood from healthy animals or from beasts dying 
from the infection. Edward and Fitzgerald (1954) described the 
type of test that has since been extensively used. Antisera and 
mycoplasmas are incubated in nutrient medium and samples removed 
at appropriate periods are titrated on solid or in liquid growth 
medium. All features of the test can be varied and the details 
of the method are different in almost every report on the- subject 
(Yamamoto and Adler 1958, Bailey et al 1961, Bailey et al 1963)*
Cottew (1963) working with sera from cattle vaccinated with M.mycoides 
suggested that the decrease in number of mycoplasmas may not be due 
to inhibition of growth, but to agglutination or aggregation of the
organisms. This point was partially clarified when Gourlay and 
Domermuth (1967) noted in a detailed study of the neutralization 
of this mycoplasma that the antibodies in infected cattle responsible 
for GI appeared to be independent from those causing agglutination.
An advantage of the neutralization test is its ability to distin­
guish between a temporary mycoplasmastatic and an irreversible myco- 
plasmacidal effect of the antisera. Mycoplasmas that show no growth 
when exposed to antiserum but are revived by subculture into fresh 
medium exhibit reversible inhibition; organisms that cannot be recovered 
have been permanently inactivated or neutralized (Brunner et al 1972).
The time taken for neutralization to be accomplished is extremely 
variable and depends on the strain of mycoplasma, quality of antisera, 
technique of the test etc. Riggs et al (1967), Gale and Kenny (1970) 
Barker and Patt (1967) and Lin and Kass (1974) all obtained inhibition 
with several different mycoplasmas in under one hour*s incubation at 
37°C in a non-nutrient medium. Gourlay and Domermuth (1967), Windsor 
(l97l) and Coleman and Lynn (1972) found that the best neutralization 
results were obtained after incubation at 37°C for at least 24 hours 
in a nutrient medium.
It has been difficult to assess the value of complement or other 
heat-labile substances in growth inhibition tests. Edward and Fitz­
gerald (1954) Clyde (1964), Gourlay and Domermuth (19 67.) and Sethi and 
Teschner (1969) tested many different species of mycoplasma including 
M.pneumoniae, M.mycoides, M.gallisepticum, M.pulmonis and M.salivarium 
in solid and liquid media and concluded that complement did not enhance 
growth-inhibit ion. Others, mainly using liquid medium tests, found
that complement increased inhibition more often than not, although the 
level found effective varied in separate systems. Barker and Patt
(1967) demonstrated that the inactivation of M.gallisepticum required
complement (fresh guinea pig serum) at a dilution of l/40. Gale and 
Kenny (1969) and Brunner et al (l97l) both reported that irreversible 
neutralization of M.pneumoniae only occurred in the presence of comple­
ment, and that the concentration was critical. The levels stated were 
1/200 and l/50 respectively. ' Tachibana et al (1970) demonstrated 
enhanced inhibition of M.canis using mouse complement.
Lin and Kass (1970) reported that inactivation of ureaplasmas was 
potentiated by complement provided there was no urea in the reaction 
mixture because ammonia, liberated from urea by ureaplasmas, inactivated 
the fourth component of complement.
The number of contradictory reports on the subject makes it clear 
that the function of complement or other heat-labile substances is not 
yet fully appreciated and at present it is accepted that in some 
circumstances complement enhances GI but under other conditions it may 
have no detectable effect.
Although most GI activity is found in the IgG immunoglobulin class 
some is also present in IgM and IgA fractions (Femald et al 1967a,
Riggs et al 1967). Rabbits hyperimmunized with M.pneumoniae produced 
GI antibodies after about 2 weeks, the maximum level was reached in 
4 - 6  weeks and after 10 weeks the antibody started to decline. . In man 
following natural infection with this mycoplasma, GI antibodies reached 
a peak 6 months after infection and were still active after 1 year (Riggs 
et al 1967). .This is the usual period over which GI antibodies are 
found, but artificial immunization can stimulate the production of anti-
i
body in a very short period, Lynn (1969) obtained GI antibody only 3 
days after injecting mycoplasma antigen into the footpads of rabbits. 
However, this type of antibody is not always formed in response to 
infection and sera from immune individuals may have no detectable GI 
activity.
Growth inhibition on solid medium is a simple and very specific 
test but it is not sensitive so in practice it is restricted to use 
with hyperimmune sera and its main value is in typing strains of 
mycoplasma. In liquid medium the test is both sensitive and specific 
and can be used to determine the potency of antisera, the mycoplasma- 
cidal or mycoplasmastatic action of the sera, or using a fixed level 
of sera, the rate of inactivation of the antigen may be determined 
(Brunner et al 197l)* This aspect of the test can be used with great 
sensitivity to distinguish between closely-related organisms. The 
disadvantage of the technique is that it is very laborious to perform 
in comparison with many other serological tests and has been found too 
cumbersome for routine epidemiological use. It has been applied 
almost exclusively to work with hyperimmune sera for the characteri­
zation of mycoplasmas or for testing the response to vaccination e.g. 
with M.pneumoniae (Metzgar et al 1966) and with M.mycoides (Davies and 
Hudson 1968).
Metabolic Inhibition (Ml).
Metabolic inhibition is a technique which measures the inhibition 
of a selected metabolic activity of mycoplasmas by specific antisera; 
an indirect assessment of growth inhibition. The test depends on the 
incorporation of a substrate in the growth medium which when metabolized 
by the mycoplasma, causes a detectable change in the medium. Jensen 
(1964) and Senterfit and Jensen (1966) described a test for the detection 
of anti-metabolic antibodies to M.pneumoniae. This mycoplasma reduced 
colourless 2.3»5* triphenyl tetrazolium chloride included in the standard 
growth medium to red formozan and specific antisera inhibited this 
reaction. The method was used for the assay of M.pneumoniae hyperimmune 
and convalescent antibody by Taylor-Robinson et al (1966c, 1966d) and 
Smith et al (1967c) and the results indicated that the test was both
specific and sensitive.
As not many species of mycoplasma reduce tetrazolium, other systems 
were soon developed. Several species ferment glucose and Taylor- 
Robinson et al (1966a) described a method using lfo glucose and 0.002^ 
phenol red in the growth medium. Fermentation of the glucose and the 
resultant drop in pH caused was detected by a colour change of the 
indicator dye from red to yellow. Other strains which failed to 
ferment glucose were found to liberate ammonia from arginine and the 
following rise in pH was also indicated by phenol red (Purcell et al 
1966a). T-mycoplasmas (Ureaplasmas), a large group of strains incapable 
of metabolizing any of the previously mentioned substrates, were found 
to utilize urea with the production of ammonia (Purcell et al 1967, 
Shepherd and Lunceford 1969) • In all of these systems the metabolic 
activity could be inhibited by specific antisera.
The test could easily be done on a small scale in microtitre 
plates (Taylor-Robinson et al 1966b), and depending on the optimum 
growth conditions of each mycoplasma strain, the test could be incu­
bated aerobically or anaerobically by sealing the wells with a drop of 
liquid paraffin. The period of incubation is also dependent on the 
strain of mycoplasma but with all organisms, the result can be read at 
two distinct times. The initial metabolic titre is read when the 
control wells (no antiserum) have changed by 0.5pH unit. Further 
incubation results in a lowering of the titre to a final metabolic 
titre, which thereafter remains stable.. The two readings are repre­
sentative of the mycoplasmastatic and mycoplasmacidal activity of the 
sera.
Like the GI tests, complement may either boost or depress the 
antibody titre in MI tests. Senterfit and Jensen (1966) and Smith 
et al (1967c) reported that fresh guinea-pig serum enhanced the titre
of M .pneumoniae antibody and Femald et al (1967a, 1967b), using the 
glucose fermentation test with M.pneumoniae included fresh horse serum 
in the medium to provide a heat-labile factor. Davies (1969b) working 
with sera from cattle and other animals hyperimmunized and naturally 
infected with M.mycoides concluded that the potentiating effect of 
complement on antisera varied considerably and was dependent on the 
type and quantity of antigenic stimulation. Other examples of the' 
use of complement in the MI test are included in the reports of Williams 
and Taylor-Robinson (1967) and Ross and Karman (1970).
The MI test has been widely used for the characterization of many 
types of mycoplasma (Purcell et al 1966b, Leach 1967, Taylor-Robinson 
and Berry 1969) and also for epidemiological studies, particularly with 
M.pneumoniae (Purcell et al 1969)• It has been used with varying 
success with swine sera; Gois (1968) found the test suitable for the 
detection of M.hyorhinis antibodies but Goodwin et al (1969a) found 
that MI gave non-specific reactions and compared very poorly with other 
methods for the detection of M.suipneumoniaeantibodies.
Metabolic inhibition is a simple, specific and sensitive serological 
technique but the drawbacks are that it can be difficult to standardize 
and when set up, the test requires constant observation as sera with 
low titres may only show a transitory inhibitory activity, easily masked 
by prolonged incubation. Metabolic inhibiting antibody is found 
predominantly in the IgG class of immunoglobulins, but IgM and IgA 
fractions may-also respond in this test. Chanock et al (1970) reported 
that activity usually appeared 2 - 3  weeks after natural infection with 
M.pneumoniae and could still be found 5 years later in people who had 
suffered a moderate to severe infection; antibody did not persist for 
this length of time in individuals who had had mild or clinically 
inapparent infections. There is some evidence that MI antibody may
be associated with resistance to M .pneumoniae infection in man, but 
there is no correlation between humoral MI antibodies and resistance 
to M. suipneumoniae in pigs and MI activity is barely detectable in rats 
and mice following infection with M.pulmonis (Whittlestone 1975)*
Passive Haemagglutination (PHA).
Passive, or indirect haemagglutination, is a technique whereby 
erythrocytes are coated with antigen .and subsequently agglutinated by 
specific antibody. Cottew (i960) applied the method to mycoplasmas 
and sensitized sheep red blood cells (RBC) with M.mycoides, either 
whole organisms or polysaccharide fractions of the mycoplasma. The 
resulting titres correlated well with those obtained by CP. Ross and 
Switzer (1963) used a similar technique which revealed considerable 
antigenic variation between different isolates of M.hyorhinis.
Sensitized antigen preparations tended to lose activity rapidly 
on storage and also not all antigens could be easily attached to fresh 
erythrocytes, so numerous methods of modifying the RBC to facilitate 
antigen adsorbtion were developed. Tully (1963) treated RBC with 
tannic acid before sensitizing with a mycoplasma protein fraction, a 
technique used earlier by Boyden (1951) for various bacterial and 
protein-antigens. Dowdle and Robinson (1964) described in detail a 
method using tanned RBC which could be successfully carried out for 
the diagnosis of M.pneumoniae infections. Taylor-Robinson et al (1965a) 
obtained reproducible results over several months by storing large 
batches of coated RBC at -70°C. Other workers preferred to use 
aldehyde-fixed RBC to overcome the problem of unstable antigen prepar­
ations. Formalin had been used by Park (1962) and Daniel (1965) for 
mycobacterial antigens and the sensitized RBC could apparently be 
stored at -20°C for several months. Bing et al (1967) preferred 
gluteraldehyde-fixation as sensitized cells could be stored for long
periods at 4°C without loss of activity and with the added advantage 
that they did not clump together as formalin-treated cells were liable 
to do. Red blood cells which were both aldehyde-fixed and then tanned 
were also used for sensitizing with antigen (Daniel et al 1963>
Kwapinski 1972). Such cells were readily coated with antigens but the 
storage life of the finished product was very poor, -only a few days at 
4°C. CThe search for a method of increasing the reliability of PHA led 
to a technique where antigens were adsorbed onto latex particles (Morton 
1967, Lynn 1967), but the improved stability of the antigen preparations 
was accompanied by a loss in sensitivity.of the test.
Immunoglobulins from the three major classes can participate in 
PHA but most of the activity is found in the IgM fraction (Pemald et 
al 1967a) which can usually be detected 3 - 4  weeks after infection and 
may persist for as long as 5 years if the initial titres were high 
(Chanock et al 1970)•
The PHA test is sensitive, specific and economical on reagents as 
it is easily adapted to small scale use in microtitre plates (Taylor- 
Robinson et al 1964) but the technique is not popular for routine use 
because of the difficulties of obtaining reproducible results and of 
sensitizing erythrocytes effectively. The method has been applied to 
epidemiological studies on human mycoplasmas (Taylor-Robinson et al 
1965a, 1966c, 1966d) and porcine mycoplasmas (Goodwin and Hodgson 1970) 
but most work with the test has been of a comparative type, for the 
identification and typing of mycoplasmas and for the study of immuno­
logical responses to mycoplasmas (Mufson et al 1965, Taylor-Robinson 
et al 1965b, Lynn 1967, Goodwin et al 1969a, Hollingdale and Lemcke
1970).
Other Serological Techniques.
Many other techniques differing in sensitivity, specificity and
complexity have been commonly used for mycoplasma studies. Direct 
agglutination of mycoplasmas by antibody was one of the earliest methods 
of characterizing the organisms, but as it is not very sensitive and 
there are usually technical difficulties in preparing an even suspension 
of organisms and avoiding non-specific agglutination (Turner and 
Etheridge 1963)? the test has been little used except for work with 
avian mycoplasmas (Adler 1970)*
Haemagglutination inhibition is another method which has been
extensively used with the avian species M.gallisepticum (Dierks et al
1967), but not with other mycoplasmas as few strains. agglutinate
erythrocytes (Manchee and Taylor-Robinson 1968) and of those that do,
the titres are usually too low to be of much use. Hemadsorption
(Del Guidice and Pavia 1964) an(^  spermadsorption (Taylor-Robinson and
Manchee 1967) exhibited* by M.pneumoniae and some other mycoplasmas can
be inhibited by immune serum but the insensitivity of the methods 
\
severely limits their use.
Gel diffusion, gel precipitation and immunodiffusion techniques 
cover a variety of methods which involve !the diffusion- of antisera, 
antigen or both through an inert gel. Serological reactions are 
indicated by lines or zones of precipitation (Lemcke 1965? Taylor- 
Robinson et al 1963). The simplicity and specificity make it a 
valuable tool for assessing relationships between strains and for 
identification studies, but because the test operates most efficiently 
with hyperimmune sera it is not suitable for epidemiological work.
Electrophoresis and Immunoelectrophoresis techniques in agar gels, 
cellulose acetate strips and polyacrylamide gels (Argaman and Razin 
1969) are designed for the detailed serological characterization of 
mycoplasma proteins. They are among the most specific methods avail­
able for identification and classification purposes (Hollingdale and
Lemcke 1970 > Dellinger and Jasper 1972, Lemcke and Allam 1974)*
Immunofluorescence has become a routine serological tool for use 
with mycoplasmas for the detection of antibody in infected animals 
(Liu et al 1959 > Chanock et al 1961, Taylor-Robinson et al 1966c), 
the identification of antigen in tissues (Lindsey et al 197l)> eggs 
(Liu 1957)> tissue cultures (Clyde 196l) and in cell-free media 
(Del Guidice et al 1967). In the last system the test is of particular 
value in locating specific mycoplasmas on primary isolation plates where 
the organisms may exhibit poor colonial growth or be overgrown by 
contaminants. The specificity compares well with that of PEA and 
MI but the test is not noted for its sensitivity and relatively large 
volumes of serum are required.
‘ Serological tests on mycoplasmas growing in tissue cultures are 
potentially useful for strains that grow poorly in acellular media but 
systems consisting of cell cultures, mycoplasmas and antibody are 
difficult to standardize and maintain and also the problem of uniden­
tified contaminating mycoplasmas in tissue cultures can confuse and 
invalidate the results.
Recently developed radioimmuno assay techniques have proved extremely 
sensitive. Brunner et al (1973^? 1973c) described a radioimmuno- 
precipitation test carried out in microtitre equipment which was 
considerably better than MI, CP and indirect immunofluorescence for 
the study of M.pneumoniae antibody in sera and nasal secretions. The 
test was an indirect assay as the specific antigen-antibody complex was 
coupled to radio-labelled antL-ijnmunoglobulins. Many aspects of the 
method demand great care; the preparation of antigens, the thoroughness 
of the washing procedures of the antigen-antibody complex and the 
quality of the anti-immunoglobulins used are critical if the results 
are to be acceptable. However, even when all the reagents are beyond
suspicion, the complexity of the techniques makes the test very 
difficult to standardize. A new staphylococcal radioimmune assay 
test (Brunner et al 1976) was reported to he simpler to operate than 
the precipitation tests and again to he far superior to CF and MI for 
the detection of M.pneumoniae antibody.
The Project
Research on equine respiratory disease lias been almost entirely concerned 
with viral and bacterial agents and has frequently been based on cases seen 
in veterinary practice. Such observational'studies are often difficult to 
evaluate because of the variable data and inevitable lack of controls.
Extensive work on laboratory animals is rare because of the expense of 
maintaining horses, so the etiology of equine respiratory disease is poorly 
understood.
The- underlying reason for the lack of funds for research is that horses 
(about 550?000 in Britain in 1976) are kept almost exclusively for pleasure 
and are of little economic importance in the usual sense. British blood­
stock as an industry (about 50,000 racehorses) is not taken seriously except 
by those directly involved; although the income from betting taxes is approx­
imately £150 million, only £8 million are reinvested in the sport (Horse and 
Hound 1976).
The problem of respiratory disease becomes prominent only when race­
horses are affected. Most racehorses start training for flat racing at lj- 
to 2 years of age, despite the fact that they do not mature fully until 
about 4 years old, (a year earlier than other breeds of horse). The mental 
stress and physical strain of working a 2-year old often irreparably 
harms the animal, particularly its respiratory system, heart and legs.
Very few of these young horses stand up to izaining for more than 2 years.
The older horses which are seen jumping are usually a coarser type of horse, 
either too backward or too slow to be worth training as a 2-year old. Flat 
racing is supported because the prizes are considerably higher than in 
steeplechasing or hurdle races; the animals are worked after only 2 years 
of keep; there are fewer risks of injury than in jumping and, if the horse 
is successful, it may have a very high stud value after only 1 or 2 seasons 
of racing. However, the immature horse has little acquired immunity to 
diseases and is liable to become infected with a series of agents of which 
those affecting the respiratory tract cause the most trouble. Even horses 
with mild clinical symptoms cannot be worked at all, or the condition will 
worsen with the risk of permanent impairment' of lung tissue.
Respiratory infections can spread rapidly through a stable, and it is 
not uncommon for a trainer to have most of his horses out of work during 
an outbreak. Particularly in areas where there are many training stables, 
like Newmarket and Lamboume, an outbreak can be very serious, since public 
gallops, training grounds and bridlepaths provide ample opportunity for the 
spread of infections. Widespread outbreaks of respiratory disease which 
significantly reduce the number of horses able to race always start a 
clamour for research from trainers, owners, vets (who can do very little to 
alleviate the symptoms) and bookmakers.
Outbreaks serious enough to have affected racing in recent years have 
occurred in 1963, 1965, 1969 and 1973 (Powell et al 1974b)? and reports 
involving lesser numbers of animals are continually being publicized. The 
cause is usually attributed to an anonymous "virus".
Partly because of the real problem, and partly because respiratory 
disease is being used as an excuse for horses that fail to perform up to 
their trainers' expectations (usually unrealistic), the Horserace Betting 
Levy Board has been financing some research. One aspect has been in the 
form of a survey, mainly of large groups of racehorses from separate stables,
which involved regular nasopharyngeal sampling for the isolation of microbes 
and regular blood samples for serology. In addition, acute and convales­
cent samples were taken from horses in stables reporting respiratory disease.
Mycoplasmas are of interest in any such survey because of their involve­
ment in respiratory illness in other animal species. As there was no 
previuusly reported work on the serological aspect, this project was under­
taken to investigate the occurrence of mycoplasma antibody in horses using 
standard serological techniques, equine mycoplasmas recently isolated at the 
Mycoplasma Reference Laboratory, Collindale, and sera collected for the 
Horserace Betting Levy Board survey.
Initially the work was concerned with culturing several different 
mycoplasmas, selecting suitable strains for the project and finding out 
which of the many techniques regularly used to detect mycoplasma antibody 
would be the most useful for a survey of large numbers of horse serum samples. 
As the work developed it became clear that hyperimmune horse sera and data 
from animals deliberately infected with mycoplasmas were necessary to 
evaluate the results obtained from racehorses.
Materials and Methods
Media
Horse Serum Medium
a) Horse Serum. Samples of sterile, unheated serum from 5 horses 
provided by the Wellcome Research Laboratories, Beckenham, Kent, 
were incorporated in liquid and solid media and tested for their - 
ability to promote the growth of 6 mycoplasma strains. The horse 
whose serum gave the best overall growth of the test mycoplasmas 
was selected; several litres of serum were obtained from that 
horse and stored at -25°C. Thawed serum was held at 4°0 for up 
to 3 weeks before use. Two batches of serum were used in this 
project.
b) Base. Liquid base was a 2.1$ (w/v) solution of Difco Bacto-PPLO 
broth (without crystal violet) made up in distilled water. The 
base was dispensed in 100 ml volumes, autoclaved at 15 pounds per 
square inch (psi) for 15 minutes and stored at 4°0. Solid base 
was prepared by adding 0.75g Oxoid Ionagar No. 2 to 70 ml of 
liquid base before autoclaving and storing as above.
c) Yeast Extract. A paste was made with 250g dried active yeast 
(Distillers Co. Ltd.) and 250 ml of distilled water and then a 
further 1 litre of distilled water was added gradually. This 
mixture was transferred to a large saucepan with a lid, brought 
to the boil as quickly as possible and kept boiling with 
occasional stirring for 5 minutes. The mixture was centrifuged 
at 2OOOg for 30 minutes, the supematent was decanted, dispensed 
in 100 ml bottles, autoclaved at 10 psi for 10 minutes and stored 
at -25°C. The thawed extract was again centrifuged at 2000g 
for 10 minutes and the resulting clear supematent was used at 
once or was stored at 4°C for up to 3 weeks before Use.
d) Thallium Acetate. A stock solution of 10$ (w/v) thallium acetate 
(B.D.H.) was made up in distilled water, autoclaved at 10 psi for 
10 minutes and stored at 4°C.
e) Penicillin. A stock solution of 100,000 units per ml (Glaxo, 
Crystapen) was made up in sterile, distilled water and stored at 
4°C for up to 3 weeks before use.
The complete horse serum medium was prepared from ingredients a) 
to e) as follows:
i) Horse serum broth (HSB) consisted of 70$ (v/v) liquid base,
20$ (y/v) horse serum, 10$ (v/v) yeast extract, 0.25$ (v/v) 
thallium acetate and 0.2$ (v/v) penicillin. This medium was 
always made up immediately before use.
ii) HorSe serum agar (HSA) was prepared by melting a 70 ml bottle 
of solid base, cooling it to 45°C and adding 20 ml horse serum, 
10 ml yeast extract, 0.25 ml thallium acetate and 0.2 ml 
penicillin. The additive s were warmed to 45^0 before mixing
with the base. Liquid HSA (5 ml volumes) was pipetted into
50 mm diameter plastic petri dishes (Esco Rubber, grade A) and 
allowed to solidify. The plates were dried for 15 minutes in 
a stream of sterile air and used immediately or stored at 4°C
for up to 1 week before use.
Pig Serum Medium
a) Pig Serum. Eresh pooled pig blood was obtained from the local 
abattoir in a 20 litre stainless steel container. The blood was 
allowed to clot overnight at 4°C before the serum was separated.
The clot was then chopped up and after 8 hours at 4°Ca second 
batch of serum was separated. The two batches were pooled and 
centrifuged at 2000g to remove cellular debris. The supernatant 
was passed through Whatman glass fibre papers grades A, B and C
respectively and then through a sterilizing grade Seitz filter 
using positive pressure obtained with an air pump running at 4*5 
psi. The serum was stored at -25°C and then required further 
filtration after thawing to remove a sticky deposit. Volumes of 
100 ml were filtered through Whatman glass fibre papers grades A 
B and C and then through a range of Mi Bipore membranes, of average 
pore diameters 0.^, 0.45yu, 0.3^, and 0.22yu, under negative 
pressure obtained from a water pump. After this treatment the 
serum was stored at 4°0 for up to 3 weeks before use.
b) Base, yeast extract, thallium acetate and penicillin were pre­
pared as previously described.
The complete pig serum medium (liquid and solid) was prepared as the 
horse serum medium except that pig serum was substituted for horse 
serum.
Lac t albumin Hydro lysate Agar Medium.
a) Agar base. A mixture of 40 ml of Hanks solution (Oxoid) and 0.7g 
Oxoid Ionagar Ho. 2 was autoclaved at 15 psi for 15 minutes and 
stored at room temperature.
b) Lactalbumin hydrolysate. A stock solution of 5$ (w/v) lactalbumin 
hydrolysate (Sigma) was made up in Hanks solution (Oxoid), steril­
ized by filtration through a 0.22yu average pore diameter Millipore 
membrane and stored at 4°C.
c) Yeast extract, pig serum, thallium acetate and penicillin were 
prepared as previously described.
The complete lactalbumin hydrolysate (LH) medium consisted of 40 ml 
of agar base, melted and cooled to 45°C, plus the following prepar­
ations (mixed and warmed to 45°^ )i 30 nil Hartleys digest broth (Oxoid), 
20 ml pig serum, (inactivated by heating to 56°C for 30 minutes), 10 ml 
lactalbumin hydrolysate, 0.5 nil yeast extract, 0.25mtthallium acetate
and 0.2 ml penicillin.
The pH of the molten medium was adjusted to 7*75 with N/lO NaOH 
and 5 nil volumes were pipetted into petri dishes as described above.
4» Phosphate Buffered Saline (PBS).
PBS was made up by adding the following AnalaR reagents to 1 litre V 
of distilled water: sodium chloride 8.0g, potassium chloride 0.2g,
disodium hydrogen phosphate l.l^g, potassium dihydrogen phosphate 0.2g 
and D-glucose 0.2g. The solution was autoclaved at 10 psi for 20 
minutes and stored at room temperature.
Mvcot>lasmas i
Thirteen strains of Mycoplasmas and.Acholeplasmas isolated from horses 
were obtained from various laboratories. Their designation, source and 
where known identification are shown in Table 2. Two strains, M.equirhinis 
(l4<.32) and N3j chosen for their apparent specificity as equine parasites 
were used for the majority of the work reported here.
Seed Cultures
On arrival at this laboratory, cultures were split into 3 portions.
One portion was stored at -196°C, one was inoculated into 10 ml HSB and 
incubated at 37°C and the remaining portion was inoculated onto HSA. All 
plate cultures were incubated at 37°C in anaerobic jars in a mixture of 
95$ N2 and 5$ C02.
If growth occurred in both media, the liquid culture was discarded, but 
if this culture was the only one to show any growth, it was subcultured and 
used to maintain the strain until growth was obtained on agar. Then 
strains were cloned by picking off a single colony and streaking it over a
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fresh agar plate to produce well-separated colonies; this process was 
repeated twice more.
Blocks of agar supporting cloned colonies were placed in 20 ml HSB and 
incubated for 5 days. 10 ml of culture was harvested at 2 days and the ' 
remainder at 5 days. These seed cultures, (0.6 ml in 1 ml ampoules) were 
stored at -196°C.
Stock Cultures
't
Cultures of each strain were prepared by a careful sequence of sub­
cultures started by inoculating 10 ml of HSB with 0.5 ml of seed culture. 
After this, cultures were incubated at 37^ C. for a specified time before 
subculturing to larger volumes (if required) as follows:
a) N3 and Nil were incubated for 2 days and the culture was added to 
10 times the original volume of fresh medium. If a larger volume 
of stock was required a further subculture in the proportion of 
1:10 was done.
b) N14, 377 and 358 were subcultured at 5-day intervals in the pro­
portion of 1:2
c) the other mycoplasma strains, (M.equirhinis, N20, N29B, 3451, Eq.l, 
Eq.2 and BHSl), were subcultured at 2 or 3~day intervals in the 
proportion of 1:2 Attempts to inoculate fresh laedium with culture 
in higher proportions than those indicated were unsatisfactory as 
the cultures usually died. All cultures were kept stationary and 
the proportion of liquid to gas phase in the bottles was not 
critical.
Stock cultures required for storage were held at -196°C in ampoules as 
previously described. The viable titres of the cultures were recorded 
before and after freezing and were checked at least annually by the method 
of Miles and Misra (1938) as modified for mycoplasmas by Butler and Knight
(i960).
Initially the viability of M.equirhinis and 377 in liquid cultures and 
on blocks of agar was compared after storage at -196°C and -25°C but later 
only the lower temperature was used for storage of live Mycoplasma and 
Acholeplasma culture's.
Strains were adapted to grow in pig serum medium by gradually substi­
tuting pig serum (PS) for horse serum (HS) in liquid cultures as follows:
a) 75$ HS + 25$ PS
b) 50$ HS + 50$ PS
c) 25$ HS + 75$ PS
d) 100$ PS
If this was not successful, the change was made more slowly.
Hyperimmune Ant is era
1. Preparation of Antigens
Large volumes ( 2 - 5  litres) of culture were prepared as previously
described. Samples of every subculture were Gram stained and examined
microscopically to check for the absence of bacterial and yeast contam-
inents. Samples of the final harvest were also checked for growth of
bacteria and yeasts by plating out onto nutrient agar, 10$ blood agar
and malt extract agar and incubating at • 37°C for 1 week. The titre of
the mycoplasmas in the final pool was recorded immediately before harvest-
8ing. M.equirhinis cultures contained about 8 x 10 colony-forming units 
(CFU)/ml, N3 cultures 1 x 10^ CPU/ml, 377 cultures 9 x 10^ CFU/ml and 
358 cultures 7 x 10 CFTj/ml. Antigens were harvested by centri­
fugation at 15,000g for 30 minutes at 4°C. They were then washed by 
re-suspending the pellet to half the original volume in PBS and
sedimenting as above. This process was repeated twice and after the 
final wash the antigens were concentrated to 100 times their original 
volume. After this treatment the viability of most strains was nil; 
traces of viability were detectable with preparations from N3 and Nil 
cultures.
A portion of each antigen preparation was sonicated with an MSE 
150W ultrasonic disintegrator running at a probe tip amplitude of 
55/j  for 3 minutes at 2°C. Whole and sonicated antigens were stored 
at -25°C.
Immunization of Rabbits.
Two rabbits were immunized with M.equirhinis (M432),2 with N3 
and 1 each with strains377 and 358. New Zealand White or Dutch rabbits 
between 4 and 6 months old and weighing2-3 kg each were immunized by 
a sequence of inocula starting with 0.5 ml intramuscular injections 
into the thigh of each hind leg of whole cells homogenized with an 
equal volume of Freund*s complete adjuvant. This was followed after 
3 weeks with 8 intravenous injections using whole or sonicated cells 
alternately administered every 3 or 4 days starting with 2 doses of 
0.5 ml and followed by 4 doses of 1.0 ml and 2 of 1.5 ml. Rabbits 
were bled five days after the last injection. Samples were taken 
before immunization and one week before the final bleed to check the 
level of antibody.
Blood samples were allowed to clot for one hour at room tempera­
tures and then overnight at 4°C. The serum was then separated, 
centrifuged at 2000g for 5 minutes to remove cellular debris, dispen­
sed • in 0.1 ml volumes in flexible vinyl microtitre plates (hinbro) 
and stored at -196°C. When required, one well containing 0.1 ml of 
serum was cut away from the microtitre plate. This enabled a sample 
to be abstracted without disturbing the bulk of the sera. All sera
subsequently referred to as "stored at -196°C" were similarly treated. 
Immunization of Horses.
This work was done in collaboration with the Wellcome Research 
Laboratories, Beckenham, Kent. The identities of the horses are given 
in the Appendix.
Five aged cobs were examined for complement-fixing (CF) antibody 
to M.equirhinis and N3> and two animals were selected for immunization 
which had no CF antibody against M.equirhinis and a low titre (l/2 0) 
against 3ST3 • None of these 5 animals was free of CF antibody to N3» 
Antigens were prepared as described previously, except that the final 
subculture was only grown for 24 hours and, before harvesting, the 
mycoplasmas were inactivated by shaking the cultures for 1 hour at 37°C 
withp-propiolactone (B.D.H.) added at a final concentration of 0.1$ 
(v/v). The horses were injected subcutaneously in each pastern with 
1.5 ml of whole cells homogenized with an equal volume of Freund* s 
incomplete adjuvant. The horse immunized with M.equirhinis was given 
an identical inoculation 8 weeks later and the other animal was given 
a similar boost with N3 10 weeks after the primary inoculation.
Samples of serum were taken at approximately weekly intervals through­
out the experiment to monitor the development of antibody and the final 
bleed was about 15 weeks after the initial inoculation. Sera were 
separated from the blood as before and stored at -25°C for up to 2 
weeks. They were then allowed to thaw when in transit to the labora­
tory ( 2 - 3  hours) and on arrival were stored at -196°C.
Serological Tests
Complement Fixation
a) Complement. Guinea pig serum was used as a source of complement.
Fresh serum from 6 - 1 0  animals was pooled and stored at ~196°C. 
Haemolytic serum. Wellcome rabbit anti-sheep haemolytic serum. 
Blood. Wellcome or Oxoid sheepTs blood in Alsevers solution, used 
within 2 weeks of preparation. Cells were washed 3 times in 
diluent immediately before use and finally used as' a 4i° suspension. 
Diluent. Oxoid CFT diluent tablets.
Antigens. Antigens were prepared as described previously, (see 
page?2). After testing the stability and sensitivity of the 
M.equirhinis antigen, preparations of this antigen were sonicated 
before use with an MSE ultrasonic disintegrator running at a probe 
tip amplitude of 55 jJ 3 minutes at 2°C. All other antigens 
were used as whole cell preparations. Antigens for use with 
rabbit hyperimmune sera were cultured in pig serum media to avoid • 
the possibility of cross-reactions between any traces of horse 
serum remaining in the CF antigen preparations and any antihorse 
serum produced by the rabbits in response to traces of horse serum 
remaining on the antigens with which they were immunized.
Antigens were stored in 0.1 ml volumes in flexible vinyl micro- 
titre plates at -25°C. Immediately before use the lOOx concen­
trated antigen was diluted lOOx to restore it to the original 
volume. Further dilutions for titration were made from this 
suspension.
Antisera. All antisera and test sera were inactivated by heating 
to 56°C for 30 minutes.
Standardization of reagents. The titration of complement, haemo­
lytic serum, antigens and standard antisera was carried out as 
described by Bradstreet and Taylor (1962) with the following 
modifications:
i) The test was done in rigid U shaped microtitre plates (Cooke).
ii) A unit volume of 0.02 ml was used.
iii) All reagents were kept between 2°C and 4°C throughout the test 
unless otherwise specified.
iv) Sensitized blood cells were always prepared immediately before 
use.
v) Overnight fixation was used for all tests.
The definition of the optimum sensitizing concentration (CSC) of 
haemolytic serum, 1 unit of complement (HC^q), the optimal dilution 
of antigen and the titre of the antiserum were exactly as described 
by Bradstreet and Taylor (1962). 
h) Titration of test sera. Sera were' tested at the following
dilutions: l/lO, l/20, l/40, l/80 and l/l60 against the optimum 
concentration of antigen and at 3 levels of complement representing 
2, 3 and 4 units of complement. Serum, antigen and complement 
controls were included in every test. Sera with a positive result 
of l/160 or more were re-tested at higher dilutions to obtain the • 
titre. • Sera from hyperimmunized rabbits and horses and the 
infected ponies were tested 3 times each sad sera with titres of 
1/10 or above were considered to have a significant level of antibody.
The 1,073 equine sera used in the serological survey were tested 
once each. Because titres of l/lO required retesting to confirm 
the result, only titres of l/20 and above were considered significant. 
Growth Inhibition (Gl).
The GI test was based on that of Clyde (1964). Agar plates were 
flooded with a fresh mycoplasma culture and allowed to dry in a stream 
of sterile air for 15 minutes. The culture was previously diluted so 
that after 2 - 5  days incubation, colonies were separated by a distance 
of 1 - 2 colony diameters (approximately 10^ CPU per ml). Sterile 
paper discs 6mm diameter, made from Whatman*s No. 1 filter paper were
saturated with anti serum and placed on the surface of the dried 
inoculated plates (2 per plate, 15 - 20 mm apart). Cultures were 
incubated until colonies were visible and the zone of growth inhibition 
surrounding the disc was measured. Prom this the area of the zone was 
calculated.
For M.equirhinis, 377 and 35$ > HSA medium was used but strain N3 
was not inhibitied by homologous antisera on HSA medium, so a suboptimal 
growth medium was made by replacing the 2Qf/o horse serum with Vfo Difco 
PPLO serum fraction and making up the remaining volume with liquid base 
medium.
In the comparative study of sequential serum samples obtained from 
hyperimmunized horses it was necessary to modify the GI test. Three 
techniques, (see pagel06), were tested and the following one was 
selected for use: plates were flooded with antigen and dried as before. 
Two wells, 5mm. diameter and 15 - 20mm apart, were cut in each plate 
and the bottoms of each well sealed with a drop of agar. The wells 
were filled with about 0.05 ml of antisera and the plates incubated 
at 4°C for 3 hours, then at 37°C for 2 - 5  days until the colonies 
developed. All GI tests were done at least in triplicate.
Metabolic Inhibition (Ml).
The MI test. for use with glucose-fermenting mycoplasmas was based on 
that of Taylor-Robinson et al (1966a) and the corresponding test for 
arginine-metabolizing strains was based on that of Purcell et al
(1966a).
a) Media. The medium used in the test and as a diluent consisted of 
Gofo liquid base, 20fo horse serum, 10^ yeast extract, lO/o D-glucose 
(B.D.H. 10^(w/v) solution in distilled water) or 10^ L-arginine 
monohydrochloride (B.D.H. 10^ (w/v) solution in distilled water), 
0.25^ thallium acetate, 0.2^ penicillin and 0.004/^ (w/v) phenol
red (B.D.H.). (Base, horse serum, yeast, thallium acetate and 
penicillin prepared as previously described). Pooled guinea pig 
serum (as a source of complement, fresh or stored at -196°C) was 
initially added to the medium at levels of Gfo, 4 2/£ and 0.5io 
(final concentrations); later all tests were carried out with the 
addition of guinea pig serum to the medium. The pH was 
adjusted to J.8 with n/10 UaOH for glucose fermenting strains and 
to 7*2 with h/10 HC1 for arginine metabolizing strains. The test 
was carried out in rigid plastic microtitre plates with U -shaped 
wells (Cooke).
Titration of Antigen,, For each mycoplasma antigen, a sample of 
the frozen stock culture was diluted in 10-fold steps. The 
microtitre plate wells were filled with 1 volume (0.025 ml) of each 
antigen dilution and 7 volumes of medium. Medium controls (8 
volumes of medium) were included in each plate. Plates were 
sealed with Selotape, incubated at 37°C for 2 - 5  days and read 
when the phenol red indicator had changed colour. A colour change 
equivalent to that caused by O.5 pH unit was taken to be signifi­
cant . The last dilution of antigen to produce such a change was 
defined as containing one colour changing unit (CCU).
Test. Antisera were diluted to l/lO and then in twofold steps.
One volume of antiserum dilution, 6 volumes of medium and 1 volume 
of antigen, previously diluted to contain 100 CCU, were placed in 
each well. Medium controls and antigen controls (7 volumes of 
medium and 1 volume of antigen) were included in each plate.
Plates were sealed and incubated as above and read when the antigen 
controls had changed colour. The titre of the serum was taken to 
be the last dilution which inhibited the colour change. All tests 
were done at least in triplicate.
Passive Haemagglutination (PHA).
Mycoplasma antigens were adsorbed onto fixed, tanned erythrocytes 
which could subsequently be agglutinated by specific antisera. Glu- 
teraldehyde fixation was based on the method of Bing et al (1967) an<^  
the remainder of the method was based on that of Dowdle and Robinson
(1964).
a) Fixation. Sheep red blood cells (RBC) preserved in Alsevers 
solution (Wellcome) were washed 3X in PBS pH 7»2. The cells 
were resuspended to a 2^ suspension and fixed in a Vfo (v/v) 
solution of gluteraldehyde (TAAB) in PBS pH 7»2 and incubated at 
4°C for 10 minutes. The cells were then washed 3x in PBS pH 7*2 
and 3x in .distilled water. Fixed RBC when not used immediately 
were stored at 4°C for up to 1 week after resuspension to J>Qffo in 
distilled water which contained thiomercal (B.D.H.) at a level of 
1:10,000 (v/v). Fixed cells were dark brown in colour and very 
sticky; vigorous agitation was required to resuspend settled cells.
b) Tanning. Fixed RBC were washed once and resuspended to a 3i°
suspension in PBS pH 7«2 An equal volume of tannic acid (B.D.H.)
in PBS pH 7»2 was added to the blood and incubated at 37°C for 15 
minutes. Tannic acid was initially tested at concentrations of 
l/20,000, l/80,000, l/32,000 and l/l,280,000 (w/v). The optimum 
concentration was used in later tests. Tanned cells were washed 
2x in PBS pH 6.4 and resuspended to 30$ in this buffer.
c) Antigen coating. Whole cell preparations were used, (prepared
as described on page72), and immediately before use the concen­
trated antigen was diluted lOOx to restore it to the original 
volume. Further dilutions were made from this suspension. One 
volume of fixed, tanned RBC was mixed with 1 volume of antigen and 
4 volumes of PBS pH 6.4 and incubated at 37°C for 30 minutes.
Antigen was initially tested undiluted and at dilutions of l/2, 
l/4, l/8, l/l6 and l/32. The optimum concentration was used in 
later tests. Fixed tanned antigen-coated RBC were washed 3x in 
PBS + 3 (v/v) normal rabbit serum (NRS) pH 6.4 and resuspended 
to jfo. (in the first tests, bovine serum albumen was added to
the diluent but all later work was done with MBS). These cells 
were used at once or up to 1 week later when stored at 4°C with 
thiomercal at a level of 1:10,000 (v/v).
d) PHA Test. Tests were done in rigid U shaped microtitre plates
(Cooke) using a unit, volume of 0.025 ml. The diluent used through­
out was PBS + 2°lo (v/v) HRS, pH 7<2. Sera were diluted to l/lO and 
then in twofold steps as required, and tested at least in triplicate. 
Tests were set up with each well containing 2 volumes of serum 
dilution, 2 volumes of diluent and 1 volume of antigen-coated RBC. 
Plates were incubated at room temperature for 3 “ 4 hours and then 
at 4°C overnight. Settled cells frequently formed a small tight 
ring rather than a button which was not to be confused with 
agglutinated cells which formed a diffuse mat in the lower half of 
the wells. Plates could be read after 3 - 4 hours, but clearer 
results were obtained after the’overnight’incubation. 
neutralization Test.
The test was based on the metabolic inhibition test and the micro­
titre plates, titration of antigen and dilution of sera were exactly 
as described in the MI test. Initially 2 media were used: (A) the 
standard MI test medium and (b) a medium in which the horse serum in 
the MI medium was replaced with Vfo Difco PPL0 serum fraction and the 
volume made up with liquid base. Only medium B was used in later tests.
Tests were set up as in the MI test; 1 volume (0.025 ml) of 
antiserum dilution, 6 volumes of medium and 1 volume of antigen
per well. Antigen and medium controls were included in every 
test. Four replicates, rows 1 - 4> of each.test were set up, 
Completed plates were sealed with Selotape and incubated at 37°C.
A sample of the antigen culture was titrated immediately after the 
plates had been completed (0 hours) to determine the number of CFTJ 
introduced into the test. The tests were sampled initially at 24 
and 48 hours and later at 6 and 24 hours. The first sample was 
taken from row 1 and the second from row 2. Rows 3 and 4 were 
left so that the MI titre could also be determined. Samples Were 
taken by removing the Selotape covering the required row of wells 
and, with Pasteur pipettes, mixing and then removing the contents 
of each well to dilution tubes for titration in the usual way.
The titre of the serum was taken to be the last dilution that 
completely neutralized (inactivated) the mycoplasmas.
Infection of Horses
This work was carried out in collaboration with Mr. R. Burrows, Animal 
Virus Research Institute,(A.V.R.I.) Pirbright.The identities of the ponies are 
given in the Appendix.
10. Selection of Horses.
Six 5 year old Welsh Mountain geldings were selected from a group 
of 14 similar ponies. The ponies were bought at a public sale as 
6 month old foals and were then kept as a single group at A.V.R.I. 
Pirbright without direct contact with other horses. This group, and
the other pony groups at Pirbright, were deliberately kept as an 
isolated herd. They were handled by people who did not associate 
with other horses outside the Institute.
Three serum samples from each of the 14 ponies collected 1 week,
7 weeks and 14 weeks before delivery to this laboratory were tested for 
CF antibody to M.equirhinis and H3. Hone of the ponies had antibody 
to M.equirhinis but 12 of the 14 had titres against H3 ranging from 
l/lO to l/l60. The 6 ponies with the lowest H3 titres were selected 
for the experiment. A further 14 serum samples from each of these 6 
ponies which had been taken half-yearly from the age of 6 months, were 
also tested for CF antibody. Ho antibody to M.equirhinis was detected 
but each animal, from time to time, had H3 antibody at titres ranging 
from l/lO to l/80.
Housing.
The 6 ponies were separated from their group 2 days before the 
start of the experiment, and until 21 days after inoculation, were 
stabled in pairs in adjacent loose boxes in a covered yard about 25 x 
12m which was otherwise empty of animals. The control pair occupied 
the box between the 2 pairs to be inoculated. During this period the 
pairs were kept apart and attempts were made to limit the possibility 
of cross infection. On exit from each box all personnel walked 
through a disinfectant trough, and overalls and gloves were changed 
between each pair of ponies.
After the first 3 weeks, the ponies were transferred to a b a m  
and kept as a single group until 206 days after infection, when they 
were mixed with the other 8 ponies from, the original group.
Inoculation.
The ponies were inoculated 1 month after the last batch of ser.a . 
had been taken for pre-inoculation antibody screening. Two ponies 
were inoculated with M.equirhinis (l and 2), 2 with H3 (3 and 4) and 
two were untreated (5 and 6). Inoculation was by passing a naso­
pharyngeal swab saturated with about 2 ml of a fresh mycoplasma culture 
into the posterior region of the ventral meatus. The M.equirhinis
culture contained approximately 10^ CFU/ml and !the N3 culture contained 
V
approximately 10 CFU/ml. After inoculation the ponies were closely 
observed for signs of respiratory disease and rectal temperatures were 
taken daily from 1 - 16 days after inoculation.
Sampling.
a) Sera. Blood was taken from the jugular vein approximately every 3 
days for !the first three weeks of the experiment and every 2 - 3 
weeks for the following 8 months. The blood was allowed to clot 
at room temperature or at 37°C for one hour, and then overnight at 
4°C. The serum was then separated, centrifuged to remove cellular 
debris and stored at -196°C.
b) Nasal secretions. Nasal secretions were collected on days 49 > 94> 
145 > 172, 189 and 280 by placing a Lillet tampon about 50™. into one 
of the pony*s nostrils for 30 minutes. After removal, between 1 
and 10 ml of fluid could be squeezed out. The average yield was 
about 4 ml which was then stored at -196°C.
c) Swabs. Nasopharyngeal, oropharyngeal or both types of swab were 
taken immediately after the blood samples. To keep contamination 
down as much as possible samples were taken early in the morning 
before the bedding was disturbed or the ponies fed.
Nasopharyngeal swabs were taken as described by Burrows (1969) • 
Oropharyngeal swabs were taken using a "Sovereign" Sterile Culture 
Swab (Sherwood Medical Industries, Ca,t. No. 7200), which consisted 
of a soft cotton string with all but the final 10mm encased in 
transparent flexible plastic. The outer case was a semi-rigid 
transparent plastic tube with a thin gelatine cap (Fig. l). For
sampling, the pony*s head was held well up and its mouth kept open
/
by holding the longue firmly outside the mouth. The complete swab 
was passed over the back of the tongue into the pharynx where the
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plastic-encased cotton swab was gently pushed out of the semi­
rigid tube, displacing the gelatine cap. The swab was rolled 
around the pharynx and then withdrawn at least 100mm back into 
the outer case and the whole assembly was removed from the ponyfs 
mouth. The swab was later completely withdrawn from the outer 
tube in order to inoculate media.
With the aid of 2 or 3 skilled handlers, the ponies were 
repeatedly sampled without being upset. The swabbing procedure 
took 10 - 15 seconds and although the occasional misdirected swab 
was chewed, as they did not splinter or disintegrate no harm was 
done to the ponies.
/
The oropharyngeal swabs were reused between 5 and 10 times 
each after the following treatment: the plastic-encased swab and
the shielding tube were thoroughly washed and dried. The plastic 
case was cut back to expose a fresh 10mm portion of cotton string. 
The outer case was trimmed and resealed with a film of ifo agar and 
then the whole swab was re-assembled, packed in plastic bags and 
sterilized with ethylene oxide gas, (Anprolene, Anderson Products). 
Culture and Identification of isolates.
Immediately after each sample was taken, the swabs were streaked 
over a plate of HSA and then the tips were cut off into 10 ml HSB.
All cultures were incubated at 37°C within 90 minutes of sampling.
The plates were incubated in a mixture of 95^ and 5$ 00^ and 
examined for the development of colonies for up to 2 weeks. Broth 
cultures were subcultured to HSA plates at 2 and 7 days and then dis­
carded.
Identification' of mycoplasma isolates was by growth inhibition. 
Cultures were tested with hyperimmune rabbit serum against M.equirhinis, 
N3 and the Acholeplasma strains 377 and 358.
Recovery of M.equirhinis was graded semi-quantitatively from 0 to 
3, where 1 represented growth from the liquid culture or less than 10 
colonies on the streak plate, 2 represented growth in both cultures 
with less than 10 colonies on the streak plate and 3 represented growth 
in both cultures with 10 or more colonies on the streak plate, (typi­
cally more than 100 colonies).
6. Detection of Antibody.
All sera and nasal secretions were tested for complement-fixing 
antibody to M.equirhinis and N3»
7• Other Horses.
Occasionally other ponies at the Institute were swabbed (oropharyn­
geal) for the presence of mycoplasmas. These animals were kept in 
separate groups (Table 8) in covered bams about 50 yards apart and all 
were at least 150 yards away from the 6 experimental ponies at ..the  ^
start of the experiment. After 3 weeks the experimental group was 
moved to a b a m  which was about 50 yards from the nearest of the other 
groups.
' Serological Surveys
Equine sera from Varying sources were tested for complement-fixing 
antibody to M.equirhinis and N3« Two surveys were carried out, the first 
being a pilot survey to see if horses had detectable CP antibody to myco­
plasmas. The second survey was a detailed study of the occurrence and 
distribution of antibody in young racehorses. The identities of all horses 
and stables are listed in the Appendix, 
l) Survey 1. 1
256 sera were collected from 81 horses housed at 10 stables between 
1971 and 1974 (Table 3)* Hine of these stables had been selected
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because respiratory disease had at some time been reported in them, 
(Tabl,e 4) > °r because one or more mycoplasmas had been isolated from 
at least one horse in the stable. In the remaining stable (No. 6) 
the animals were neither swabbed for mycoplasma isolation studies, nor 
was clinical respiratory disease reported in the 6 test horses through­
out the sampling period.
Details of sampling dates and number of samples per horse are 
shown in Table 27 > parts 1 - 10.
Sera from Stables 1 and 2, a riding school and a private stable, 
were collected from animals between 5 and 14 years old by Mr*.* R.G-. 
Allpress, Tadworth, Surrey. The riding school horses had been at the - 
stable for at least 6 months. Sera from Stable 3 were provided by 
the Wellcome Research Laboratories, Beckenham, Kent, and these horses
v
had been collected from 2 - 5 weeks before the serum samples were - 
obtained, from various sources for slaughter. Stables 4 “ 10 were 
training stables with throughbred racehorses aged between 6 months and 
12 years. Some of these horses were sampled as foals when at stud. 
Horses from Stable 7 were b o m  in America and after arrival in England 
they spent 6 months in quarantine at a stud. The dates of transfer 
from studs to training stables are given in the Appendix. The sera 
were collected by Mr. D. Powell, Equine Research Station, Newmarket, 
as part of a Horserace Betting Levy Board survey. Although some of 
these samples were obtained directly from Mr. Powell, the majority 
were held at the A.V.R.I., Pirbright, or the Royal Veterinary College, 
London.
Sera from Stables 1 and 2 were collected immediately after 
separation from the blood and were stored at -196°C within 48 hours 
of sampling. Sera from Stable 3 were frozen at -25°C immediately 
after separation and stored for up to 2 weeks. They were allowed to
Table 4« Clinical Respiratory Disease in Survey 1 Horses
Stable Horse Dates of Illness Nature of Illness
1 4 Dec. 1973 Nasal discharge
Jul. 1974 Nasal discharge
6 Jul. 1974 Nasal discharge
2 11 Sep. 1973 Severe nasal discharge
and conjunctivitis
12 Sep. 1973 Severe nasal discharge 
and conjunctivitis
3 EL72 Mar. 1973 Nasal discharge
EL78 Mar. 19.73 Severe nasal discharge 
and high temperature
K168 Mar. 1973 Nasal discharge
KL69 Mar. 1973 Nasal discharge
EL75.. Mar. 1973 Severe strangles
4 34 Nov. 1972 Nasal discharge
35 Apr. 1972 Nasal discharge
36 May 1974 Nasal discharge
37 Jun. 1972 High temperature
38 Nov. 1972 Nasal discharge
39 Jul. 1973
Nov.73-Mar.74
Nasal discharge 
Spontaneous nose bleeds
40 Jan. 1972 
Jun. 1972
Catarrh
High temperature
5 48 Jan.-Feb. 72 ‘ Cough
49 Jan. 1972 Cough
50 Jan. 3 972 Cough
52 Jan.-Feb. 72 Cough
53 Jan.-Feb. 72 Cough
54 Jan. 1972 Cough
55 Jan. 1972 Cough '
56 _ Jan. 1972 Cough
/continued
Table 4 continued.
Stable Horse Dates of Illness Nature of Illness
7 63 Feb. 1973 Serous nasal discharge 
and high temperature
64 Feb. 1973 Purulent nasal discharge
65 Oct. 1973 Cough
8 67 Sep. 1972 
Jun. 1974
Profuse nasal discharge 
Mild respiratory disease
68 Sep. 1972 
Jun. 1974
•Profuse nasal discharge 
Mild respiratory disease
69 Sep. 1972 
Jun. 1974
Profuse nasal discharge f 
Mild respiratory disease
70 Sep. 1972 
Jun. 1974
Profuse nasal discharge J 
Mild respiratory disease^
71 Sep. 1972 
Jun. 1974
£
Profuse nasal discharge j 
Mild respiratory disease?
72 Sep. 1972 
Jun. 1974
Profuse nasal discharge { 
Mild respiratory disease;
9 73 Apr. 1974
|
Profuse nasal discharge j 
and frequent cough j
74 Apr. 1974 Nasal discharge and J 
frequent cough j
75 Apr. 1974
*
Nasal discharge and j 
cough ]
16 Apr. 1974 Nasal discharge and j 
cough . j
77 Apr. 1974 Nasal discharge and { 
cough j
78 Apr. 1974 Nasal discharge and 
cough
Data from Stables 1 and 2 provided by Mr. RCG. Allpress, Tadworth.
Data from Stable 3 provided by Wellcome Research Laboratories,Beckenham.
Data from Stables 4, 5, 7, 8 and 9 provided by Mr. D. Powell,
Equine Research Station, Newmarket.
thaw while in transit to this laboratory ( 2 - 3  hours) and on arrival 
were stored at -196°C. Sera from Stables 4 - 10 had a varied history. 
Samples had been held at -25°C for up to 2j years. Many had been 
frozen and thawed at least once, and some had been previously heated 
to 56°C for j- hour. All were sent to- this laboratory by post, which
took 24 - 48 hours. On arrival, samples were stored at -196°C.
Survey 2.
817 sera were collected from 85 yearling and 2-year old thoranghbred X  
racehorses housed at 7 stables in 1974 1975* (Table 5)» Samples
were taken within about 1 month of the horses entering the stables and 
thereafter at monthly intervals for one year. The exact date of arrival 
of each animal at the stables was not recorded. The stables were chosen 
because they had several young horses coming into training and their 
trainers were willing to keep detailed records of the management and 
health of the horses throughout the survey (Table 6). Details of sampling 
dates and number of samples per horse are shown in Table 28, parts 1 - 7«
All sera were collected by Mr. D. Powell, Equine Research Station, 
Newmarket, as part of a Horserace Betting Levy Board study on equine 
respiratory disease. After separation from the blood, sera were stored 
at -25°C for up to one month and kept at this temperature while being 
transported to this laboratory. On arrival sera were thawed and re­
stored at -196°C.
Some of these horses were also sampled for the isolation of myco- 
plasmas during the survey. Nasopharyngeal swabs were examined by 
Dr. R.M. Lemcke, Lister Institute, London, and Dr. J. Poland, Royal 
Veterinary College, London, and their results are summarized in Table 7» 
Other Serum and Nasal Secretion Samples
a) Sera from 2 equine foetuses about 7 months old were provided
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Table 6. Clinical Respiratory Disease in Survey 2 Horses
Stable Horse Dates of Illness (Nature of Illness Not Recorded)
12 97 Nov.74 - Aug.75» Oct.75
98 Nov.74 ~ Jan.75? Mar.75? Jul«75? Oct.75
99 Dec.74 - Jan.75? Mar.75? Jul.75
100 Oct.75
103 Dec.74? Aug.75
104 Dec.74? Aug.75
105 Dec.74
107 Dec.74? Aug.75
108 Jul.75
13 ill Dec.74
112 Dec.74
113 Dec.74
115 Aug. 75
117 Aug. 75
118 Aug.75
119 Aug. 75
14 121 Nov.74 - Apr.75
122 Nov.74? Feb.75? Jun.75
123 Dec.74 - Jan.75? Mar.75 i
124 Nov.74? Mar75? Jun.- Aug.75? Oct.75
125 Jan.75? Apr.75
126 Nov.74? Mar.75? Jun.75? Aug.75
127 Nov.74? Dec.74 - Apr.75
128 Nov. - Dec:74
131
____
Mar.75? Jun.75
/continued
Table 6 continued.
Stable Horse Dates of Illness (Nature of Illness Not recorded)
15 133 Oct. 75
134 Sep. 75
135 Dec. 74, Apr. 75, Sep. 75
136 Dec. 74
137 Dec. 74
138 Dec. 74? Mar. 75"
140 Nov. 75 i
141 Sep. 75
142 Jan. 75? Sep. 75
'V1—1 Jan.-Mar. 75* Nov. 75
16 145 Aug. 75
147 Dec.74-Jan.75? Jun. 75
148 May 75
149 Feb. 75, Jun. 75, Aug. 75
150 Jan. 75? Jan* 75
151 Feb. 75? Jun* 75
153 Jan. 75
17 155 Apr. 75, Jul. 75
156 Apr. 75, Aug. 75
157 Nov. 74? Oct. 75
158 May-Jul.75? Oct. 75
159 Jan. 75? May 75
160 Jan.-Feb.75? May-Jul.75? Sep.-Oct.75
161 Jun.-Jul.75
162 Jun. 75
163 May-Jul.75
/continued
Table 6 continued.
j Stable Horse Dates of Illness (Nature of Illness Not Recorded)
I64 May - Jul.75
165 Jun.75
166 Jun. - Aug.75? Oct.75
.... - -------  --  ---- — ------ - -----— -
Data provided by Mr. D. Powell, Equine Research Station, Newmarket.
Table 7» Isolation of Mycoplasmas from Survey 2 Horses
Stable
Number 
of Horses 
Swabbed
Number
of
Swabs
Number(l) 
of Positive 
Swabs
Mycoplasmas
Isolated
Number
of
Isolations
11 7 37 27 M.equirhinis 13
A.laidlawii 10
Acholeplasma sp 2
SGM (2) • 5
12 1 8 39 28 M.equirhinis 21
Acholeplasma sp 2
SGM 6
13 8 38 23 M.equirhinis 14
A.laidlawii 4
Acholeplasma sp 11
14 7 30 12 M.equirhinis '6
A.laidlawii 4
A.oculi 3
Mycoplasma sp 1
15 4 20 18 M.equirhinis 11
A.laidlawii 12
Acholeplasma sp 5
16 6 30 20 M.equirhinis 19
A.laidlawii l
17 8 39 24 M.equirhinis 16
A.laidlawii 7
Acholeplasma sp 1
SGM 1
Mycoplasma sp 1
Total 48 233 152 M.equirhinis 100
A.laidlawii 38
Acholeplasma sp 21
SGM 12
A.oculi 3
Mycoplasma sp 2
/continued
Table 7 continued.
(1) The maximum number of types from a single swab was 3
(2) SGM = Slow glucose-metabolizing mycoplasma
The data for this table were provided by Mr. D. Powell, Equine 
Research Station, Newmarket; Dr. R.M. Lemcke, Lister Institute, 
London, and Dr. J. Poland, R.V.G.,London.
by Mr. D. Goodridge, A.V.R.I. Pirbright. These samples had been 
heated to 56°C for 30 minutes before being stored at - 196°C.
b) Sera and nasal secretions from 2 approximately 10-week old foals 
were provided by Dr. J. Poland, Royal Veterinary College, London.
The foals has been inoculated intranasally with an aerosol suspension 
of live N3* Samples were available at intervals of about 1 week 
from 4 days before to 72 days after inoculation (Table 22). The 
sera and nasal samples were stored at -25°C for up to four weeks, 
posted to this laboratory and then stored at - 196°C.
Tests to determine the effects of storage of sera on CP results.
Some horse and rabbit sera were retested by CP after 20 - 30 months 
at -196°C and some after 12 months at -25°C to assess the effect of 
storage at these temperatures on the M.equirhinis and N3 antibody levels.
As some sera had been inactivated at 56°C more than once during 
previous■handling, the effect of this treatment was investigated by 
holding fresh serum samples at 56°C for 30, 60 and 90 minutes and then 
comparing, the CP antibody levels. A similar comparison was .made 
between fresh sera which had been frozen (-196°C) and thawed (25°C)
1, 2 and 3 times.
Results
Development of Techniques
Storage of Mycoplasmas.
0
The survival of liquid cultures of M. equirhinis and 377 at -25 C and 
-196°C is shown in Table 8. Strain 377 d-id- not survive storage at 
-25°C and only low levels of M. equirhinis were recoverable after 2 
weeks at this temperature. Cultures of both strains held at -196°C 
were recovered with minimal loss of titre. All' Mycoplasma and 
Acholeplasma strains stored at this temperature were preserved for at 
least 3 years without any significant loss of viability.
Cultures of both M. equirhinis and'377 were recovered from blocks 
of agar covered with colonies stored at -25°C for 2 weeks, but not 
from similar blocks stored for 2 months at this temperature. Colonies 
on agar blocks remained viable for at least 3 years at -196°C.
C omplement-Fixat ion.
a) Methodology. The titration of complement and haemolytic serum 
gave consistent results throughout the study; a l/l26 dilution of 
guinea pig serum contained 1 unit of complement and the optimum 
sensitizing concentration of haemolytic serum was between l/800 
and l/l600. For no obvious reasons, occasionally M.equirhinis 
antigen preparations were unstable and gave unreliable results 
with standard sera. Tests on different batches of antigen showed 
that sonicated M. equirhinis preparations gave the most consistent 
results with a range of complement and haemolytic serum dilutions 
(Table 9) and this type of antigen also remained stable during 
storage. N3> 377 and 358 antigens were not modified as the whole 
cells produced satisfactory results. Large batches of antigen 
were made up and tested with standard sera on at least 4 separate 
occasions before being used with test sera.
Table 8. Comparison of the Survival of M. equirhinis and 377
at -25°C and -196°C . .
Mycoplasma
ritre Before 
Storage
Titre After 2 Weeks 
at -25°C
Titre After 2 Weeks 
at -196°C
M. equirhinis 4 x 102 (l) 0 4 x 101
4 x 104: 2 x 101 . l x l O 4
3 x 108 5 x i o 1 2 x 108
377 5  X  102 : 0 4 x 101
2 x 104 0
'lbI—1X
CM
8 x 106 0 8 x 106
(l) CFTj/ml
Table 9» Activity of M. equirhinis CF Antigen Preparations
Concentration
of
laemolytic Serum
Antigen Concentration 
of Antigen
Units of Complement (HC[-n)
4 3 2.5 2
1/200 M432 (1) Neat “(5) — 20(6) 40
1/2 - - - -
1/4 — _ — —
506 (2) Beat - - ■ 20 40
♦ 1/2 - - ■ - -
1/4 _ . — —
M432 (3) Neat .20 40 40 , 40
sonicated 1/2 - 20 40 . 40
1/4 _ _ 20 20
M432 (4) Neat 40 40 40 40
boiled 1/2 - 40 40 40
1/4 _ 20 20 20
1/1000 M432 Neat - 80 160 160
1/2 - 20 - 80
| 1/4 ■ — \ _ — —
506 Neat - 20 40 40
1/2 - - - 40
1/4 — — — —
M432 Neat 40 ; 160 160 160
sonicated 1/2 - 40 40 160
1/4 — 40 40
M432 Neat 40 40 80 .] 80
boiled 1/2 20 40 40 1 40
1/4 - 40 40 I 40 ..
Tests carried out using hyperimmune horse serum.
(1) M.equirhinis strain M432.
(2) M.equirhinis strain $06.
(3) M.equirhinis strain M432.
(4) M. equirhinis strain M432.
(5) Less than l/lO.
(6) Reciprocal of titre.
Untreated antigen.
Untreated antigen.' 
Sonicated 3 minutes at 2°C. 
Boiled for 10 minutes.
The optimum concentration of antigen for all strains was the 
highest concentration that was not anti-complementary. Concen­
trations below the optimum gave markedly lower serum titres (Table 10). 
Difficulties arose as any slight variation in the test system upset 
the critical antigen concentration. The factors causing the 
variations could not be pinpointed, so to avoid worthless results 
from a large batch of unknown test sera, 3 concentrations of antigen 
were routinely used for every serum sample. . Control sera included 
in each batch of tests ensured that the results were standardized.
This system made the test workable, but it was soon discarded 
I because more reliable results were;obtained using 1 level of
antigen and 3 levels of complement representing A, 3 • and 2 HC.-^ .3U
b) Analysis of Results. Geometric means were used to assess the
average levels of antibody in horses and stables as this technique 
appeared to be the most widely ..used method of averaging titres. 
Arithmetic means gave the same overall pattern of results but the 
individual values were [higher.'
Detailed date analysis (average levels of antibody in horses 
in one stable on each sampling date) of the Survey 1 horses was 
not done because the sampling was not regular enough to make the 
results meaningful.
Growth Inhibition.
Three methods of improving the sensitivity of the GI technique 
were tested. For each method antiserum was applied on discs and in 
wells and in each case 2 discs or wells, 15 - 20mm apart were used 
on each plate. Details of the methods used and the results are given 
in Table 11. Method B with the antiserum applied in wells proved the 
most sensitive for use with hyperimmune horse sera against M. equirhinis 
and N3-
Table 10. The Effect of Antigen Concentration on CF Titre
Antigen
Antigen Concentration
2x Reat ; 1/2 1/4 1/8 1/16
M. equirhinis AC (1) 320 (2) 80 20 “ (3) -
R3 AC AC 5120 640 20 0
Tests carried out with hyperimmune horse sera gainst homologous anidgais
(1) Anti-complementary
(2) Reciprocal of CF titre
(3) Less than l/lO
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Metabolic Inhibition.
The titre of antisera against M. equirhinis and N3 was increasingly- 
enhanced by the addition of guinea pig serum (as a source of complement) 
up to a final concentration of t$o in the test medium. Without any 
complement, no inhibition of these two mycoplasmas could be detected 
(Table 12). The titre of antiserum to the Acholeplasma strain 377 
was unaffected by the level of complement in the medium. Guinea pig 
serum at a final concentration of &fo was toxic to all strains.
Passive Haemagglutination.
Bovine serum albumin (BSA) or NRS was added to the diluent in the X 
final stages of the test to facilitate the settling of the red blood 
cells. When testing rabbit hyperimmune sera, both additives were 
equally efficient, but with horse sera the addition of BSA resulted in 
non-specific titres of l/80 to l/l280 for every sample tested. NRS 
did not cause these non-specific reactions and in fact the test failed 
to detect antibody in any equine sera, including samples which were 
positive when tested by CP (Table 13) • A further 28 horse sera with 
no detectable CP antibody and 8 horse sera with CP titres of l/80 to 
1/320 were tested with only M S  diluent. All of these sera were 
negative in the PHA test.
Neutralization Test.
The test was improved by using medium B, the serum fraction medium, 
rather than medium A, the horse serum medium, as titres were increased 
and neutralization was detectable over a wider range of serum dilutions 
(Pig. 2). Maximum sensitivity was attained with a 6-hour incubation 
period, but even under the optimum conditions, neutralizing titres 
were 2 - 4  fold lower than comparable MI titres.
Table 12. The Effect of Complement on MI Titres
Mycoplasma
Complement (Final Concentration)
Of, Aio 2io 0.51o 0
M. equirhinis m  (1) 2,048 (2) 512 52 - (3)
N3 m 151,072 52,768 128 -
577 m 128 128 64 128
Tests carried out with hyperimmune rabbit seraagainst horn ologous antngais
(1) No growth of mycoplasma in antigen controls.
(2) Reciprocal of MI titre
(3) Less than l/2
Table 15« A Comparison of PHA and CF Reactions of Rabbit and Horse Sera
Against N5 Antigen
Sera
i
PHA Test * CF Test
BSA Diluent HRS Diluent
Rabbit Pre-immune
i
- - -
Rabbit Hyperimmune 65,556 (2) 65,556 40,960
K137 (1) 64O - (5) ~ ' -
KL35 1280 -• 40
K143 80 - -
X1 640 - 20
X2 ■ 1280 - 20
BS1 640 160
BS2 640 - 520
LI 640 - 80
L2 1280 - 520
H9945 640 - -
H9659 80 - 40
H9957 640 - -
H117 320 - -
KI38 640 - -
K121 320 - -
K131 1 640 - -
K133 1280 - -
3425 320 — 80
(1) Horse sera.
(2) Reciprocal of.titre.
(3) Less than l/lO
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Culture of Kvcoplasmas
Growth Kinetics.
Typical growth curves of M.equirhinis, N5. N29B, H20, 377 and 358 
cultured in HSB and pig serum broth (PSB) are shown in Fig. 3. Vary­
ing the level of the inocula above a minimum value did not greatly alter 
the growth kinetics. The minimum inocula required for growth was 
approximately 50 CFTj/ml for N3 and N20, and 500 CFU/ml for M.equirhinis, 
H29B, 377 and 358. •
M. equirhinis reached a maximum value of about 10^ CFU/ml in 2 days 
and was never recoverable from broth cultures sampled after 4 days 
growth. This mycoplasma was normally cultured in HSB and attempts to 
grow it in PSB were not always successful; however, when adapted to 
grow in this medium the growth kinetics were as in HSB.
N3 grew to a maximum titre of 10^ CFU/ml in HSB or PSB within 1 - 3
days and was usually non-viable by 6 days. N20, tested only in HSB,
8also grew very rapidly, reached a titre of 10 CFTj/ml in 24 hours and 
then declined until by 4 days it was not recoverable. N29B grew 
sluggishly in HSB to reach a maximum titre of 10 CFU/ml but the 
culture remained viable for at least 6 days; when cultured in PSB this 
mycoplasma grew to a titre of 10 CFU/ml in 24 hours and died out in
a further 48 hours. The two Acholeplasma strains, 377 and 358 grew
to a maximum titre of 10 CFH/ml in 4 - 7 days. Subsequently viability 
declined gradually and became indetectable by about 11 days. These
strains could be adapted to PSB in which they also grew slowly to a
n
slightly lower maximum titre of 10 CFU/ml.
Detailed growth studies of N14 were restricted because it grew 
poorly on solid media which made colony counts unreliable. The 
formation of colonies on agar was not only unpredictable but individual
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colonies were poorly formed and fragmented. However, the development 
of turbidity in broth cultures enabled an estimation of the growth rate 
to be made. Cultures reached maximum turbidity (judged by eye) 
between 5 and 7 days. Viability then declined rapidly as subcultures 
from 8 - 9  <lay broth cultures failed to grow. This mycoplasma was not 
investigated further because of the difficulties experienced in 
handling it.
Detailed studies of strains 506, Nil, 3451? Eq. 1> Eq. 2 and BHS 1 
were not undertaken. 506 was a strain of M. equirhinis and Nil was 
indistinguishable from N3» (Dr. R.M. Lemcke, personal communication). 
The American isolates 3451 > Eq. 1 and Eq. 2 were cultured to titres of 
approximately 10^ CPU/ml in HSB and PSB but were not investigated 
further because no information could be obtained about their source or 
previous history. BHS 1 grew well on both media but appeared to be 
a culture of two distinct colony types and no attempt was made to 
characterize it further.
Colony Morphology.
All strains except N3 and N14 produced larger and more regular 
colonies on HSA than on pig serum agar (PSA). N3 produced equally 
good colonies on both media and N14 formed the best colonies on LH 
agar. In general colony size was affected by the degree of crowding 
on the agar and- only well isolated colonies developed to the maximum 
size; furthermore such colonies often showed progressive changes in 
morphology throughout their growth. Isolated colonies of all strains 
ceased growing after 7 - 9  days, but under crowded conditions they 
appeared to reach a static state in 2 - 4 days and did not show mapy 
of the morphological changes observed in isolated colonies.
The colonies of M. equirhinis became visible by eye after 1 or 2 
days when they were about 0.25mm in diameter and when viewed with an
inverted microscope (x22 magnification) distinct central zones could 
be seen (Fig. 4)* About one day later dark crystals (due to refrac­
tive properties, not pigmentation) appeared in the peripheral region 
of the colonies (Fig. 5) and after a further day the crystals started 
to form round the edges of the colonies and over .the surface of the 
surrounding agar (Fig 6). These crystals steadily extended and 
eventually formed a complete layer over the colonies. The growth 
of isolated colonies and the accumulation of crystalline material 
stopped after 5 or 6 days by which time the colonies had a diameter 
of about 1.5nnn. Under crowded conditions colonies were covered with 
crystals after 2 days and growth apparently ceased.
N3 colonies were visible after 12 - 24 hours incubation as small, 
smooth colonies with a pin-point central zone. These colonies 
increased in size (Fig. 7) and by 4 days isolated colonies were Jwm 
in diameter after which the size increased very little but the 
appearance changed strikingly. Random dark patches and rings 
developed throughout the colonies and the formerly smooth edge became 
irregular (Fig. 8). Occasionally a distinctive atypical "multi- 
centered" type of colony arose (Fig. 9) especially after the organism 
had been subcultured successively in 3 or 4 liquid cultures and was 
then plated out. Fig. 10 shows a .normal and a multicentered colony 
of N3. .
The Acholeplasma strains 377 and 358 had similar types of colonies, 
first visible after 2 - 3  days as minute transparent smooth colonies 
with a central zone. These colonies, which reached a maximum size 
of about 0.75 - lmm diameter, did not change greatly in appearance 
as they aged except that they became slightly granular (Fig. 11) and 
concentric rings were sometimes seen. Both strains tended to produce
rather variable colonies; for instance the central zone could be dark
Fig.4 M.equirhinis 2-day colony on HSA. x60
Fig.6 M.equirhinis 4~day colonies on HSA. x60
Fig.8 N3« 7-day colony on HSA. x60
2-day "multicentered” colony on HSA
Fig.10 N3. 4-day normal and "multicentered" colonies on HSA. x60
►Fig.11 Acholeplasma 358* 4-^ay colony on HSA. x75
l b
Fig.12 Acholenlasma 377* 4~day colonies on HSA. x75
«
and well defined, faint and diffuse or almost non-existent (Fig. 12). 
Both strains after cultivation two or more times in liquid pig serum 
medium occasionally produced deeply pigmented yellow colonies when 
plated out on HSA. The presence of yellow pigment was also noticed 
in organisms deposited from dense broth cultures (HSB or PSB) by 
centrifugation.
H14 formed minute irregular and indistinct spots of growth on HSA 
or PSA (Fig. 13)« Colonies on LH agar were both more regular and 
better defined with a distinct central zone, but even then, irregular 
and fragmented colonies were observed (Fig. 14) The maximum diameter 
was about 0.3nnn.
N20, N29B, 3451 > Eq.l, Eq.2 and BHS 1 all produced typical "fried 
egg” colonies visible from as little as 1 day. Their maximum sizes 
ranged from 1mm to 1.75 nim and older colonies often developed dark 
zones, patches and rings (Figs. 15 - 20).
Hyperimmune Antisera
Rabbit Sera.
Hyperimmune sera against M.equirhinis, H3> 377 and 358 were tested 
by CF, MI and GI (Table 14)> and in addition N3 antisera was tested 
by the PHA and neutralization tests. The pre-immune sera.from each 
rabbit was negative in every test.
Complement-fixation generally gave the highest titres but there 
were also some cross-reactions which in the case of the Acholeplasmas 
were so high that specific values were only 2 times greater than the 
cross-reactions. However the CF results were highly reproducible 
and the test was relatively easy to standardize.
In contrast, the MI test, which was absolutely specific in the
Fig.13 H14. 4-day colonies on HSA. x75
Fig.14 N14. 4-day colonies on LH agar. x75
* W m *  *
Fig.15 H20. 4~day colonies on HSA. x60
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Fig.16 H29B. 4-day colonies on HSA. x60
Fig.17 5451. 4-day colonies on HSA. xlOO
Fig.18 Eql. 4-day colony on HSA. xlOO
Fig.19 Eq2. 4-day colonies on HSA. x60
Fig.20 BHS1. 4-day colonies on HSA. xlOO
Table 14« Homologous and Heterologous Reactions of
Rabbit Hyperimmune Sera Measured by CF, HU and GI
Test Antigen
Antisera
M. equirhinis N3 377 358
M. equirhinis: 20,480 (l) 160 80 80
Complement N3 160 40,960 80 160
Fixation 377 320 160 5,120 1,280
358 320 160 2,560 2^60
M.equirhinis 2,048 (1) 0 0 0
Metabolic H3 0 131,072 o ' 0
Inhibition 377 0 0 128 8
358 0 0 0 61
M.equirhinis 121 (2) 0 0 0
Growth N3 0 398 0 0
Inhibition 377 0 0 121 75
358 0 0 0 156
(1) Reciprocal of titre
2
(2) Zone of inhibition in mm
sense that no cross-reactions were detected, was difficult to 
standardize because the results were only reproducible if the antigen 
culture contained exactly 100 CCH of mycoplasmas. Any variation from 
this level caused the test to fail, or it resulted in suboptimal 
titres. The test functioned well with N3, moderately with 
M.equirhinis; but it did not give satisfactory results with the 
Acholeplasma strains. With all strains the test required close 
observation throughout the incubation period (2 - 5  days) in order to 
achieve optimum values, because once the result was readable, the • 
titre did not remain static but decreased after 6 - 1 2  hours of further 
incubation.
The growth-inhibition test was also completely specific and it was 
the simplest test to set up. The best results were obtained 
using undiluted sera, since sera diluted to more than l/lO usually 
did not cause any growth inhibition. Normally the zone of inhibition 
was completely free of mycoplasma colonies but within the zone around 
antisera to M. equirhinis small stunted colonies were frequently found 
growing right up to the edge of the antiserum-soaked disc. But after 
3 - 4  days incubation a clearly-delineated zone free from the 
characteristic crystalline layer was apparent. This zone.was accepted 
as a measure of the growth-inhibiting activity of the sera.
The PHA test detected a high level of antibody to N3 (1/64,000) 
but it also gave a cross-reaction with M. equirhinis (l/l60). The 
test was easily standardized but laborious to set up.
The neutralization test against N3 gave a titre of 1/65,536 and 
was completely free of cross-reactions against M.equirhinis, but the 
difficulties experienced in standardizing the antigen culture in the 
ME test applied equally to the neutralization test and in addition 
this test was very time-consuming to perform.
Horse Sera*
Hyperimmune sera against M.equirhinis and N3 were tested by CF,
MI and G-I (Tables 15 and 16). Antibody was first detectable 3 - 6  days 
after the primary inoculation in the animal immunized with N3> and 
7 - 1 1  days after inoculation in the M.equirhinis animal. Overall 
the response to immunization of both horses was very similar. The 
response reached a peak in 2 - 3 weeks. Thereafter antibody declined 
but following the second inoculation levels of antibody rose sharply 
to about 4 times the level of the first peak and persisted -for 2 - 3  
weeks before falling off again. The development.of antibody formed 
a pattern which was reflected by all three serological tests (Figs.21 
and 22). For both antisera the CF test was the most sensitive but 
the least specific in that there were cross-reactions with the hetero­
logous antigens. MI and GI were highly specific but less sensitive.
In contrast to the rabbit serum, hyperimmune horse sera were able 
to inhibit the development of colonies of M.eqiirhinis but the formation 
of the crystalline layer was more sensitive to the anti serum than the 
colonies and results were calculated from the zones of inhibiton of 
this layer.
The CF and MI titres recorded for the M. equirhinis sera were 
generally lower than those for N3. Furthermore the cross-reactions 
of the M.equirhinis sera against N3 detected by the CF test were so 
high that in some instances, (samples 10 and ll) they were the same 
as the homologous reaction. The cross-reactions in the CF test between 
N3 antisera and M.equirhinis were relatively small.
The horse immunized with N3 was badly injured in a fight with 
another horse about 5 weeks after the first inoculation and its health 
during the rest of the experiment was very poor; this was not apparently 
reflected in the levels of antibody formed.
Table 15. Homologous and Heterologous Reactions of Horse
M.equirhinis Hyperimmune Sera Measured by CF, MI and GI.
Serum
Sample
Days Before 
and After 
Primary (l) 
Inoculation
Test and Antigen
CF (3) MI (3) GI (4)
M.equirhinis H3 3ML equirhinis N3 M. equirhinis N3
1 -60 . -(2) 20 - - 0 0
2 -46 - 10 - - 0 ,8.6
3 0 - - - - 0 0
4 4 - '10 - - 0 8.6
5 7 - 20 10 - 0 18.9
6 i 11 80 40 40 - 75.5 18.9
7 14 80 40 40 - 113.2 18.9
8 28 320 40 20 - 113.2 0
9 35 80 40 20 - 44.0 0
10 42 40 40 20 - 30.7 8.6
11 50 20 20 20 - 75.5 8.6
12 57 80 40 20 - 75.5 8.6
13 63 160 40 40 - ■ 44.0 18.9
14 67 640 80 40 113.2 0
15 70 64O 80 80 - 156.2 0
16 74 1280 80 40 - 134.4 0
17 77 64O 80 40 - 134.4 0
18 81 320 80 40 - 156.2 0
19 84 320 80 80 - 156.2 I8.9
20 91 160 40 80 - • 113.2 0
21 100 160 40 40 - . 93.5 0
(1) Secondary inoculation on day 58
(2) - = Less than l/lO
(3) Reciprocal of titre
2
(4) Zone of inhibition in mm
Table 16. Homologous and Heterologous Reactions of 
Horse N5 Hyperimmune Sera Measured by CF, MI and GI
Serum
Sample
Lays Before 
and After 
Primary (l) 
Inoculation
Test and Antigen ' !
CF (3) MI (3) GI (4)
Mequirhinis N3 M.equirhinis N3 M.equirhinis N3 •
1 -54 -(2) 10 - - 0 0
2 -40 - 20 - - 0 8.6
3 0 - 10 - - 0 8.6
r 4 .3 - 10 - - 0 30.7
5 6 - 640 - 20 0 30.7
6 ' 10 20 1280 - 20 0 44.0
7 13 40 1280 - 40 0 44.0
8 17 40 1280 - 160 0 59.0
9 20 40 64O - 160 0 75.5
10 34 20 64O - 80 0 59.0
11 41 10 640 - 80 0 59.0
12 48 - 320 - 80 0 44.0
13 56 10 320 - 10 0 44.O
14 63 10 1280 - 40 0 30.7
15 69 10 1280 - 20 0 44.0
16 76 - 1280 - 20 0 59.0
17 80 20 256O - 160 0 156.2
18 83 10 5120 - 64O 0 156.2
19 87 40 5120 - 1280 0 113.2
20 90 20 5120 - 640 0 113.2
21 97 40 5120 - 64O 0 113.2
22 106 40 1280
- 160 0 59.0
(1) Secondary inoculation on day 72
(2) - = Less than l/lO
(3) Reciprocal of titre
(4) Zone of inhibition in mm
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Infection of Horses
Health.
Throughout the experiment there were no clinical signs of respira­
tory disease in any of the ponies housed ab the A.V.R.I., Pirbright.
In all of the experimental ponies (Nos. 1 - 6) a slight drop in 
temperature was recorded 4 - 6  days after inoculation (Fig. 23). The 
temperatures remained depressed for about a week before slowly rising. 
The pair or ponies inoculated with M. equirhinis (l and 2) were the 
first to show this pattern and also their temperatures were lowered 
for longer than the temperatures of the other ponies.
Pony 5 started to lose condition between days 21 and 42 and by day 
42 the animal was very poor, i.e. thin, in bad coat and rather depressed. 
The pony got steadily worse and had to be removed from the group on day 
144 as the other ponies prevented him from feeding. Despite special 
feeding and nursing this state persisted for about 2 months before 
the animal regained some alertness and fed better, but he continued to 
look emaciated until the end of the experiment. The cause was not 
established and no obvious equine pathogens or parasites were isolated 
from the animal.
Isolation of Mycoplasmas.
No mycoplasmas were isolated in the. samples taken immediately before 
inoculation but on day 3 M.equirhinis was isolated from pony 1 and by 
day 5 it was isolated from all 6 ponies in large numbers, indicating 
that the organism had spread naturally from the artificially-infected 
ponies to the others. The high rate of recovery continued for 6 weeks 
before dropping off to a lower level which remained fairly constant 
throughout the experiment (Tablel7).
Fig.25. Temperatures of Ponies 1 - 6  from 1 - 1 6  days after. Inoculation.
Pony 1
-
53 7 1513II
Pony 2too
15133 5 7 II
Pony 5100-
5 7 15II
Pony 4100-
-
13II 155 73
100-
53 7 13II 15
Pony 6ioo-
153 5 7 II 13
Days After Inoculation
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Some weeks after the start of the experiment M.equirhinis was also 
detected in the 8 ponies remaining from the original group of 14,
(Nos. 7 - an(l in addition from 2 other small groups, (ponies
15 - 23 and 38 - 42). M.equirhinis was not isolated from a further 
group of ponies (24 - 37)• Table 18 shows the number of isolations 
of this organism from the other pony groups, all of which were housed 
separately with no direct contact with any other horses.
M.equirhinis was isolated more frequently from oropharyngeal swabs 
than from nasopharyngeal swabs (Table 19)• From 42 paired samples 
M.equirhinis was isolated from both types of swab 13 times; from the 
oropharyngeal but not the corresponding nasopharyngeal swab 26 times, and 
from the nasopharyngeal but not the oropharyngeal swab only once. On 
two occasions no mycoplasmas were recovered from either type of swab.
At no stage was N3 isolated from any of the experimental or other 
ponies at the Institute, but throughout the study an Acholeplasma 
strain and an unidentified Mycoplasma strain were occasionally isolated. 
From a total of 162 swabs from ponies 1 - 6  the Acholeplasma strain- was 
isolated 31 times and the Mycoplasma was isolated 6 times (Table 20). 
These organisms were also found in the other ponies (Nos. 7 - 42); 
from l6l oropharyngeal swabs, the Acholeplasma was recovered on 13 
occasions and the Mycoplasma on 5 occasions.
The Acholeplasma strains partially cross-reacted in the GI test 
with Acholeplasma 358 and to a lesser extent with Acholeplasma 377.
The Mycoplasma strains did not cross-react with M.equirhinis or N3 
hyperimmune antisera and were not characterized beyond the fact that 
they produced typical small mycoplasma colonies on solid medium.
Serology.
The frequency of sampling and the occurrence and persistence of 
CF antibody to M.equirhinis and N3 in the sera are shown in Table 21.
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M.equirhinis antibody found in the nasal secretions is shown in Table 
22. Antibody was first detected about 3 months after the beginning 
of the experiment; it appeared earlier and to a higher titre in the 
nasal secretions than in the sera and persisted in individual ponies 
for 7 to 10 weeks before becoming indetectable. The appearance of 
antibody coincided with a drop in the rate of isolation of M.equirhinis 
(Fig. 24). The average CF antibody level in the nasal secretions of 
the 6 ponies reached a maximum titre of about 1/64 and the average 
serum antibody level reached a maximum of l/l6. In the group of 
animals antibody was detectable over a period of about 18 weeks.
CF antibody to 1T3 was present throughout the experiment at levels 
similar to those found In the sera collected over the previous 5 years 
(l/lO - l/80). N3 antibody was not found in any of the nasal 
secretions.
Serological Surveys
Sampling.
Serum samples from many of the horses were collected at rather 
irregular intervals (Tables 27 and 28)• Several sera intended for 
Survey 1 were not available as they had been completely used up in 
other studies by the laboratories holding the samples. Samples for 
Survey 2 were collected more consistently and were all available for 
use immediately. The few samples which were missing from individual 
animals were mostly lost because the horse had been moved to another 
training stable; it was away racing when the stable was sampled; it 
had been prematurely retired .because of injury in training or had died. 
In some cases one of the survey horses left a stable shortly after 
sampling began and another horse was substituted. In this case,
Table 22. Antibody to M.equirhinis in Nasal Secrefcions from Ponies 1 - 6
Pony MycoplasmaInoculated
Days after Inoculation
49 94 145 179 189 280
1 M.equirhinis 80* 20 - - -
2 M.equirhinis - 80 10 - - -
3 N3 ■ ■ - 20 10 - - -
4 N3 - 20 20 - - -
3 Nil - 320 - - -
6 Nil - 40 — 10 — —
* Reciprocal of titre 
- Less than l/aO
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samples from the original animal were not tested.
The Effect of Some Storage Conditions of Sera on CF Results.
a) Storage of sera at -196°C for 20 - 30 months. The results of CF 
tests carried out on 27 horse sera and 2 rabbit sera before and 
after approximately 2 years storage in liquid nitrogen (-196°C) 
are given in Table 23. In general the CF titres of the horse sera 
to M.equirhinis and N3 were unaffected by the period of storage. 
Occasionally 2-fold increases or decreases in titre were observed 
with both antigens and in one of the 58 tests, a 4-fold decrease
in N3 antibody titre was recorded (serum 3425).
Sera 9634 an<^  9645 from hyperimmunized horses were used as 
controls in every batch of CF tests carried out for the Survey 2 
sera, (a period of about 18 months), and the titres never varied 
more than 2-fold.
The rabbit hyperimmune sera showed a 2 - 4-fold drop in the 
homologous titre after storage, the heterologous titres were 
unaffected.
b) Storage of sera at -25°C for 12 months. Some horse serum samples 
showed a slight loss of titre after 12 months storage, others 
remained unchanged. No increases in the titre were recorded 
(Table 24). The antibody in the two hyperimmune rabbit sera 
deteriorated and an 8-fold drop in the homologous titres was 
apparent•
c) Heating of sera to 56°C for 30, 60 and 90 minutes. Table 25 
shows that heating sera to 56°C for up to 90 minutes instead of 
the normal 30 minute period of inactivation had no significant 
effect on the CF antibody titres.
d) Freezing and thawing of sera. Table 26 shows that the freezing 
(-196°c) and thawing (25°C) of sera up to 3 times had no significant 
effect on the CF antibody titres.
Table 25. Comparison of CF Titres Before and After
Storage of Sera at -196°C for 20 - 50 months.
Sera Titre Before Storage Titre After StorageM.equirhinis N3 M.equirhinis N3
EL31 3 (l) 20 (2) - 20 —
K131 4 40 - 40 10
50 6 320 - 160 ~
648 c 10 160 10 80
241 160 - 160 10
3425 320 80 320 20
15 66 320 10 320 10
2314 80 10 80 -
2969 80 20 80 20
3306 40 20 80 10
3944 80 40 40 40
7066 - 10 10 10
7146 - 10 - 10
7226 - 20 - 10
HI - - - -
H4 - 10 - 10
H7 - 10 - -
H10 - - - -
H14 - - - -
H15 - - - -
HI 6 40 20 40 20
H23 10 10 10 10
H24 - - - -
H25 - - - -
A15 - 40 - 40
A16 10 10 20 10
A23 40 20 40 40
9645 320 40 320 40
9634 40 1280 40 1280
Rabbit Anti
M.equirhinis 20480 160 5120 160
Rabbit Anti 
N3 160 40960 160 20480
(l) Horse Sera (2) Reciprocal of titre - Less than l/lO
Table 24. Comparison of CF Titres Before and After
Storage of Sera at -25 C for 12 months.
Sera Titre Before Storage Titre After StorageM.equirhinis N3 M.equirhinis N3
963 o (1) - 20 - 20
963 0 - 10 - 10
963 2 - 640 - 320
963 4 40 1280 40 1280
963 6 40 640 40 640
963 8 - 320 - 160
964 c - 10 - 10
964 0 - - - -
964 2 - 20 - 10
964 4 80 40 40 40
964 6 40 40 40 40
964 8 80 40 80 40
Rabbit Anti 
M.equirhinis 20480 160 1280 160
Rabbit Anti 
N 3 160 40960 80 5120
(1) Horse Sera
(2) Reciprocal of titre 
- Less than l/liO
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3. Serology.
a) Survey 1. Antibody to M.equirhinis was found in some horses in 
all of the 10 stables and antibody to N3 was found in various 
animals in all but 1 of the stables (Table 27 parts 1 - 10).
Titres of up to I/64O were recorded for both mycoplasmas. 
M.equirhinis antibody was detected in 75$ and N3 in 38$ -of the 
horses at some time during the survey.
Average antibody levels between stables varied considerably 
(Table 31) > as did antibody levels in individual horses within any 
stable. In stables 3> 7 and 9 there was very little antibody to 
either mycoplasma. In stable 3>;2 of 21 horses had low levels 
(1/40) of N3 antibody, and of 10 animals with M.equirhinis anti­
body 1 had a titre of l/80 and the rest had titres of l/40 or l/20. 
Of the 4 horses in stable 7> 1 had persistent titres of l/20 to 
both mycoplasmas for about 1 year, and 1 other horse had a titre 
of l/20 to M.equirhinis on two occasions. In stable 9 there was 
virtually no N3 antibody and very little M.equirhinis antibody 
except for 1 animal (73) which had high titres to this ..mycoplasma. 
Its antibody rose from l/40 to I/64O and then declined gradually.
Both stables 5 and 8 had high M. equirhinis titres but very low 
levels or no antibody to N3* Some of the animals in stable 5 had 
high M.equirhinis titres while a few had no antibody. Horses in 
stable 8 all had similar M.equirhinis antibody levels, and the 
titres of each horse remained constant over the 19-month sampling 
period.
In stables 1, 4 and 10, the majority of horses had M.equirhinis 
antibody at a fairly constant level for up to 27 months. IT3 
antibody was equally persistent but titres were generally lower and 
about half of the animals only in each of these stables had antibody
Table 27 (l). CF Antibody to M.equirhinis and N3 in Stable No. 1
Horse
Sample Bates Geometric
Mean
Titre10.12.73 23.1.74 8.5.74' 10.7.74 28.8.74
M.equirhinis
1 20* 80 - 20 80 19
2 20 20 20 20 160 30
3 80 - 40 80 22
4 40 80 40 40 40 46
5 80 80 40 40 80 60
6 - 40 20 20 - 7
7 80 80 80
8 40 20 20 20 40 26
9 .80 80 - 20 40 22
10 - - 20 - 64O 7
N3
1 20 20 - 20 20 11
2 - - - - 20 2
3 - - , 20 2
4 80 40 40 20 40 40
5 20 40 20 20 40 26
6 - - - - - 0
7 80 40 56
8 - 20 - - - 2
9 - - - - - 0
10 - - - - 0
* Reciprocal of titre
Blank = No sample
- Less than l/20
Table 27 (2). CF Antibody to M.equirhinis and N3 in Stable No. 2
Horse
Sample Dates Geometric
Mean
Titre
6.9.73 28.9.73
M.equirhinis
11 160* - 13
12 160 160 160
N3
11 160 320 224
12 80 320 160
* Reciprocal of titre 
” Less than l/20
Table 21 (3). CF Antibody to M.equirhinis and N3 in Stable No. 3
Horse Sample Dates M.equirhinis N3
13 13-2.73 20* -
14 12.2.73 - -
15 13.2.73 - 40
16 12.2.73 - -
17 27.2.73 20 -
18 27.2.73 - -
19 19.2.73 - 40
20 19.2.73 - -
21 27.2.73 20 -
22 19.2.73 20 -
23 27.2.73 - -
24 13.3.73 40 -
25 6.3.73 - -
26 13.3.73 20 -
27 13.3.73 - -
28 13.3.73 80 -
29 13.3.73 40 -
30 6.3.73 - -
31 6.3.73 40 -
32 6.3.73 - -
33 10.2.73
r0 -
!t 13.2.73 20
► (1)
-
ft 15.2.73 40 —
n 19.2.73 20 -
* Reciprocal of titre Less than l/20
(l) Geometric mean titre*28
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Table 27 (5). CF Antibody to M.equirhinis and N3 in Stable No.5
Horse
Sample Bates Geometric 
Mean 
Tit re14.1.72 3.2.72 9.3.72
M.equirhinis
47 40 40
48 40* 80 640 125
49 640 80 224
50 - - 0
51 - 0
52 320 40 112
53 - 20 5
54 - - 0
55 - 80 9
56 - 160 13
N^ >
47 - 0
48 - - - 0
49 - - 0
50 - - 0
51 - 0
52 - - 0
53 - - 0
54 - - 0
55 - - 0
56 — — 0
* Reciprocal of titre
Blank = No Sample
“ Less than l/20
Table 27 (6). OF Antibody to M.equirhinis and N3 in Stable Uo. 6
Horse
Sample Dates Geometric
Mean
Titre
31.10.72 9.3.73 3,8.73 14.11.73 8.3.74
M.equirhinis
57 40* . 40 40 40 80 46
58 40 80 80 40 40 52
59 20 40 40 32
60 320 80 80 40 80 91
61 160 160 40 80 80 91
62 20 40 40 80 40 40
N3
57 20 20 40 40 40 30
58 80 640 80 40 40 91
59 20 20 20 20
60 20 20 20 20 40 23
61 40 20 20 160 80 46
62 40 40 40 80 40 46
* Reciprocal of iitre 
Less than l/20 
Blank = No Sample
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Table 27 (lO). OF Antibody to M.equirhinis and N3 in Stable No.10
Horse Sample Dates GeometricMean
Titre27.11.72 1.12.72 5.4.73 25.4.73
M.equirhinis
79 40* - 160 18
80 80 80
81 80 20 40
N3
79 80 160 - 23
.80 - 0
81 - - 0
* Reciprocal of titre 
- Less than l/20 
Blank = No sample
to this organism.
Of the stahles with a reasonable number of samples available, 
stable 6 was the only one in which every horse had significant 
levels of antibody to both mycoplasmas. Titres persisted at 
moderately Constant levels for 17 months.
Stable 2, (which only had 4 serum samples), was the only yard 
in this survey with higher antibody titres to N3 than to 
M.equirhinis.
Survey 2.
Every horse developed CF antibody to both mycoplasmas at some 
time during the survey (Table 28, parts 1 - 7)* The highest 
titre recorded for either organism was I/64O.
The results of individual animals and the average titres on 
separate sampling days show that in stables 2,3,4>5 and 6 most of 
the young horses had no antibody to M.equirhinis when first sampled 
but after 1 or 2 months antibody invariably developed to a level of 
l/80 to 1/640 and then persisted throughout the sampling period at 
varying levels in individual horses. The level in most horses 
dropped slightly after the initial peak, but after about 6 months 
the titres rose slightly again in about 55$ of the horses.
N3 levels were similar to M.equirhinis but more animals had 
substantial antibody on arrival at the stables, and the rise in 
the titre over the first 2 months was not so marked.
The majority of horses in stables 1 and 7 had antibody to 
M.equirhinis in their first samples but apart from that, there 
was little difference in the overall distribution of.antibody in 
the 7 Survey 2 stables. However, the average titres of individual 
horses were very different; e.g. horses in stable 12 had average 
antibody levels to N3 ranging from l/7 to l/l95; in general there
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was a wide variation in the antibody level to both mycoplasmas in 
every stable.
Most stables had one or two animals with noticeably less 
antibody than their companions over the whole year; horses 83, 84,
101, 104, 111, 112, 121, 122, 159 and l6l had low (< l/lO) average 
titres to M.equirhinis and horses 82, 98, 114 and 117 had low (cl/lO) 
average titres to N3» Similarly some horses had consistently high 
antibody levels (average > l/l20); horses 95> 96 and 103 had high 
M.equirhinis titres and horses 107, 122, 126 and 154 had high titres 
to N3.
Overall levels of antibody to both mycoplasmas were about equal 
in stables 11 and 13, but in all the others, (12,14, 15> 16 and 17) 
the level of N3 antibody exceeded that of M.equirhinis antibody. 
Combined results of Surveys 1 and 2. The proportion of horses and 
the proportion of serum samples with detectable OF antibody to . 
M.equirhinis and N3 are shown in Tables 29 and 30» Antibody to 
both mycoplasmas was found more frequently in the second than in 
the first survey. In the first survey particularly, the average 
levels of antibody in the different stables varied widely (Table 31) • 
Six of the 10 Survey 1 stables had significant levels (over l/20) of 
M.equirhinis antibody and 2 had significant levels of N3 antibody, 
but in the second survey every stable had significant levels of 
antibody to both mycoplasmas.
Other Serum and Nasal Secretion Samples.
i) Foals inoculated with N3. Following intranasal inoculation of 
N3 two foals exhibited a rise in serum CF antibody to this 
mycoplasma (Table 32). F19 had significant levels of CF anti­
body (1/40) in the pre-inoculation sample, and the antibody 
response in this foal reached a peak 4 days after inoculation
Table 29. Horses with CF Antibody to M. equirhinis and H3
Survey
Humber
of
Horses
M.equirhinis
Antibody
io
H3
Antibody
io
Nil
Antibody
i
M.equirhinis 
and H3 
Antibody io
1 81 75 38 22 36
2 85 100 100 0 100
Table 30* Sera with CF Antibody to M.equirhinis and H3
Humber M.equirhinis H3 Hil M.equirhinis
Survey of
Sera
Antibody
i
Antibody
i
Antibody
i
and H3 
Antibody io
1 256 75 34 22 31
2 817 83 93 4 79
Table 31» Average Antibody Levels in Stables 1 - 1 7
Stable Number of Sera M.equirhinis ^ Average titre
N3 t
Average titre
Survey 1
1 46 23* 4
2 4 45 118
3 24 6 1
4 50 30 4
5 19 15 0
6 28 56 38
7 19 3
V
2
8 33 39 2
9 27 4 1
10 6 30 5
Survey 2
11 134 43 39
12 119 24 45
13 116 30 28
14 128 30 70
!5 110 35 50
16 97 57 86
17 113 20 43
* Reciprocal of titre 
"f Geometrib means
Table 32. CF Antibody to N3 in Inoculated Foals
Bays Before and 
After Inoculation
F19 F20
Serum NasalSecretions Serum
Nasal
Secretions
-4 40* - - . _ .
4 160 - 10 -
10 80 - 10 -
18 80 - 20 -
25 -
51 80 - 20 -
37 40 - 40 -
45 20 - 4° -
52 20 - 20 -
58 20 20
66 20 - 20 -
72 10 20
* Reciprocal of titre 
-Less than l/lO 
Blank = No sample
and then gradually declined over the next 10 weeks. Antibody 
in F20 reached a slight peak about 6 weeks after inoculation.
No OF antibody was detected in any of the nasal secretions, and 
no antibody was detected against M.equirhinis in any of the 
samples.
ii) Foetal Serum. Sera from two 7-month old equine foetuses had 
no OF antibody to M.equirhinis and N3«
Discussion
Mycoplasmas
When the study was started in August 1972, only 4 mycoplasma isolates 
had been made in England, and over the next 2 years the tally was increased 
to 14 isolates from a total of 328 nasopharyngeal swabs (Allam and Lemcke 
1975) plus 9 isolates from the tracheas of 21 slaughtered horses (Windsor 
1973 9 Allam and Lemcke 1975)- Subsequently, these 23 isolates were divided 
into 7 species of which the M.equirhinis and N3 types were apparently the 
only specific equine strains and these organisms were thus chosen for the 
majority of the work in this study. The Acholeplasma strains were not 
investigated further as Acholeplasmas have only rarely been implicated as 
pathogens in other animal species. (McDuffie and Imura (1970) and Stip- 
kovits et al (1974b) have associated A.granularum and A .axanthum with 
arthritis in swine, and Ross (1973) reviewed reports of the involvement of 
A.granularum and A.laidlawii in swine pneumonia). M.felis and M.pulmonis 
organisms were not used as it was probable that these mycoplasmas were 
casual inhabitants of the equine respiratory tract picked up from the 
bedding or fodder after contamination by other animals. These strains
had formerly been isolated only from cats and rodents. However, by the
end of 1974 the M.felis type appeared to occur quite frequently in horses 
and claimed the largest number of isolates, 9 of Allam and Lemcke’s and 
Windsor’s 23 strains. It was also isolated by Dr. J. Poland (personal 
communication) from a trachea swab and Kirchhoff(1974) reported 17 strains 
of this type, (referred to as M.equipharyngis) isolated from the respira­
tory tract of horses.
In England isolation studies were continued on a regular basis for a 
further year (October 1974 - November 1975) and in this period there was 
a sudden increase in the rate of isolations from nasopharyngeal swabs from 
the 4io recorded in the 2-g- years up to October 1974 to 65fo; that is, myco-
plasmas were isolated from 152 of 233 swabs, and furthermore several swabs
/
yielded more than one strain (Dr. R.M. Lemcke and Dr. J. Poland, personal 
communication).
M.equirhinis has proved to be a very common equine parasite, being 
isolated regularly from every stable sampled from October 1974 to November 
1975> and it accounted for 57^ of the total number of organisms recovered. 
The Acholeplasmas, at least 3 separate strains, comprised 355^  and the 
remaining &fo were unidentified strains of Mycoplasmas.
The reasons for this increased isolation rate were not clear. Naso­
pharyngeal swabs were used throughout the study and were all taken by the 
same man using a standard procedure; all reached the laboratory within 6 
hours of sampling. Throughout the study a wide range of media was used 
for inoculation with the swab material but growth occurred randomly on any 
of the media (Allam and Lemcke 1975)* The only obvious change in the 
method employed in the last year was that the transport medium, formerly 
Difco PPLO broth alone, was supplemented with jfo pig serum and bacterial 
inhibitors (Dr. R.M. Lemcke, personal communication). A comparison of 
the efficiency of the two transport media was not done, so whether the 
improved medium was responsible for It he vastly improved rate of isolation 
or whether there were fluctuations in the mycoplasma population inhabiting 
the nasopharynx cannot be determined.
During the spate of M.equirhinis isolations, N3 was conspicuous by its 
absence. After the first two isolations, made within a fortnight in 1972, 
the mycoplasma has not been recovered from live or slaughtered horses.
The organism was unlikely to have been a laboratory contaminent as no 
mycoplasmas of the same type had been handled in that laboratory for .2 
months and indeed, although it shows some serological cross-reactions with 
M.mycoides and M. capri, it seems to be a distinct strain which had not 
previously been described (Dr. R.M. Lemcke, personal communication).
However, since the organism has proved very elusive, it must he regarded 
with some suspicion as a very rare equine inhabitant, or it could be assumed 
that the site sampled and isolation techniques used were not suitable for 
the recovery of this organism.
M.felis and M.pulmonis also were not isolated from any of the horses 
sampled in the last year. The disappearance of the M.felis type from the 
scene is even more inexplicable than that of N3> considering the prominence 
of this group in the early studies. Because it was isolated easily in 
different laboratories under different conditions, it was unlikely to have 
been affected by the minor changes in the media used for culturing the swab 
material, and the possibility that the natural hosts of M.felis and 
M.pulmonis, i.e. cats and rodents, have been excluded from all contact with 
horses in 7 different stables is even more remote.
At this stage it is clear [that not enough is known about the distri­
bution of equine mycoplasmas to say which species are normal inhabitants of 
the respiratory tract and which are not, and if the population of any
species, whether commensal or pathogenip, fluctuates from time to time or not.
Hyperimmune Ant is era
Immunized rabbits produced satisfactory levels of serum antibody which 
was used to evaluate the sensitivity and specificity of various serological 
assay techniques. Rabbit hyperimmune sera were also used throughout the
study to identify or check the purity of cultures.
Rabbits immunized with N3 produced the most potent sera, while those 
immunized with the Acholeplasmas produced the weakest sera which may be 
partly due to the method used to prepare the antigens prior to immunization. 
All cultures were harvested at their maximum titre and concentrated to 100 
times their original volume; thus the titre injected into rabbits of N35
12 11 10M.equirhinis and the Acholeplasmas was about 10 ,10 , and 10 CFTj/ml
respectively. The N3 rabbits therefore received a substantially higher 
• dose of antigenic material than the Acholeplasma rabbits, but this probably 
does not entirely account for the low levels of antibody. Mycoplasma and 
Acholeplasma cell membranes, which are major antigenic components of the 
organisms, differ considerably in lipid composition. The Acholeplasma 
membrane lipids contain about 4•5‘fo cholesterol and Yfo carotenoids in 
contrast to the approximately 36fo cholesterol of the parasitic mycoplasmas 
(Razin 1969) and this would contribute to a difference in antigenicity 
between the 2 types of cells. Alternative methods of preparation of the 
Acholeplasma antigen or a varied immunization schedule may have resulted 
in the production of a more potent antiserum.
The two horses showed a normal response to primary and secondary 
immunization and produced good levels of specific antisera, but again the 
titre of the N3 serum was higher than that of the M.equirhinis serum. The 
speed of the response of the N3 animal to immunization coupled with the 
evidence of low levels of antibody present in the serum before the first 
injections indicated that the animal had probably previously encountered 
the antigen in the form of a natural infection.
Serological Tests
Complement-fixation proved the most sensitive test for use with horse 
serum and mainly for this reason was chosen for the study of sera from 
racehorses and infected ponies. Other advantages of the CP test over the 
other serological tests were the comparative ease of operation, the standard 
incubation period, the consistency of the results and the fact that the test 
did not have to be carried out under strict aseptic conditions. The large 
number of serum samples to be investigated made these factors very valuable.
The cross-reactions of the M.equirhinis sera were high in some samples but 
the specific MI and GI tests detected such low levels of . antibody in the 
hyperimmune horse serum that CP was considered the more useful technique.
Many of the advantages of the CP test were shared by the PHA test and 
the results were of comparable specificity and sensitivity, but this test 
was not used for any of the survey work because of the lengthy method of 
preparation and very poor storage life of the antigen-coated red blood 
cells. Furthermore, PHA compared very poorly to CP for the detection of 
antibody in equine sera. The titres obtained when BSA was used in the 
diluent were almost certainly not directed against H3 as all traces of 
activity disappeared when NRS was substituted. However, the high reactions 
observed when BSA was used might have indicated a specific reaction between 
bovine protein and antibovine antibody in the horse. Most horses and 
ponies are immunized against tetanus and many against influenza also, and 
it is possible that traces of bovine protein from the media in which these 
organisms were cultured were present in the vaccines and thus elicited an 
antibody response in the horses. This theory was not followed up as sera 
from young animals known not to have been immunized were not available at 
the time the PHA test was being investigated.
The GI test was unsuitable for the survey of equine sera because of its 
insensitivity but the modified agar-well technique was successfully !• used 
to compare the levels of antibody in sequential samples from hyperimmunized 
horses. The main value of the GI test was as a quick and simple method 
of checking the identity and purity of stock cultures and fresh isolates.
Metabolic inhibition proved to be an unreliable test. It could be 
exceedingly sensitive under the optimum conditions, as demonstrated by the 
titre of 1/131,072 recorded for the reaction between N3 antigen and homo­
logous rabbit sera, and in general the performance of the test with this 
antigen was moderately consistent. But when applied to the M.equirhinis
antigen the test often gave odd results and had to be repeated several times 
to obtain a result that could be considered valid. Even worse results were 
recorded with the Acholeplasma antigens. The success of this test m a y  be relate 
to the ease of handling the antigen culture. N3 cultures grew rapidly to a 
completely predictable titre and they were absolutely trouble-free to prepare. 
M.equirhinis cultures grew more slowly and demanded great care in preparation 
if they were to perform reliably. The Acholeplasma cultures grew very slowly 
and the maximum titres were always lower than those of the other cultures.
The function of unheated guinea pig serum as a source of complement in GI
and MI tests has been much discussed, (Sethi and Teschner 1969, Davies 1969b,
Taylor-Robinson and Berry 1969, Riggs and Sharp 1970, Coleman et al 197^), an(l 
the beneficial effect of complement on the titre has been amply demonstrated
for many mycoplasma species. However, the inhibition of other strains has
been shown to be unaffected by complement and in some cases unheated guinea 
pig serum alone was inhibitory to mycoplasmas (Freundt 1952). The inhibition 
of N3 and M.equirhinis was greatly enhanced by complement but the titre of the 
Acholeplasma 377 antiserum was ■unchanged when tested with several dilutions of 
guinea pig serum. It seemed that the techniques used were not well suited 
to demonstrate the immune inhibition of Acholeplasmas.
The neutralization test had no advantages over the MI test either in ease 
of technique or sensitivity of results, but the mycoplasma static and mycoplas- 
macidal effects of the antiserum could be clearly differentiated in this test 
as it involved a direct assessment of the numbers of viable cells.
Infection of Ponies
1. Re-isolation of Mycoplasmas.
M. equirhinis was inoculated into only two ponies but it apparently
spread within 5 days to the other 4 ponies despite precautions to 
prevent the transfer of infection on the hands and clothing of the 
handlers, and a few weeks later the mycoplasma was also detected in 
other groups of ponies. The 6 experimental ponies which were housed 
in adjacent loose boxes were probably infected by airborne spread of 
the organism, but this is less likely to have occurred with the other 
groups which were all housed at least 50m away in separate covered 
yards. The most probable explanation was that the organism survived 
in the upper respiratory tract of the animal attendants and the 
infection was spread from group to group during normal handling 
procedures.
The sampling of other groups was determined by chance factors, the 
most important of which was the availability of the handlers, since 
rounding-up, catching and sampling even a small group of ponies took 
at least 3 people and usually 4 a minimum of 1 hour. However, if 
visits to the experimental group happened to coincide with the times 
when other groups were being sampled for other studies, it was some­
times possible to take advantage of the fact that the animals were 
being caught, and mycoplasma swabs could be taken without inconveni­
encing the staff. Also, as the staff at the Institute became 
accustomed to the method of swabbing and saw that the ponies were not- 
upset by the procedure, the opportunities to sample other groups 
increased. Because these other groups were only sampled occasionally 
it was difficult to draw any conclusions about the extent of the spread 
to these ponies. Results from the experimental group show that 
although the overall rate of isolation was high for 6 weeks after 
infection, the mycoplasma was only isolated regularly from every pony 
for the period of 5 - 14 days after infection. Results from the 
occasional sampling of the other groups gave no clue to the date when
these ponies were first infected, or the stage of the infection at the 
time of sampling. The possible dates of infection of the other ponies 
Was also complicated by the differing degree of handling experienced by 
each group. The 6 experimental ponies were, at the beginning of the 
experiment, handled more frequently than any of the other groups at the 
Institute for two reasons, -firstly, the regular sampling and daily 
temperature checks required by the experiment, and secondly the small 
loose boxes were cleared out every day. Other groups housed in large 
covered yards were bedded on deep litter which did not require daily 
attention. Some of the other groups were being caught and sampled 
for other studies, some were very occasionally given ridden exercise 
and others were only caught for a blood sample approximately every 2 
months. In addition, some groups were naturally friendly while other 
groups were extremely nervous and kept as far away from all humans as 
possible. The group from which no mycoplasmas were isolated (Nos. 24 
- 37) was in fact the shyest group at the Institute.
The M.equirhinis infection in ponies 1 - 6  persisted throughout 
the experiment (280 days) and this re-isolation of mycoplasmas from 
the respiratory tract several months after infection has been noted 
in other animal species. Whittlestone et al (1972) regularly isolated 
M.pulmonis from the lungs of rats naturally exposed to this mycoplasma 
from 50 to 715 days after infection, and Whittlestone (1975) reported 
that organisms resembling M. suipneumoniae were detected in the lungs of 
pigs infected with this organism 7 to 262 days previously. M.mycoides 
has been isolated from 10-month old sequestrated lung lesions in cattle 
(Turner 1954)*
The ease with which the mycoplasmas were isolated from the ponies 
was unexpected because as noted previously, at the start of the experi­
ment the isolation rate from nasopharyngeal swabs reported by Allam
and Lemcke (1975) was very low and for this reason extensive swabbing 
of the ponies before inoculation was not thought worthwhile.
The possibility that M.equirhinis was endemic in the pony herd 
before the start of the experiment was thought to be unlikely because 
the swabs taken just before inoculation revealed no mycoplasmas, and 
no CF antibody was detected in the large number of sera collected from 
the experimental group over the previous 5 years. This absence of 
M.equirhinis antibody contrasted markedly with the results of the two 
surveys of equine sera in which 75/ and 100/ of horses tested had 
antibody to this mycoplasma.
It was unfortunate that only nasopharyngeal swabs were used for 
the day 0 and day 3 samples as the oropharyngeal swabbing technique 
later proved superior for the isolation of M.equirhinis. Neverthe­
less, based on the results obtained from the comparison of the 
swabbing methods, there should have been at least 2 positive isolations 
from the nasopharyngeal swabs on both days 0 and 3 if the organism were 
present at the same level that it was on days 5 “ 42. In fact there
were no isolations on day 0 and only 1 isolation on day 3> so, combined 
with the serological evidence, it seemed probable that the ponies had 
not encountered M.equirhinis before it was introduced in the experiment. 
The fact that the oropharyngeal swabs proved more efficient than the 
nasopharyngeal swabs for the isolation .of M.equirhinis suggested that 
the organism was an oropharyngeal parasite, and this observation has 
been made in relation to other respiratory mycoplasmas (Taylor-Robinson
1975).
The inability to re-isolate N3 in. the pair of ponies which were 
inoculated with the organism could have been accounted for in several 
ways. The mycoplasmas might have become so adapted to laboratory 
media that they lost the ability to infect horses, or conversely, (but
far less likely), an infection might have been successfully established 
but after passage in horses, the mycoplasmas might have altered their 
nutritional requirements and no longer have been able to grow on 
laboratory media. Alternatively, the mycoplasmas might have been 
unable to establish themselves in the pharynx in the face of circulating 
antibody which was not only detectable originally but was maintained 
throughout the experiment. It was also feasible that the mycoplasmas 
were lower respiratory tract parasites and thus inaccessible to -swabbing 
but if such an infection did occur, it did not have any detectable effect 
on the antibody levels.
It seems improbable that small numbers of N3 were masked by the 
large numbers of M.equirhinis present because in the laboratory N3 bad 
a faster growth rate and was generally more robust than M.equirhinis.
Because of the failure to isolate N3 from any horses since 1972 
the possibility that the mycoplasma may not be an equine parasite cannot 
be ignored, and if this were the case it would be surprising if an 
infection were established after the simple intranasal inoculation of 
the mycoplasma. Workers experimenting with well extablished myco­
plasma pathogens frequently experienced considerable difficulty in 
successfully infecting the host species under laboratory conditions. 
Contagious bovine pleuropneumonia was particularly difficult to produce 
experimentally and early researchers were convinced that some other 
agent was involved as the disease could only be produced by inoculation 
of suspensions of infected lung homogenate (Campbell 1958) or inocu­
lation of the organism (M.mycoides) with chopped agar, blood clots or 
egg material (Daubney 1955 > Hudson 1965). Gourley (1964) concluded 
that the virulence of individual strains and stress factors were also 
important. Inoculation directly into the trachea or bronchi, or 
inhalation of infective aerosols were not always successful in producing
pleuropneumonia in cattle and if the animal did contract the disease 
the lesions were not typical of those found after natural-infection.
In the natural state the aerosol produced by an infectious animal is 
of varying droplet size and contains a complex mixture of inflammatory 
exudate, products of lung degeneration and mycoplasmas (Lloyd and 
Trethewie 1970).
Thus the experimental infection of ponies with mycoplasmas of 
uncertain specificity for equines could only be a hopeful attempt to 
mimic the process of natural infection.
Serological Response.
The 3 month period between infection and the peak of the antibody 
response probably indicated that under the conditions of the experiment 
M.equirhinis was not very invasive and it existed on the mucosal 
surface of the respiratory tract for some time without eliciting a 
detectable CF antibody response. The mechanisms by which mycoplasmas 
reach the local lymph nodes from the respiratory epithelial surface 
:are poorly understood (Whitt lest one 1972a) but the M.equirhinis anti­
body response was very slow in comparison to that produced by many 
pathogenic mycoplasmas. Davies (1969a) detected CF antibody in cattle 
10 days after artificial infection with M.mycoides and Roberts (1968) 
found CF antibody in pigs artificially infected with M .hyopneumoniae 
after a similar time.
The approximately 10 week duration of the M.equirhinis antibody 
response in the infected ponies was short compared with the 12 month 
period in which antibody was detectable in racehorses, and it is 
difficult to speculate on the incongruity of these observations, 
particularly as mycoplasmas were isolated from both groups throughout 
the periods of study, -9 months for the ponies and approximately 12 
months for the racehorses. The pony group were artificially infected
with a mycoplasma strain that had been handled in the laboratory and 
passed several times on acellnlar media while the racehorse group 
were presumably naturally infected with a wild strain; either of these 
factors could have caused a stronger antibody response .in the race­
horses. Although there is no evidence for the existence of variants 
of M.equirhinis, it is possible that the strain used for the infection 
experiment had become attenuated to some degree by subculture in 
laboratory media. Some virulent M.mycoides strains can be measurably 
attenuated by as few as 10 subcultures in broth (hyson and Smith 1976). 
Wild M.equirhinis strains may be more virulent than the laboratory 
strain and promote a longer-lasting antibody response. Immunogenicity 
of M.mycoides strains has been shown to be at least partly related to 
virulence (Sheriff and Piercy 1952) and Fernald and Clyde (1970) 
reported vaccine studies with virulent and avirulent strains of 
M.pneumoniae which indicated that strain variation was an important 
determinant of the immune response to this mycoplasma.
The ponies led a quiet, unstressed life and were not brought into 
contact with any other equines; the racehorses were subjected to 
exactly the opposite conditions. Continuous contact with strange 
animals and humans, possibly carrying the mycoplasma may have kept the 
antibody levels boosted throughout the year in the racehorses. In 
contrast to the ponies, the racehorses frequently had clinical symptoms 
of respiratory disease and mixed infections of mycoplasmas and viral 
or bacterial agents may have stimulated higher levels of mycoplasma 
antibody than levels resulting from an infection with mycoplasmas 
alone. Even the age difference between the two groups could have 
contributed to the two patterns of antibody response. Which, if any, 
of these factors accounted for the difference in duration of the CP 
antibody is impossible to determine from this study.
It was interesting that M.equirhinis was recovered consistently 
from the pharynx of all 6 ponies up to the time of the appearance of 
nasal and serum antibody, but much less frequently thereafter, which 
suggested that the antibody inhibitied the multiplication of the 
organism in situ. The organism, however, was not eradicated and it 
continued to be re-isolated at a low rate from the oropharynx when 
antibody was no longer detectable by complement-fixation. The 
inability of specific antibody to eradicate the organisms against 
which it is directed has been noted in other mycoplasma infections. 
Biberfeld and Sterner (1969) reported that M.pneumoniae persisted 
in the respiratory tract of humans in the presence of specific secretory 
antibody, and in cattle although CP titres may remain at low levels for 
several months after the acute phase of bovine pleuropneumonia, myco­
plasmas continue to be excreted (Cottew and Leach 1969). It was 
believed that titres persisted until the organisms were no longer 
present, but in some cases antibody apparently completely declined 
leaving viable organisms in sequestrated lung lesions. Such animals 
became carriers and potential spreaders of the disease despite their 
healthy appearance and lack of detectable antibody.
The antibody found in both the nasal secretions and the serum 
samples was detected by the same technique, complement fixation.
It is generally thought that the dominant immunoglobulin present in 
nasal secretions is IgA, and that IgA does not fix complement, (Tomasi 
and Bienenstock 1968). The possibility that IgG or IgM had leaked 
out from the serum to the nasal secretions was contraindicated because 
the serum antibody developed later and to a lower titre than the nasal
antibody. The nature of the immunoglobulins present in the nasal
\
samples collected from the experimental ponies was not investigated 
because most of the samples had been used up and collection of further
positive samples was not possible in the time left for completion of 
the study.
Pahud and Mach (1972) and McGuire and Crawford (1972) have reported 
the isolation of horse secretory IgA and have dennmstrated that it is • 
the predominant immunoglobulin in saliva, mature milk, nasal and 
bronchial secretions, but the functional properties of equine IgA had 
not been investigated because of the difficulty experienced in identi­
fying and isolating it. McGuire and Crawford (1973) summarized the 
properties of the equine immunoglobulins in a table but they have left 
the question of the reactions of IgA unanswered, and Roberts, reviewing 
the equine immune system in 1975 > reprinted the table without being 
able to add anything about the characteristics of IgA.
IgA can now be readily prepared from donkeys, but it is still very 
difficult to isolate in a pure form from horses, mules or zebras,
(Allen et al 1976) and its properties, including the ability to fix 
complement, have not yet been investigated.
Ogra and Morag (1975) reviewing the immune system in the human 
respiratory tract, noted that although 11S IgA predominated in external 
secretions, appreciable quantities of IgG, IgM, 7SIgA and IgE are 
contained in many secretions and these may be largely produced, locally 
at secretory sites. If such a system occurred in the horse, the CF 
activity in the nasal secretions of the-infected ponies could be due 
to IgG or IgM antibodies produced independently of the serum immuno­
globulins •
The immunological response to intranasal inoculation shown by the 
experimental ponies of nasal antibody followed by lower titre serum 
antibody has been reported by other workers investigating antibody 
response to vaccination in humans and horses. Waldman (1969) showed 
that intranasal or oral immunization with live or inactivated influenza
or parainfluenza viruses in human volunteers commonly caused a stronger 
local than serum antibody response while parenteral immunization had 
the opposite effect. Ogra and Karzon (1969) demonstrated that intra­
nasal immunization with inactivated polio vaccine elicited a. naso­
pharyngeal antibody response in the absence of any detectable response 
in the serum. Montgomery et al (1976) reported that intranasal or 
oral immunization of horses with a non-infective agent resulted in a 
response in which the secretory antibody was detected in advance of 
the serum response and the titres of the secretory IgA exceeded those 
of the serum IgG.
Health of Ponies.
None of the ponies showed any signs of respiratory disease, but 
the 6 experimental ponies all showed a drop in temperature shortly 
after infection; nevertheless this was so slight that it was difficult 
to attach any significance to this observation, especially as no pre­
experiment temperatures were recorded.
The very poor condition which developed in pony 5 a few weeks after 
the start of the experiment was most unusual in a 6-year old animal 
which had a history of good health and excellent maintenance. None 
of the common equine maladies could be implicated and it was thought 
that the pony might be suffering from a type of chronic grass sickness. 
The etiology of grass sickness remains a mystery and this normally 
lethal disease had not been recorded in the south of England before 
an isolated outbreak at the A.V.R.I. Pirbright the previous year, 
(Spring 1974)» in which several animals died. One other pony at the 
Institute, a 3-year old filly, developed a similar but not so severe 
condition at the same time as pony 5«
M.equirhinis showed no signs of pathogenicity in these ponies but 
it may play a role in respiratory disease when acting synergistically
with other respiratory tract parasites, or when the animals are under 
conditions of stress such as during training or transportation. The 
differences between stolid mature 5-year old pony geldings and highly- 
strung immature 2-year old thoroughbred colts and fillies are so great 
that it would be difficult to predict the effect of a mycoplasma 
infection on the latter group from the results of experiments carried 
out on the ponies.
Serological Surveys
Storage of Serum Samples.
The tests designed to assess the effects of the previous handling 
of the sera on the M.equirhinis and N3 CF antibody titres confirmed 
that the equine antibody was unaffected by storage at -25°C, but the 
hyperimmune rabbit sera lost some of their potency at this temperature. 
The thawing and re-freezing, to which most of the sera were subjected, 
and the heating to 56°C for hour of all the racehorse sera leaving 
the A.V.R.I. Pirbright, appear unlikely to have affected adversely the 
CF antibody levels, but as these factors were tested individually and 
not in combination, the possible detrimental effect of previous 
handling cannot be disregarded. However, of the three Survey 1 stables 
from which serum samples were directly available, one had antibody to 
both mycoplasmas; one had high levels against M.equirhinis and low 
levels against N3> and the third had low 'M.equirhinis antibody and 
virtually no N3 antibody. The antibody levels in these stables were 
similar to those observed in the other 7 stables, so from these results 
there was no reason to suspect that the "secondhand” sera had deterior­
ated before reaching this laboratory. Storage, of equine and rabbit 
sera in this laboratory at -196°C proved very satisfactory, and the
loss of titre, after 2 years of storage was negligible.
Survey 1.
The high frequency of complement-fixing antibody probably reflected 
a significant response to some form of specific infection and the fact 
that the antibody to M.equirhinis was more frequent and present at 
higher levels than the N3 antibody implied that M. equirhinis infections 
were the more common, or that they more readily stimulated humoral 
antibody.
Every stable had some horses with antibody to one or both of the 
mycoplasmas, but there were considerable differences between the average 
levels in each stable. In general, the stables which had a group of 
horses together for some time, and had frequent contact with strange 
horses and people, tended to have more antibody than the other stables.
Stables 3>7 and 9 had very little antibody to either mycoplasma.
The stable 3 horses were quite different from the other groups in that 
they were collected from various sources for slaughter, and had only 
been together for 2 - 5  weeks. These horses were likely to have been 
relatively isolated in their previous homes, and it was possible that 
neither M.equirhinis nor N3? if present in any of the animals, could 
have spread to the other horses and elicited an antibody response by 
the time the horses were sampled.
The 4 horses from stable 7 had been brought from America, and had 
spent their first 6 months in England in quarantine before being 
transferred to a training stable. The very low titres (l/20) shown 
by 2 animals are of doubtful significance. It is not known how much 
contact these horses had with other animals, but if they were in full 
training and were racing, they were unusual in not producing CF antibody.
Stable 9 is interesting because it is the only one of 4 apparently
similar racing stables, (Nos. 4>6,8 and 9) in which the horses had 
almost no antibody. However, compared to animals in the other 3 
stables, these were almost certainly kept in relative isolation, 
because throughout the time when serious training and racing would 
normally begin, (Spring 1974)> all these horses were afflicted with 
respiratory disease, and were coughing. Coughing horses cannot be 
worked without risk of permanent lung damage, and cannot be taken on 
a racecourse without causing much indignation among other trainers, 
so these animals would have been kept quietly at home.
The only animal to have significant levels of antibody in this 
stable, (9), was horse 73» which developed a high titre (1/640) of 
M.equirhinis antibody; this then gradually declined. This horse was 
also the worst affected by the respiratory disease. Stable 9 'was the 
only stable to have 1 horse with high M. equirhinis titres and no 
detectable antibody in any of the other animals, and it is not known 
if horse 73 was isolated from the rest because of its severe respira­
tory symptoms, and was the only one to become infected with this 
mycoplasma. Alternatively, this may have been the only animal with 
M.equirhinis antibody because the severe respiratory disease in the 
animal may have facilitated an infection with the mycoplasma.
The other stables consisted of training yards, a riding school 
and a private yard; each of these groups had been formed for at least 
three.. months» and because of the nature of their work, had been 
regularly in contact with animals and humans from other ‘equine 
establishments. M.equirhinis antibody was found in all these stables 
and every animal for which there were more than 2 samples available 
either had antibody or developed it by the time the third sample was 
taken. The occurrence of N3 antibody in these stables was strikingly 
different; 2 stables, (5 and 8) had negligible antibody; in 3 stables,
(1,4 and 10) some of the horses had antibody, and in only one stable 
(6) every horse had antibody. These observations suggest that N3 was 
neither as common, nor as infectious as M.equirhinis.
It is interesting to speculate on the degree of contact between 
horses which is necessary to spread the mycoplasmas, (presuming that a 
positive CF titre means that the animal has been infected). M.equirhinis 
antibody was so abundant that it is probable the organism was airbo.rne 
spread, but this was less likely with H3* If a study of sfcables 6, 1 
and 4 showed that the animals in stable 6 (where every horse had N3 
antibody) were managed differently from the animals in the other 2 
stables, (where only some animals had antibody to 1T3)> it might he 
possible to gain some insight into the mode of spread of this mycoplasma. 
Survey 2.
Every horse had CF antibody to both mycoplasmas at some time during 
the survey, and the levels of N3 antibody were slightly higher than 
the M.equirhinis levels in five stables, and approximately equal in 
the other two stables. Infection with _the two mycoplasmas appeared 
equally common. The development of M.equirhinis CF antibody seen in 
many of the horses after 1 - 2  months at the training stables indicated 
that the animals had become infected with this mycoplasma shortly after 
their arrival. Several horses had U3 antibody before entering the 
stables, but those that did not, acquired it within: two months, again 
probably as the result of an infection with the organism.
The transition from the studs, where the animals had spent all 
their lives in a very relaxed manner, to the training stables and their 
rigorous routine, stressed the horses considerably, and that, combined- 
with the immaturity of the animals, made them particularly vulnerable 
to infections. In a busy yard, where horses were constantly moving 
to and from public sales, public training grounds and race meetings,
'the young horses inevitably came up against all the common equine 
parasites and pathogens. The results of virus studies on the same 
horses (Mr. h. Powell, personal communication), showed that many of 
these animals also experienced rhinovirus type 1, Swiss rhinovirus 
(RH2), rhinopneumonitis virus (H45) and adenovirus infections in this 
period and, as expected, clinical signs of mild respiratory disease were 
frequently reported.
Except for illustrating the initial lac!k of antibody in several 
stables, and then the acquisition and general persistence of antibody 
throughout the year, the average titres of groups of racehorses in one 
stable sampled on one day, are not very informative because the dates 
of entry of each horse to the stables were not recorded. Animals 
arrived at the stables over a period of at least one month, so the 
exposure of horses to the various infectious agents found in training 
yards was unsynchronized. In addition, the handling of the horses 
was not standardized, (each having an individual programme of exercise, 
travelling and racing), and this undoubtedly influenced the course of 
the infections and subsequent antibody responses in each animal. 
Comparison of Results of Surveys 1 and 2.
The two surveys gave conflicting results on the occurrence and 
distribution of CP antibody to both mycoplasmas. In the first survey, 
75$ of horses had antibody to M.equirhinis and 38$ had antibody to U3; 
in the second survey, every horse had antibody to both mycoplasmas.
Once antibody to either or both mycoplasmas had developed, horses in 
both surveys tended to exhibit the same persistence of antibody at a 
roughly constant level throughout the remainder of the sampling period.
It is difficult to compare the results of the separate surveys for 
two reasons. Firstly, Survey 1 was a pilot study, to. see if horses 
had mycoplasma antibody and the stables were purposely chosen to include
a wide range of animals of varying age, (6 months to 14. years), kept 
under different conditions. Animals included racehorses, hacks, 
ponies and a miscellaneous group of old, unsound or unwanted horses 
collected for slaughter. The second survey animals were all of one 
type and were sampled at a period of their lives when they were 
expected to come in contact with several infectious microbes for the 
first time. These horses were all thoroughbreds, 88$ of which were 
about 18 months old and the remaining 12$ were about 30 months old 
when first sampled.
Secondly, far more sequential samples were available from each 
horse in the second survey, thus increasing the chance of finding 
antibody in any one animal. The other factor in which the surveys 
differed was the uncertain history of the first survey samples, but 
for reasons already discussed, the antibody was unlikely to have 
deteriorated during previous storage of the sera and the CF titres 
obtained from these sera were considered representative of the anti­
body levels present in the horses at the time of sampling.
Taking all the above factors into account, there is some justi­
fication for a comparison of the two sets of results, and it is clear 
that in the second survey far more samples had antibody to both 
mycoplasmas, implying that infection with both these organisms, 
particularly N3> was more frequent in the second survey than in the 
first completed about 2 years previously. Certainly M.equirhinis 
was commonly isolated from the Survey 2 horses (Dr.R.M. Lemcke and 
Dr.J. Poland, personal communication); whereas at the time the first 
survey samples were taken, the rate of isolation was very poor, 
(Allam and Lemcke 1975)*
Despite the very common occurrence of N3 antibody in Survey 2, 
attempts to isolate this mycoplasma from horses have largely failed,
which casts some doubt on the specificity of the antibody. Of the 
horses in the recent survey, 80$ of both the 18 and the 30-month old 
animals coming into training had N3 antibody in the first sample and 
the remaining 2Qffo acquired antibody shortly after arrival. In the 
first survey only 38$£ of horses of all ages had antibody to N3. The '
6 experimental ponies at the A.VoR.I. Pirbright had antibody at 6 months 
old, but two 7-nionth equine foetuses had no detectable CP antibody to 
either mycoplasma. Of the pair of foals deliberately infected with 
N3 at about 10 weeks old at the Royal Veterinary College, one developed 
antibody after infection and the other had antibody in the pre-infection 
sample-which rose to a slight peak after infection and then declined.
It was possible that this animal could have encountered the mycoplasma 
before it was due to be infected. These observations show that N3 
antibody was acquired by animals at different stages in their lives 
which suggests that the antibody was produced in response to an infection 
by a specific agent and was not a non-specific serum factor.
In conclusion, the presence of antibody in immunized and infected 
horses gave some confidence that the antibody in racehorses was both 
significant and. specific. However, the contribution of mycoplasmas 
in the production of clinical respiratory disease cannot be determined 
from these studies and similarly, whether the M.equirhinis and U3 
humoral antibody developed as a result of a single mycoplasma infection 
or a mixed infection with viral and bacterial agents is not clear.
The level of mycoplasma antibody developing in any animal may also be 
dependent on concurrent viral or bacterial infections, and if different 
infections predominate in the various stables, it may explain the 
differences in the average myoplasma antibody levels observed in these 
stables.
The first survey has shown that horses develop specific antibody
to mycoplasmas and the second survey has provided a lot of data about 
the occurrence of respiratory parasites and the corresponding serology 
at a critical point in the life of a young racehorse. A much more 
detailed and controlled study of fewer animals, and mixed infection 
experiments, are necessary to determine the sequence of infection and 
the relative importance of each agent in the aetiology of respiratory 
disease.
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Appendix
Identity of Horses and Stables
Hyperimmunized Horses. Wellcome Research Laboratories, Beckenham, Kent. 
Horse immunized with M.equirhinis Number 964 B o m  1966 or earlier 
Horse immunized with N3 Number 963 B om 1966 or earlier
Infection Experiment. 
Pony Number 
1 
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20 
21
Animal Vims Research Institute, Pirbright, Surrey.
Name
Amie
Dennis
Ian
Herbert
Mac
Clint
Bamie
Eddie
Finn
George
Luke
Neil
Owen
Sam
Ella
Emma.
Greta
Jennie
Nicky
Pam
Peggy
Year of Birth
1969 
1969 
1969 
1969 
1969 
1969 
1969 
1969 
1969 
1969 
1969 
1969 
1969 
1969
1962 approx.
1969
1964 approx. 
1964 approx. 
1964 approx. 
1964 approx. 
1964 approx.
Pony Number Name Year of Birth
22 Simone 1962 approx.
23 Stephanie 1964 approx'.
24 Ann 1971
25 Alvis 1971
26 Betsy 1971
27 Claire 1971 ‘
28 Dot 1971
29 * Dora 1971
30 Elma 1971
31 Elsie 1971
32 Freda 1971
33 Gwen 1971
34 Hattie 1971
35 Hannah 1971
36 Petula 1971
37 Sindy 1971
38 Colonel 1968 approx.
39 Major 1968 approx.
40 Michael 1966
41 Monty 1968 approx.
42 Hitch 1968
Survey No.l
Horse Number Name Year of Birth
Stable No. 1 Oaks Park. (Riding School).
1 Toby Between I960-
2 Blue Mist I960-
3 Bond I960-
56
7
8
9
10
abl€
11
12
able
1.3
14
15
16
17
18
19
20
21
22
23
24
25
26
Name Year of Birth
Dobbin
Firenza
Danny Boy
Mijenka
Corvette
Lady Beth
Follow
Between 1960-69 
1960-69 
1960-69 
1960-69 
1960-69 
1960-69 
1960-69
Orchard Farm. (Private Hacks).
Bloody Sunday 
Lusty
Not known 
Not known
Wellcome Research Laboratories. (Slaughter Horses).
K137/BHS3
H9943/BHS2
H9659/BHS4
H9957/BHS1
H121/BHS12
K138/BHS9
KL35/BHS8
KI43/BHS6
H117/BHS11
K133/BHS7
K160/BHS10
K178/BHS21
K169/BHS16
K166/BHS17
K172/BHS18
1965 or earlier 
1968
1965 or earlier 
1968 
1969
1965 or earlier 
1965 or earlier 
1965 or earlier
1969
1965 or earlier 
1965 or earlier 
1965 or earlier 
1965 or earlier 
1965 or earlier 
1965 or earlier
Horse Number Name Year of Birth
28 K175/BHS19 1965 or earlier
29 K159/BHS20 1965 or earlier
30 K148/BHS13 1965 or earlier
31 KI53/BHSI4 1965 or earlier
32 K168/BHS15 1965 or earlier
33 K131/BHS5 1965 or earlier
Stable No. 4 Castle. (Racehorses).
34 Brava 1971
35 Bywater 1968
36 Carlevaris 1971
37 Farsighted 1970
38 Humming Top 1971
39 Night Talk 1971
40 Only A Monkey 1970
41 Lucien 1971
42 Broadway Bear 1971
43 Chilli Girl 1971
44 Galoprise 1971
45 Hard Ruler 1971
46 Mister Moon 1971
Stable No. 5 Hall Place. (Racehorses).
47 Golden Top Not known
48 Limbus 1968
49 Mariners Lantern Not known
50 Ramrig , Not known
51 Lucky Paddy Not known
Horse Number Name Year of Birth
52 Garden Boy Not known
53 Red Coat Not known
54 Scorched Earth Not known
55 McKenzie Not known
56 Mayflower Not known
Stable No. 6 Clivedon Stud. (Racehorses. Transferred to Seven Barrows
October 1973V*
57 Bygone 1972
58 Minton 1972
59 No Alimony 1972
60 One Over Parr 1972
61 Rose Amber 1972
62 Sgt. Bibot 1972
Stable No. 7 Solario Stud. (Racehorses. In quarantine from America.
Transferred to St. Gatien April 1973~T^  '
63 Veeraswamy 1971
64 Escorale 1971
65 Flying Diplomat 1971
66 Rulers Princess 1971
Stable No. 8 Mentmore Stud. (Racehorses. Transferred to Palace
September 19737*
67 Busmans Holiday 1972
68 Chil The Kite 1972
69 Cricket Match 1972
70 Hanger-On 1972
71 Red Roan 1972
72 Song of Solomon 1972
Stable No. 9 Carlburg Stud. (Racehorses. Transferred to Clarehaven
~ April 1975l«
Horse Number Name Year of Birth
73 Master Petard 1972
74 Singing Lad 1972
75 Bitty Boy 1972
76 Feather Top 1971
77 Soldier's Tale 1972
78 Thornton Green 1972
Stable No. 10 Caldecote. (Racehorses).
79 Crusader Not known
80 Mountain Ash Not known
81 Star Studded Not known
Survey No. 2
Stable No. 11 Castle. (Racehorses. Same stable as No. 4 in
Survey No. l).
82 Glastonbury 1973
83 Glimmer 1973
84 Man Of Harlech 1973
85 Gartree Hill 1973
86 Sterling Gold 1973
87 Trusted 1973
88 Beau Castel 1973
89 Welsh Goddess 1973
90 Palmerston 1973
91 Roderick Dhu 1973
92 Pink Paddy 1973
93 Bridstow 1973
Horse Number Name Year of Birth
94 Queen of Navarre 1973
95 Persian Dawn 1973
96 Little Tern 1973
Stable No. 12 St. Gatien. (Racehorses).
97 Net Call 1973
98 Cereum 1973
99 Antimacassar 1973
100 ' Diamond Bill 1973
101 Harry Hall 1973
102 Fools Rush In 1973
105 Hay Ride 1973
104 Swallow Son 1973
105 Bariole 1973
106 Melion 1973
107 Bally Knoud 1973
108 Tutorial 1973
Stable No. 13 50 Acre Bam. (Racehorses).
109 Mad Carew 1973
110 Grace Aureole 1973
111 Emijo 1973
112 Night Story 1973
113 Hey Presto 1973
114 Alanrod 1973
115 Nice Romance 1972
116 Orchid 1972
117 Noble Affair 1972
Horse Humber Hame Year of !
118 Spring Barley 1972
119 Irene’s Girl 1973
120 Hight Sky 1972
Stable Ho. 14 Clarehaven. (Racehorses').
• 121 Sassy Cat 1973
122 Royal Major 1973
123 Early Dawn 1973
124 - All Hope 1973
125 Lucastown 1973
126 .Stingo 1973
127 Artist Boy 1973
128 Spring Hope 1973
129 Young Pip 1973
130 Green Hope 1973
131 Tanella 1973
132 Welsh Petal 1973
Stable Ho. 15 West Ilsley^ (Racehorses).
133 Valuation 1973
134 Katmandu 1973
135 Bel Fallas 1973
136 Smuggler 1973
137 Hunstanton 1973
138 Regalian 1973
139 Sea Legs 1973
140 Over To You 1973
141 Relkino 1973
Horse Humber 
142 
143
Hame
Rehearsal
Arapaho
Year of Birth
1973
1973
Stable Ho. 16 Palace House. (Racehorses).
144 Ebony Rock 1973
145 Gwent 1973
146 Harlequin 1973
147 Hiliarchos 1973
148 Le Chat 1973
149 Renda 1973
150 Everything Hice 1973
151 Pass The Port 1973
152 Victorian Habit 1973
153 Royal Flare 1973
154 Grey Baron 1973
Stable Ho. 17 Highfield. (Racehorses).
155 King Zeus 1972
156 Solaire 1973
157 Pearl Wedding 1972
158 La Carrageen 1972:
139 African Star 1972
160 Carrigbeg Prince 1973
161 Merry Matelot 1972
162 Abrovian 1973
163 Derby 1972
164 Main Chance 1973
165 Widgeon 1973
166 Broomley 1973
5. Additional Serum Samples.
Animal Virus Research Institute, Pirbright, Surrey.
EF1 7 month equine foetus
EF2 7 month equine foetus
Royal Veterinary College, London.
PI9 10 week old foal
P20 10 week old foal
